Processing 00000000.tx.1: Molecular imaging: novel tools in visualizing rheumatoid arthritis A. 

Phrase: "Molecular imaging"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1537028:Molecular Imaging [Diagnostic Procedure]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: ":"

Phrase: "novel tools in visualizing rheumatoid arthritis A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0336791:Tool [Manufactured Object]
   714   C2827396:Tool [Manufactured Object]
Processing 00000000.tx.2: Wunder, R. 

Phrase: "Wunder,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.3: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: Straub, S. 

Phrase: "Straub,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.5: Gay1, J. 

Phrase: "Gay1,"

Phrase: "J."
Processing 00000000.tx.6: Funk and U. 

Phrase: "Funk"

Phrase: "and"

Phrase: "U."
Processing 00000000.tx.7: Mller-Ladner Division of Rheumatology and Clinical Immunology, Department of Internal Medicine I, University of Regensburg, Germany and 1 World Health Organization Collaborating Centre for Molecular Biology and Novel Therapeutic Strategies for Rheumatic Diseases, University of Zrich, Zrich, Switzerland. 

Phrase: "Mller-Ladner Division of Rheumatology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1293097:Division [Therapeutic or Preventive Procedure]
   760   C2919030:Division [Organization]
   760   C2919031:Division [Activity]

Phrase: "and"

Phrase: "Clinical Immunology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1319413:Clinical immunology [Biomedical Occupation or Discipline]
   861   C0152036:Immunology [Biomedical Occupation or Discipline]
   861   C1522005:immunology [Qualitative Concept]
   789 E C0205470:Immunological [Functional Concept]

Phrase: "Department of Internal Medicine I,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "University of Regensburg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: "and"

Phrase: "1 World Health Organization Collaborating Centre for Molecular Biology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0475309:Health center [Health Care Related Organization,Manufactured Object]
   742   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Novel Therapeutic Strategies for Rheumatic Diseases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679199:strategies [Mental Process]

Phrase: "University of Zrich,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0041740:University [Manufactured Object,Organization]

Phrase: "Zrich,"

Phrase: "Switzerland."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]
Processing 00000000.tx.8: Correspondence to: A. 

Phrase: "Correspondence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "A."
Processing 00000000.tx.9: Wunder, Experimental Neurology, Charite Hospital, Humboldt University, Schuhmannstrasse 20/21, 10098 Berlin, Germany. 

Phrase: "Wunder,"

Phrase: "Experimental Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "Charite Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Humboldt University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Schuhmannstrasse 20/21,"

Phrase: "10098 Berlin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005125:Berlin [Geographic Area]

Phrase: "Germany."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]
Processing 00000000.tx.10: E-mail: andreas.wunder{at}charite.de  Abstract Top Abstract Background Development of novel molecular... 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "andreas.wunder{at}charite.de  Abstract Top Abstract Background Development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0243107:development [Physiologic Function]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]

Phrase: "of novel molecular..."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
Processing 00000000.tx.11: Imaging modalities Recent advances in molecular... 

Phrase: "Imaging modalities Recent advances in molecular..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0725066:Advance [Medical Device]
Processing 00000000.tx.12: Molecular imaging in RA Outlook References  Molecular imaging is a rapidly emerging field in biomedical research, aiming at the visualization, characterization and quantification of molecular and cellular processes non-invasively within intact living organisms. 

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "imaging in RA Outlook"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   806   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   760   C0003864:Arthritis [Disease or Syndrome]
   760   C0004271:Outlook [Mental Process]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0079595:Imaging [Diagnostic Procedure]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Molecular imaging"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1537028:Molecular Imaging [Diagnostic Procedure]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: "is"

Phrase: "a rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "emerging"

Phrase: "field in biomedical research,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0683945:field research [Research Activity]
   770   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   770   C1521738:Field [Conceptual Entity]
   770   C2346620:Field [Conceptual Entity]
   770   C2349184:Field [Conceptual Entity]
   770   C3539073:FIELD [Spatial Concept]

Phrase: "aiming at the visualization,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0175631:Visualization [Mental Process]
   770   C2827662:Visualization [Occupation or Discipline]
   737   C1947946:Aim [Idea or Concept]
   737   C2948600:Aim [Pharmacologic Substance]
   737   C3540471:AIM [Gene or Genome]
   737   C3540472:AIM [Functional Concept]

Phrase: "characterization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "quantification of molecular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709793:Quantification [Quantitative Concept]

Phrase: "and"

Phrase: "cellular processes non-invasively within intact living organisms."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C0007613:Cellular Process [Cell Function]
   754   C1325880:cellular process [Cell Function]
   711   C1184743:Process [Body Part, Organ, or Organ Component]
   711   C1522240:Process [Phenomenon or Process]
   709   C0031845:Organismal Process [Physiologic Function]
Processing 00000000.tx.13: To sense biological processes such as gene expression, angiogenesis, apoptosis or cell trafficking in vivo, imaging reporter agents that interact specifically with molecular targets and appropriate imaging systems are currently under development. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: "biological processes such as gene expression,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1517486:Gene Expression Process [Genetic Function]
   790   C0031845:Biological Processes [Physiologic Function]
   719   C1184743:Process [Body Part, Organ, or Organ Component]
   719   C1522240:Process [Phenomenon or Process]

Phrase: "angiogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "or"

Phrase: "cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "reporter agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "interact"

Phrase: "specifically with molecular targets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   770   C1521991:Molecular [Qualitative Concept]
   737   C1521840:Target [Functional Concept]
   737   C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "appropriate imaging systems"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   884   C2697665:Imaging System [Manufactured Object]
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "are"

Phrase: "currently under development."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0243107:development [Physiologic Function]
   790   C0521116:Currently [Temporal Concept]
   790   C0678723:Development [Organism Function]
   790   C1527148:Development [Functional Concept]
   718 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.14: In rheumatoid arthritis, these novel tools will be used to evaluate physiological and pathophysiological processes, to facilitate diagnosis and monitor therapeutic regimens, to enable reliable prognosis and to support the development of new therapies. 

Phrase: "In rheumatoid arthritis,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]

Phrase: "these novel tools"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0336791:Tool [Manufactured Object]
   827   C2827396:Tool [Manufactured Object]

Phrase: "will"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "physiological"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205463:Physiological [Functional Concept]
   928 E C0031842:Physiology [Biomedical Occupation or Discipline]
   928 E C0031843:physiology [Physiologic Function]

Phrase: "and"

Phrase: "pathophysiological processes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "therapeutic regimens,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1276413:Therapeutic regimen [Therapeutic or Preventive Procedure]
   861   C2945654:regimens [Intellectual Product]
   827 E C0040808:Regimen [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "reliable prognosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033325:Prognosis [Health Care Activity]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the development of new therapies."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
   745   C0556496:Developmental therapy [Therapeutic or Preventive Procedure]
   745   C1522647:Developmental Therapy [Research Activity]
Processing 00000000.tx.15: In this review, we summarize the basic principles of molecular imaging, such as the development of molecular imaging agents, the actual capabilities of different imaging modalities and the most recent advances in molecular imaging, demonstrating the potential of this technology. 

Phrase: "In this review,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "we"

Phrase: "summarize"

Phrase: "the basic principles of molecular imaging,"

Phrase: "such as the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of molecular imaging agents,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]
   734   C1537028:Molecular Imaging [Diagnostic Procedure]

Phrase: "the actual capabilities of different imaging modalities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C2698977:Capability [Qualitative Concept]

Phrase: "and"

Phrase: "the most recent advances in molecular imaging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0725066:Advance [Medical Device]

Phrase: "demonstrating"

Phrase: "the potential of this technology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.16: With regard to their applicability in rheumatic diseases, we discuss potential molecular targets, current experimental approaches and the future prospects for molecular imaging in rheumatoid arthritis. 

Phrase: "With regard to their applicability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C1272460:applicable [Qualitative Concept]
   928   C1706839:Applicable [Qualitative Concept]

Phrase: "in rheumatic diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0035435:Rheumatic Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "we"

Phrase: "discuss"

Phrase: "potential molecular targets,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   793   C1521840:Target [Functional Concept]
   793   C2986546:TARGET [Diagnostic Procedure]

Phrase: "current experimental approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]

Phrase: "and"

Phrase: "the future prospects for molecular"

Phrase: "imaging in rheumatoid arthritis."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   833   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   770   C0003864:Arthritis [Disease or Syndrome]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.17: KEY WORDS: Magnetic resonance tomography, Nuclear imaging, Optical imaging, Radiography, Ultrasound  Background Top Abstract Background Development of novel molecular... 

Phrase: "KEY WORDS"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "Magnetic resonance tomography,"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   901   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]

Phrase: "Nuclear imaging, Optical imaging,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]
   756   C0042789:Vision [Organism Function]
   756   C2707266:Vision [Clinical Attribute]

Phrase: "Radiography,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0034571:radiography [Functional Concept]
  1000   C0043299:radiography [Diagnostic Procedure]
  1000   C1962945:Radiography [Diagnostic Procedure]
   928 E C0444708:Radiographic [Natural Phenomenon or Process]
   900 E C1306645:Radiograph [Diagnostic Procedure]
   900 E C1548003:Radiograph [Intellectual Product]

Phrase: "Ultrasound  Background Top Abstract Background Development of novel molecular..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0243107:development [Physiologic Function]
   742   C0678723:Development [Organism Function]
   742   C1527148:Development [Functional Concept]
Processing 00000000.tx.18: Imaging modalities Recent advances in molecular... 

Phrase: "Imaging modalities Recent advances in molecular..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0725066:Advance [Medical Device]
Processing 00000000.tx.19: Molecular imaging in RA Outlook References  Diagnosis and monitoring of rheumatoid arthritis (RA) by imaging techniques is difficult and restricted almost exclusively to the anatomical level. 

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "imaging in RA Outlook"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   806   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   760   C0003864:Arthritis [Disease or Syndrome]
   760   C0004271:Outlook [Mental Process]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0079595:Imaging [Diagnostic Procedure]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Diagnosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "monitoring of rheumatoid arthritis (RA)"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   881   C0588350:Rheumatoid arthritis monitoring [Health Care Activity]
   819   C0554833:Arthritis monitoring [Health Care Activity]
   773 E C0419873:Gout monitoring [Therapeutic or Preventive Procedure]
   770   C0150369:Monitoring [Health Care Activity]
   770   C1516647:monitoring [Research Activity]

Phrase: "by imaging techniques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079595:Imaging Techniques [Diagnostic Procedure]
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]

Phrase: "is"

Phrase: "difficult"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332218:Difficult [Qualitative Concept]
   928 E C1299586:Difficulty [Finding]

Phrase: "and"

Phrase: "restricted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443288:Restricted [Functional Concept]

Phrase: "almost exclusively to the anatomical level."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0220784:Anatomical [Qualitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.20: The majority of current imaging methods used in clinical medicine, especially radiography, X-ray computed tomography (CT), magnetic resonance tomography (MRT) and ultrasound, rely predominantly on energy/tissue interactions. 

Phrase: "The majority of current imaging methods"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680220:majority [Social Behavior]

Phrase: "used in clinical medicine,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0008964:Clinical Medicine [Biomedical Occupation or Discipline]
   770   C0013227:Medicine, NOS [Pharmacologic Substance]
   770   C0025118:Medicine [Biomedical Occupation or Discipline]
   770   C0205210:Clinical [Qualitative Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "especially radiography,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0034571:radiography [Functional Concept]
   861   C0043299:radiography [Diagnostic Procedure]
   861   C1962945:Radiography [Diagnostic Procedure]
   789 E C0444708:Radiographic [Natural Phenomenon or Process]
   761 E C1306645:Radiograph [Diagnostic Procedure]
   761 E C1548003:Radiograph [Intellectual Product]

Phrase: "X-ray computed tomography (CT),"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
  1000   C0040405:Tomography, Xray Computed [Diagnostic Procedure]
           computed tomography
           tomography
   923   C0040404:Tomography, X-Ray [Diagnostic Procedure]
   861   C0034571:X-ray [Functional Concept]
   861   C0043299:X-ray, NOS [Diagnostic Procedure]
   861   C0043309:X-ray [Natural Phenomenon or Process]
   861   C1306645:X-ray [Diagnostic Procedure]
   861   C1552357:Computed Tomography [Professional or Occupational Group]
   861   C1962945:X-ray [Diagnostic Procedure]
   812   C0040395:tomography [Diagnostic Procedure]
   812   C0086894:ray [Fish]
   812   C0851346:ray [Natural Phenomenon or Process]
   812   C1441526:Computed [Laboratory Procedure]
   812   C1880157:Computed [Activity]
   812   C2314876:ray [Fish]

Phrase: "magnetic resonance tomography (MRT)"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   901   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]

Phrase: "and"

Phrase: "ultrasound,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041618:Ultrasound [Diagnostic Procedure]
  1000   C0041621:ultrasound [Natural Phenomenon or Process]
  1000   C0220934:ultrasound [Functional Concept]
  1000   C1456803:Ultrasound [Natural Phenomenon or Process]
  1000   C1875843:ULTRASOUND [Medical Device]

Phrase: "rely"

Phrase: "predominantly on energy/tissue interactions."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0040300:Tissue [Tissue]
   760   C0424589:Energy [Finding]
   760   C0542479:Energy [Natural Phenomenon or Process]
   760   C1442080:Energy [Quantitative Concept]
   760   C1547928:Tissue [Intellectual Product]
   726   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.21: Most contrast agents are unspecific and do not interact with specific molecular targets. 

Phrase: "Most contrast agents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009924:Contrast Agents [Indicator, Reagent, or Diagnostic Aid]
   861   C1979874:Contrast [Qualitative Concept]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "are"

Phrase: "unspecific"

Phrase: "and"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interact with specific molecular targets."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   760   C0205369:Specific [Qualitative Concept]
   760   C1521991:Molecular [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]
   726   C1521840:Target [Functional Concept]
   726   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.22: Therefore, the contrast necessary for (computerized) visualization to differentiate pathological from normal tissue is based on anatomical, physiological or metabolic heterogeneity rather than identifying specific cellular or molecular events that underlie disease. 

Phrase: "Therefore,"

Phrase: "the contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "necessary for"

Phrase: "(computerized"

Phrase: ")"

Phrase: "visualization to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0175631:Visualization [Mental Process]
   861   C2827662:Visualization [Occupation or Discipline]

Phrase: "differentiate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205615:differentiate [Qualitative Concept]

Phrase: "pathological from normal tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030664:Pathological [Biomedical Occupation or Discipline]
   770   C1521733:Pathological [Functional Concept]

Phrase: "is"

Phrase: "based on anatomical, physiological"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   802   C2987514:Anatomical base [Body Location or Region]
   770   C0205463:Physiological [Functional Concept]
   770   C0220784:Anatomical [Qualitative Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   761   C0237066:anatomy physiology [Biologic Function]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "or"

Phrase: "metabolic heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "rather than"

Phrase: "identifying specific cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0007634:Cellular [Cell]
   827   C0178539:Cellular [Functional Concept]
   755 E C1516377:Cellularity [Qualitative Concept]

Phrase: "or"

Phrase: "molecular events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "that"

Phrase: "underlie"

Phrase: "disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.23: In RA, articular bone erosion and joint space narrowing are relatively well delineated by conventional radiography. 

Phrase: "In RA,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]

Phrase: "articular bone erosion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0587240:bone erosion [Pathologic Function]
   827   C0333307:Erosion [Acquired Abnormality]
   827   C1880549:EROSION [Phenomenon or Process]
   827   C1959609:Erosion [Pathologic Function]
   706   C0545594:joint bone [Body Space or Junction]

Phrase: "and"

Phrase: "joint space narrowing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1859695:Joint space narrowing [Finding]
   827   C0332463:Narrowing [Spatial Concept]
   827   C0333164:narrowing [Quantitative Concept]
   734   C0224497:Joint space [Body Space or Junction]

Phrase: "are"

Phrase: "relatively well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "delineated by conventional radiography."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034571:radiography [Functional Concept]
   770   C0043299:radiography [Diagnostic Procedure]
   770   C0439858:Conventional [Qualitative Concept]
   770   C1962945:Radiography [Diagnostic Procedure]
Processing 00000000.tx.24: In the past, high-resolution ultrasound, and especially MRT, have improved substantially the ability to detect and visualize initial destruction during the first stages of RA, sometimes even preceding the clinical symptoms necessary to establish diagnosis, but still report relatively late in the course of the disease and do not provide any information about cellular and molecular mechanisms [13]. 

Phrase: "In the past,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444637:Past [Temporal Concept]

Phrase: "high-resolution ultrasound,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0041618:Ultrasound [Diagnostic Procedure]
   827   C0041621:ultrasound [Natural Phenomenon or Process]
   827   C0220934:ultrasound [Functional Concept]
   827   C1456803:Ultrasound [Natural Phenomenon or Process]
   827   C1875843:ULTRASOUND [Medical Device]
   734   C1719039:High resolution [Laboratory Procedure]

Phrase: "and"

Phrase: "especially MRT,"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   861   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   861   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   861   C1551403:Magnetic resonance [Laboratory Procedure]
   812   C0024488:Magnetic [Occupation or Discipline]
   812   C0040395:tomography [Diagnostic Procedure]
   812   C0040405:tomography [Diagnostic Procedure]
   812   C0231881:Resonance [Finding]
   812   C0459800:resonance [Natural Phenomenon or Process]
   812   C0563532:magnetic [Natural Phenomenon or Process]
   812   C0684213:Resonance [Qualitative Concept]
   741 E C0024483:Magnet [Manufactured Object]
   741 E C0577554:Resonant [Qualitative Concept]
   741 E C0885556:magnets [Pharmacologic Substance]
   741 E C1706318:Magnet [Manufactured Object]

Phrase: "have"

Phrase: "improved"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0184511:Improved [Qualitative Concept]
  1000   C0332272:Improved [Qualitative Concept]
  1000   C1561611:Improved [Intellectual Product]

Phrase: "substantially"

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "and"

Phrase: "visualize"

Phrase: "initial destruction during the first stages of RA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1261381:Destruction [Therapeutic or Preventive Procedure]
   742   C1948029:Destruction [Activity]

Phrase: "sometimes even"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1998882:Sometimes [Temporal Concept]

Phrase: "preceding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:Preceding [Temporal Concept]

Phrase: "the clinical symptoms necessary to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0683368:symptoms [Functional Concept]
   812   C1457887:Symptoms [Sign or Symptom]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "diagnosis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]

Phrase: "but"

Phrase: "still"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "relatively late in the course of the disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0242656:disease course [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0205087:Late [Temporal Concept]
   744   C0750729:Course [Temporal Concept]

Phrase: "and"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "any information about cellular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1533716:Information [Idea or Concept]

Phrase: "and"

Phrase: "molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "[13"

Phrase: "]."
Processing 00000000.tx.25: Recent advances in the molecular basis of disease, the development of target-specific imaging agents, and new developments in the field of imaging are increasingly allowing the non-invasive evaluation of cellular and molecular events, such as gene expression, angiogenesis, apoptosis and cell trafficking, within the context of physiologically authentic environments of living organisms. 

Phrase: "Recent advances in the molecular basis of disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0725066:Advance [Medical Device]

Phrase: "the development of target-specific imaging agents,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "new developments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0243107:development [Physiologic Function]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   777 E C0458003:Developmental [Qualitative Concept]

Phrase: "in the field of imaging"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C3539073:In the Field [Spatial Concept]
           FIELD
   760   C0150312:In [Quantitative Concept]
   760   C0332285:In [Spatial Concept]
   760   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   760   C1521738:Field [Conceptual Entity]
   760   C2346620:Field [Conceptual Entity]
   760   C2349184:Field [Conceptual Entity]

Phrase: "are"

Phrase: "increasingly"

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "the non-invasive evaluation of cellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220825:Evaluation [Functional Concept]
   753   C1261322:Evaluation [Health Care Activity]

Phrase: "and"

Phrase: "molecular events,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "such as gene expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "angiogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: ","

Phrase: "within the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of physiologically authentic environments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014406:Environments [Spatial Concept]

Phrase: "of living organisms."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0029235:LIVING ORGANISMS [Organism]
           Organisms
Processing 00000000.tx.26: This technology, called molecular imaging, has its roots in nuclear medicine, which uses tracers that bind specifically to molecular targets [46]. 

Phrase: "This technology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:Technology [Occupation or Discipline]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "molecular imaging,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1537028:Molecular Imaging [Diagnostic Procedure]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: "has"

Phrase: "its roots in nuclear medicine,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0242726:Roots [Plant]
   726 E C0040452:Root [Body Part, Organ, or Organ Component]
   726 E C1318154:Root [Body Part, Organ, or Organ Component]
   726 E C1705917:Root [Idea or Concept]

Phrase: "which"

Phrase: "uses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "tracers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522485:tracers [Indicator, Reagent, or Diagnostic Aid]

Phrase: "that"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "specifically to molecular targets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   816   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   770   C1521991:Molecular [Qualitative Concept]
   737   C1521840:Target [Functional Concept]
   737   C2986546:TARGET [Diagnostic Procedure]

Phrase: "[46"

Phrase: "]."
Processing 00000000.tx.27: Cellular and molecular changes often occur a long time before any signs of anatomical, physiological or metabolic changes become evident. 

Phrase: "Cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007634:Cellular [Cell]
  1000   C0178539:Cellular [Functional Concept]
   928 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "molecular changes often"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "a long time before any signs of anatomical, physiological"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1279919:time before [Temporal Concept]
   742   C0040223:Time [Temporal Concept]
   742   C3541383:Time [Temporal Concept]

Phrase: "or"

Phrase: "metabolic changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "become"

Phrase: "evident."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.28: Therefore, non-invasive visualization and quantitation of biological processes at the molecular level facilitates earlier detection, and furthermore it provides more detailed information about basic molecular events involved in disease compared with conventional imaging methods. 

Phrase: "Therefore,"

Phrase: "non-invasive visualization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0175631:Visualization [Mental Process]
   827   C2827662:Visualization [Occupation or Discipline]
   734   C0205303:Non-invasive [Functional Concept]

Phrase: "and"

Phrase: "quantitation of biological processes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "at the molecular level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "facilitates"

Phrase: "earlier detection,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0596473:Early Detection [Diagnostic Procedure]
   861   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "furthermore"

Phrase: "it"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "more detailed information about basic molecular events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0681322:information event [Occupational Activity]
   748   C1533716:Information [Idea or Concept]

Phrase: "involved in disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0012634:Disease [Disease or Syndrome]
   790   C1314939:Involved [Functional Concept]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "compared with conventional imaging methods."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   806   C1275506:imaging methods [Functional Concept]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0079595:Imaging [Diagnostic Procedure]
   760   C0439858:Conventional [Qualitative Concept]
   760   C0449851:Methods [Functional Concept]
   760   C1707455:Compared [Activity]
   726 E C0871511:METHOD [Intellectual Product]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.29: Consequently, molecular imaging is a promising tool for the evaluation of physiology and pathophysiology. 

Phrase: "Consequently,"

Phrase: "molecular imaging"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1537028:Molecular Imaging [Diagnostic Procedure]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: "is"

Phrase: "a promising tool for the evaluation of physiology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0336791:Tool [Manufactured Object]
   744   C2827396:Tool [Manufactured Object]

Phrase: "and"

Phrase: "pathophysiology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031847:pathophysiology [Functional Concept]
  1000   C0277785:Pathophysiology [Qualitative Concept]
Processing 00000000.tx.30: It enables a more fundamental understanding of key processes, for earlier and more reliable prognosis, earlier assessment of treatment response and the development of new therapies, which are urgently needed in many diseases. 

Phrase: "It"

Phrase: "enables"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "a more fundamental understanding of key processes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162340:Understanding [Mental Process]

Phrase: "for earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "more reliable prognosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033325:Prognosis [Health Care Activity]

Phrase: "earlier assessment of treatment response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "and"

Phrase: "the development of new therapies,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
   745   C0556496:Developmental therapy [Therapeutic or Preventive Procedure]
   745   C1522647:Developmental Therapy [Research Activity]

Phrase: "which"

Phrase: "are"

Phrase: "urgently"

Phrase: "needed in many diseases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0012634:Diseases [Disease or Syndrome]
   770   C0027552:Needed [Qualitative Concept]
   770   C0686904:needed [Functional Concept]
Processing 00000000.tx.31: Molecular imaging technologies are currently being developed, based not only based on nuclear medicine techniques, but also on MRT, ultrasound and the emerging field of optical imaging. 

Phrase: "Molecular imaging technologies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1704382:Imaging Technologies [Biomedical Occupation or Discipline]
   827   C0039421:technologies [Occupation or Discipline]
   734   C1537028:Molecular Imaging [Diagnostic Procedure]

Phrase: "are"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "being"

Phrase: "developed"

Phrase: ","

Phrase: "based"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1527178:Based [Functional Concept]
  1000   C1705938:Based [Idea or Concept]
   966 E C0002055:base [Inorganic Chemical]
   966 E C0178499:Base [Chemical Viewed Functionally]
   966 E C1880279:Base [Biomedical or Dental Material]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "based on nuclear medicine techniques,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0028582:Nuclear Medicine [Biomedical Occupation or Discipline]
   806   C0034606:Nuclear medicine [Diagnostic Procedure]
   806   C0203634:Nuclear medicine [Diagnostic Procedure]
   760   C0013227:Medicine, NOS [Pharmacologic Substance]
   760   C0025118:Medicine [Biomedical Occupation or Discipline]
   760   C0025664:techniques [Intellectual Product]
   760   C0449851:Techniques [Functional Concept]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "but"

Phrase: "also on MRT,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   806   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   806   C1551403:Magnetic resonance [Laboratory Procedure]
   760   C0024488:Magnetic [Occupation or Discipline]
   760   C0040395:tomography [Diagnostic Procedure]
   760   C0040405:tomography [Diagnostic Procedure]
   760   C0231881:Resonance [Finding]
   760   C0459800:resonance [Natural Phenomenon or Process]
   760   C0563532:magnetic [Natural Phenomenon or Process]
   760   C0684213:Resonance [Qualitative Concept]

Phrase: "ultrasound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041618:Ultrasound [Diagnostic Procedure]
  1000   C0041621:ultrasound [Natural Phenomenon or Process]
  1000   C0220934:ultrasound [Functional Concept]
  1000   C1456803:Ultrasound [Natural Phenomenon or Process]
  1000   C1875843:ULTRASOUND [Medical Device]

Phrase: "and"

Phrase: "the emerging field of optical imaging."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C1830736:Field of vision [Clinical Attribute]
   753   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   753   C1521738:Field [Conceptual Entity]
   753   C2346620:Field [Conceptual Entity]
   753   C2349184:Field [Conceptual Entity]
   753   C3539073:FIELD [Spatial Concept]
Processing 00000000.tx.32: They will have a profound impact in research and the clinical management of numerous disorders, including cancer and cardiovascular, neurological and inflammatory diseases [46]. 

Phrase: "They"

Phrase: "will"

Phrase: "have"

Phrase: "a profound impact in research"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]

Phrase: "and"

Phrase: "the clinical management of numerous disorders,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1516615:Clinical Management [Health Care Activity]
   753   C0001554:Management [Occupational Activity]
   753   C0376636:management [Health Care Activity]
   753   C1273870:Management [Occupational Activity]
   753   C3273539:Management [Occupation or Discipline]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cancer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006826:Cancer [Neoplastic Process]
  1000   C0998265:Cancer [Eukaryote]
  1000   C1306459:Cancer [Finding]

Phrase: "and"

Phrase: "cardiovascular, neurological"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205494:Neurological [Qualitative Concept]
   861   C2707261:Neurological [Clinical Attribute]

Phrase: "and"

Phrase: "inflammatory diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1290884:Inflammatory disease [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "[46"

Phrase: "]."
Processing 00000000.tx.33: In RA, monitoring of specific biological processes, such as inflammatory and destructive pathways, in experimental arthritis models and in human disease would undoubtedly be very helpful for both basic research in arthritis and the clinical management of patients. 

Phrase: "In RA,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]

Phrase: "monitoring of specific biological processes,"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   806   C0031845:Biological Processes [Physiologic Function]
   797   C0005517:Biological Monitoring [Occupational Activity]
   760   C0005532:Biological [Biomedical Occupation or Discipline]
   760   C0150369:Monitoring [Health Care Activity]
   760   C0205369:Specific [Qualitative Concept]
   760   C0205460:biological [Qualitative Concept]
   760   C1516647:monitoring [Research Activity]
   760   C1552740:specific [Intellectual Product]
   726 E C0030695:monitor [Health Care Activity]
   726 E C0181904:Monitor [Medical Device]
   726 E C0596972:Monitor [Medical Device]
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726 E C1521743:Monitor [Professional or Occupational Group]
   726   C1522240:Process [Phenomenon or Process]
   726 E C1704646:Monitor [Manufactured Object]

Phrase: "such as inflammatory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333348:Inflammatory [Functional Concept]

Phrase: "and"

Phrase: "destructive pathways,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "in experimental arthritis models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0086272:Models, Experimental [Intellectual Product]
   827   C3161035:Models [Intellectual Product]
   734   C0993582:Arthritis, Experimental [Experimental Model of Disease]

Phrase: "and in human disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0086418:Human [Human]
   770   C1515981:And [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "would"

Phrase: "undoubtedly"

Phrase: "be"

Phrase: "very helpful for both basic research"

Phrase: "in arthritis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003864:Arthritis [Disease or Syndrome]
   907 E C0018099:Gout [Disease or Syndrome]

Phrase: "and"

Phrase: "the clinical management of patients."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1516615:Clinical Management [Health Care Activity]
   760   C0001554:Management [Occupational Activity]
   760   C0376636:management [Health Care Activity]
   760   C1273870:Management [Occupational Activity]
   760   C3273539:Management [Occupation or Discipline]
Processing 00000000.tx.34: The development of molecular imaging methods is a challenging multistep process, especially in RA. 

Phrase: "The development of molecular imaging methods"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0178742:method development [Intellectual Product]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]

Phrase: "is"

Phrase: "a challenging multistep process,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "especially in RA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   833   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   770   C0003864:Arthritis [Disease or Syndrome]
Processing 00000000.tx.35: Of particular importance is the development of molecular imaging agents enabling the analysis of pathophysiological events crucial in disease and the choice of an adequate imaging modality applicable in clinical settings [7, 8].  

Phrase: "Of particular importance"

Phrase: "is"

Phrase: "the development of molecular imaging agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]

Phrase: "enabling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1171285:Enabling [Mental Process]
   966 E C0562342:enable [Mental Process]

Phrase: "the analysis of pathophysiological events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "crucial in disease"

Phrase: "and"

Phrase: "the choice of an adequate imaging modality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0008300:choice [Individual Behavior]
   748   C1707391:Choice [Activity]

Phrase: "applicable in clinical settings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1272460:applicable [Qualitative Concept]
   770   C1706839:Applicable [Qualitative Concept]

Phrase: "[7,"

Phrase: "8"

Phrase: "]."
Processing 00000000.tx.36: Development of novel molecular imaging agents Top Abstract Background Development of novel molecular... 

Phrase: "Development of novel molecular imaging agents Top Abstract Background Development"

Phrase: "of novel molecular..."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
Processing 00000000.tx.37: Imaging modalities Recent advances in molecular... 

Phrase: "Imaging modalities Recent advances in molecular..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0725066:Advance [Medical Device]
Processing 00000000.tx.38: Molecular imaging in RA Outlook References  The design of molecular imaging agents is demanding because numerous critical issues need to be addressed: (i) of the multitude of extra- and intracellular processes in RA, the identification of a suitable molecular target by target screening and verification at the subcellular, cellular and tissue level is mandatory; 

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "imaging in RA Outlook"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   806   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   760   C0003864:Arthritis [Disease or Syndrome]
   760   C0004271:Outlook [Mental Process]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0079595:Imaging [Diagnostic Procedure]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The design of molecular imaging agents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1707689:Design [Activity]
   753   C2983265:DESIGN [Intellectual Product]

Phrase: "is"

Phrase: "demanding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441516:demanding [Therapeutic or Preventive Procedure]
  1000   C0699784:demanding [Idea or Concept]

Phrase: "because"

Phrase: "numerous critical issues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0033213:Issue [Finding]
   793   C1706387:Issue [Intellectual Product]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "(i) of the multitude of extra-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "intracellular processes in RA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "the identification of a suitable molecular target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "by target screening"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0220908:Screening [Health Care Activity]
   861   C0220909:screening [Functional Concept]
   861   C1698960:screening [Intellectual Product]
   861   C1710031:Screening [Diagnostic Procedure]
   861   C1710477:SCREENING [Research Activity]

Phrase: "and"

Phrase: "verification at the subcellular, cellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237944:Verification [Research Activity]
   760   C1711411:Verification [Functional Concept]

Phrase: "and"

Phrase: "tissue level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0040300:Tissue [Tissue]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C1547928:Tissue [Intellectual Product]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "mandatory"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514873:Mandatory [Functional Concept]
  1000   C1554132:Mandatory [Idea or Concept]
  1000   C1619643:Mandatory [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.39: (ii) a ligand that binds to this molecular target with high specificity and affinity by ligand screening needs to be identified; 

Phrase: "(ii"

Phrase: ")"

Phrase: "a ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "that"

Phrase: "binds to this molecular target"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1521840:Target [Functional Concept]
   760   C1521991:Molecular [Qualitative Concept]
   760   C2986546:TARGET [Diagnostic Procedure]

Phrase: "with high specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "affinity by ligand screening"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ";"
Processing 00000000.tx.40: (iii) this ligand needs to be labelled with a signal molecule for visualization depending on the imaging modality used to sense the imaging agent; 

Phrase: "(iii"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "this ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "labelled with a signal molecule"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0567416:Molecule [Substance]
   760   C1710082:Signal [Phenomenon or Process]
   726   C0181496:Label [Manufactured Object]
   726   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "for visualization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175631:Visualization [Mental Process]
  1000   C2827662:Visualization [Occupation or Discipline]

Phrase: "depending on the imaging modality"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C1275506:Imaging modality [Functional Concept]
   806   C1551339:imaging modality [Manufactured Object]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0079595:Imaging [Diagnostic Procedure]
   760   C0695347:Modality [Idea or Concept]
   760   C1547664:Modality [Diagnostic Procedure]
   726   C0725813:depend [Medical Device]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: "the imaging agent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   861   C0450442:Agent [Chemical Viewed Functionally]
   861   C1254351:Agent [Pharmacologic Substance]
   861   C1521826:Agent [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.41: (iv) biological barriers for the imaging agents during on the way to the molecular target must be overcome not only in vitro but also in vivo; 

Phrase: "(iv) biological barriers for the imaging agents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1706912:BARRIER [Medical Device]

Phrase: "during"

Phrase: "on the way"

Phrase: "to the molecular target"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]

Phrase: "must"

Phrase: "be"

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "not only in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021135:In Vitro [Intellectual Product]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C2827718:In Vitro [Functional Concept]

Phrase: "but"

Phrase: "also in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: ";"
Processing 00000000.tx.42: and (v) strategies for signal amplification in order to increase sensitivity need to be established. 

Phrase: "and ("

Phrase: "v) strategies for signal amplification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679199:strategies [Mental Process]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0036667:Sensitivity [Quantitative Concept]
  1000   C0312418:Sensitivity [Mental Process]
  1000   C0427965:Sensitivity [Finding]
  1000   C1511883:Sensitivity [Quantitative Concept]
  1000   C1522640:Sensitivity [Qualitative Concept]
  1000   C2346484:SENSITIVITY [Phenomenon or Process]
  1000   C2349185:Sensitivity [Qualitative Concept]
   928 E C0332324:Sensitive [Functional Concept]
   928 E C1550474:sensitive [Idea or Concept]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "established."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]
Processing 00000000.tx.43: The final steps in the development of molecular imaging strategies are clinical trials to verify and validate clinical applicability and practical utilization in human disease (Fig. 1) [46]. 

Phrase: "The final steps in the development of molecular imaging strategies"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C1261552:steps [Conceptual Entity]
   706 E C1704379:Step [Functional Concept]
   706 E C1705117:Step [Quantitative Concept]
   706 E C2825408:Step [Manufactured Object]

Phrase: "are"

Phrase: "clinical trials to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0008976:Clinical Trials [Research Activity]
           Trial
   901   C1096775:clinical trials [Intellectual Product]
   827   C0205210:Clinical [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "and"

Phrase: "validate"

Phrase: "clinical applicability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C1272460:applicable [Qualitative Concept]
   789   C1706839:Applicable [Qualitative Concept]

Phrase: "and"

Phrase: "practical utilization in human disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0042153:utilization [Functional Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "[46"

Phrase: "]."
Processing 00000000.tx.44: View larger version (48K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(48K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.45: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.46: Principle of molecular imaging and the development of molecular imaging agents. 

Phrase: "Principle of molecular imaging"

Phrase: "and"

Phrase: "the development of molecular imaging agents."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]
Processing 00000000.tx.47: In order to visualize molecular events non-invasively, imaging agents need to be designed that interact specifically with appropriate molecular targets involved in the pathophysiology of disease. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "visualize"

Phrase: "molecular events non-invasively,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441471:Events [Event]
   812   C3541888:Events [Classification]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "that"

Phrase: "interact"

Phrase: "specifically with appropriate molecular targets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   760   C1521991:Molecular [Qualitative Concept]
   760   C1548787:Appropriate [Qualitative Concept]
   726   C1521840:Target [Functional Concept]
   726   C2986546:TARGET [Diagnostic Procedure]

Phrase: "involved in the pathophysiology of disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012634:Disease [Disease or Syndrome]
   753   C0031847:pathophysiology [Functional Concept]
   753   C0277785:Pathophysiology [Qualitative Concept]
   753   C1314939:Involved [Functional Concept]
Processing 00000000.tx.48: This includes markers for early diagnosis, the stage or the severity of disease, treatment efficacy or prognosis. 

Phrase: "This"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "markers for early diagnosis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0005516:Marker [Clinical Attribute]

Phrase: "the stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "or"

Phrase: "the severity of disease,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0521117:disease severity [Qualitative Concept]
   770   C0439793:Severity [Qualitative Concept]
   770   C2983285:Severity [Intellectual Product]

Phrase: "treatment efficacy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0087113:Treatment Efficacy [Qualitative Concept]
   861   C1280519:Efficacy [Qualitative Concept]
   861   C1707887:EFFICACY [Research Activity]

Phrase: "or"

Phrase: "prognosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033325:Prognosis [Health Care Activity]
Processing 00000000.tx.49: Once a suitable target has been defined, a ligand that binds to the target with high affinity and specificity needs to be designed. 

Phrase: "Once"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720092:Once [Intellectual Product]
  1000   C1948045:Once [Temporal Concept]

Phrase: "a suitable target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: ","

Phrase: "a ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "that"

Phrase: "binds to the target"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1521840:Target [Functional Concept]
   770   C2986546:TARGET [Diagnostic Procedure]

Phrase: "with high affinity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "designed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]
Processing 00000000.tx.50: Depending on the imaging modality, a signal molecule (label), such as a radioisotope for nuclear imaging, a fluorochrome for optical imaging, a magnetic particle for MRT, an acoustic reflective compound for ultrasound or a high-atomic-number atom that absorbs X-rays (e.g. iodine) for CT, has to be linked to the ligand, facilitating the sensitive detection of the imaging agent in a clinical setting. 

Phrase: "Depending on the imaging modality,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C1275506:Imaging modality [Functional Concept]
   806   C1551339:imaging modality [Manufactured Object]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0079595:Imaging [Diagnostic Procedure]
   760   C0695347:Modality [Idea or Concept]
   760   C1547664:Modality [Diagnostic Procedure]
   726   C0725813:depend [Medical Device]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "a signal molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "(label"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181496:Label [Manufactured Object]
  1000   C2827499:Label [Governmental or Regulatory Activity]

Phrase: ")"

Phrase: ","

Phrase: "such as a radioisotope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034595:Radioisotope [Element, Ion, or Isotope]

Phrase: "for nuclear imaging,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: "a fluorochrome for optical imaging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]

Phrase: "a magnetic particle for MRT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597177:Particle [Chemical Viewed Structurally]

Phrase: "an acoustic reflective compound for ultrasound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205198:Compound [Qualitative Concept]
   753   C1706082:Compound [Chemical]

Phrase: "or"

Phrase: "a high-atomic-number atom"

Phrase: "that"

Phrase: "absorbs"

Phrase: "X-rays"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0043299:X-Rays [Diagnostic Procedure]
  1000   C0043309:X-Rays [Natural Phenomenon or Process]
  1000   C1306645:X-rays [Diagnostic Procedure]
   966 E C0034571:X-ray [Functional Concept]
   966 E C1962945:X-ray [Diagnostic Procedure]
   861   C0086894:RAYS [Fish]
   861   C0851346:Rays [Natural Phenomenon or Process]
   827 E C2314876:ray [Fish]

Phrase: "("

Phrase: "e.g. iodine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021966:Iodine- [Inorganic Chemical]
  1000   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0885449:iodine [Pharmacologic Substance]
  1000   C2348268:Iodine [Element, Ion, or Isotope]

Phrase: ")"

Phrase: "for CT,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0040405:computed tomography [Diagnostic Procedure]
           tomography
  1000   C1552357:Computed Tomography [Professional or Occupational Group]
   861   C0040395:tomography [Diagnostic Procedure]
   861   C1441526:Computed [Laboratory Procedure]
   861   C1880157:Computed [Activity]

Phrase: "has"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "linked to the ligand,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023688:Ligand [Chemical]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "facilitating"

Phrase: "the sensitive detection of the imaging agent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in a clinical setting."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3176918:Clinical setting [Spatial Concept]
   861   C0542559:setting [Functional Concept]
   861   C1318139:{Setting} [Quantitative Concept]
Processing 00000000.tx.51: Finally, the acquired images need to be reconstructed and processed using computer systems.  

Phrase: "Finally,"

Phrase: "the acquired images"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C2347172:Acquired Image [Intellectual Product]
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "reconstructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348043:Reconstructed [Qualitative Concept]

Phrase: "and"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "computer systems."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0009612:Computer Systems [Intellectual Product,Manufactured Object]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.52: Imaging agents can be subdivided into three categories: non-specific probes, targeted probes, and activatable probes (Fig. 2). 

Phrase: "Imaging agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "subdivided into three categories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205449:Three [Quantitative Concept]
   770   C0683312:Categories [Intellectual Product]
   737 E C1555713:category [Idea or Concept]

Phrase: ":"

Phrase: "non-specific probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0182400:Probes [Medical Device]
   793 E C1704681:Probe [Gene or Genome]
   793 E C2347609:Probe [Chemical Viewed Functionally]
   793 E C3536729:Probe [Manufactured Object]
   734   C0205370:Non-specific [Qualitative Concept]

Phrase: "targeted probes,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "activatable probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.53: View larger version (31K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.54: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.55: Types of imaging agents. 

Phrase: "Types of imaging agents."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   786   C2346471:Image Type [Qualitative Concept]
   770   C0332307:Types [Qualitative Concept]
   737 E C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.56: The most commonly used imaging agents are non-specific, i.e. they do not bind to a specific molecular target. 

Phrase: "The most commonly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "imaging agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "are"

Phrase: "non-specific, i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "they"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to a specific molecular target."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   753   C0205369:Specific [Qualitative Concept]
   753   C1145667:Bind [Activity]
   753   C1167622:bind [Molecular Function]
   753   C1521840:Target [Functional Concept]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   753   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.57: These probes have compartmental distributions and can be used for imaging changes in blood volume, perfusion and blood flow. 

Phrase: "These probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "have"

Phrase: "compartmental distributions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0037775:Distributions [Spatial Concept]
   827 E C0520511:distribution [Idea or Concept]
   827 E C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "used for imaging changes"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C1705241:Change [Quantitative Concept]
   737 E C1947944:Use [Intellectual Product]
   737 E C3542466:Image [Intellectual Product]

Phrase: "in blood volume,"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005850:Blood Volume [Organism Attribute]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "perfusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031001:Perfusion [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "blood flow."
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0232338:Blood flow [Organism Function]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0806140:Flow [Natural Phenomenon or Process]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.58: In contrast, targeted and activatable probes interact with specific targets and therefore make it possible to image biological processes at the cellular or molecular level. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "activatable probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "interact with specific targets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]
   737   C1521840:Target [Functional Concept]
   737   C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "therefore"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "it possible to image biological processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332149:Possible [Qualitative Concept]
   753   C1705910:Possible [Qualitative Concept]
   753   C2362652:Possible [Qualitative Concept]

Phrase: "at the cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007634:Cellular [Cell]
  1000   C0178539:Cellular [Functional Concept]
   928 E C1516377:Cellularity [Qualitative Concept]

Phrase: "or"

Phrase: "molecular level."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.59: Targeted probes bind to specific targets, such as receptors, and can be used to image receptor expression and distribution (e.g. of cytokine receptors). 

Phrase: "Targeted probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "bind to specific targets,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205369:Specific [Qualitative Concept]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1552740:specific [Intellectual Product]
   737   C1521840:Target [Functional Concept]
   737   C2986546:TARGET [Diagnostic Procedure]

Phrase: "such as receptors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "used to image receptor expression"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0597360:receptor expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1273517:used [Finding]
   760   C1704254:Image [Intellectual Product]
   760   C1704922:Image [Entity]
   760   C3542466:Image [Intellectual Product]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "("

Phrase: "e.g."

Phrase: "of cytokine receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206552:Receptors, Cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ")."
Processing 00000000.tx.60: Activatable probes are activated after interaction with a specific target. 

Phrase: "Activatable probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "are"

Phrase: "activated after interaction"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1704675:Interaction [Functional Concept]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "with a specific target."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.61: A number of activatable probes have been developed to non-invasively image, for instance, the activity of matrix-degrading enzymes such as MMPs or cathepsins. 

Phrase: "A number of activatable probes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "developed to non-invasively image,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1518422:Non [Functional Concept]
   760   C1704254:Image [Intellectual Product]
   760   C1704922:Image [Entity]
   760   C3542466:Image [Intellectual Product]

Phrase: "for instance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "the activity of matrix-degrading enzymes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0243102:enzyme activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "such as MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "or"

Phrase: "cathepsins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007428:Cathepsins [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.62: Adapted from [9].  

Phrase: "Adapted from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2937289:adapted [Organic Chemical]

Phrase: "[9"

Phrase: "]."
Processing 00000000.tx.63: Non-specific imaging agents These have compartmental distributions and do not interact with a specific molecular target. 

Phrase: "Non-specific imaging agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   779   C0450442:Agent [Chemical Viewed Functionally]
   779   C1254351:Agent [Pharmacologic Substance]
   779   C1521826:Agent [Intellectual Product]

Phrase: "These"

Phrase: "have"

Phrase: "compartmental distributions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0037775:Distributions [Spatial Concept]
   827 E C0520511:distribution [Idea or Concept]
   827 E C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interact with a specific molecular target."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   753   C0205369:Specific [Qualitative Concept]
   753   C1521840:Target [Functional Concept]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   753   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.64: They accentuate dissimilarities between tissues, such as differences in permeability or perfusion, and are helpful in characterizing physiological processes such as blood volume, flow or perfusion [9]. 

Phrase: "They"

Phrase: "accentuate"

Phrase: "dissimilarities between tissues,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C0443202:Dissimilar [Qualitative Concept]

Phrase: "such as differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "in permeability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031164:Permeability [Natural Phenomenon or Process]
   928 E C0205326:Permeable [Functional Concept]

Phrase: "or"

Phrase: "perfusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031001:Perfusion [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "are"

Phrase: "helpful in characterizing physiological processes"

Phrase: "such as blood volume,"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005850:Blood Volume [Organism Attribute]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "flow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "perfusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031001:Perfusion [Therapeutic or Preventive Procedure]

Phrase: "[9"

Phrase: "]."
Processing 00000000.tx.65: In RA, the synovium of inflamed joints shows a large number of capillaries, enhanced capillary perfusion and permeability. 

Phrase: "In RA,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]

Phrase: "the synovium of inflamed joints"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0224494:Synovium of joint [Tissue]
           Joint synovium
   781   C1305077:Joint synovium [Tissue]
   760   C0039099:Synovium [Body Part, Organ, or Organ Component]
   745 E C0224507:Synovial joint [Body Space or Junction]
   745 E C1267110:Synovial joint [Body Space or Junction]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a large number of capillaries,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "enhanced capillary perfusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031001:Perfusion [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "permeability."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031164:Permeability [Natural Phenomenon or Process]
   928 E C0205326:Permeable [Functional Concept]
Processing 00000000.tx.66: After intravenous injection, higher amounts of unspecific contrast agents can therefore be detected in arthritic synovium compared with surrounding healthy tissue or normal synovium. 

Phrase: "After intravenous injection,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0021494:Intravenous injection [Functional Concept]
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0348016:Intravenous [Spatial Concept]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "higher amounts of unspecific contrast agents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "can"

Phrase: "therefore"

Phrase: "be"

Phrase: "detected in arthritic synovium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039099:Synovium [Body Part, Organ, or Organ Component]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "compared with surrounding healthy tissue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0040300:Tissue [Tissue]
   760   C1282914:Surrounding [Spatial Concept]
   760   C1547928:Tissue [Intellectual Product]
   760   C1707455:Compared [Activity]

Phrase: "or"

Phrase: "normal synovium."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0039099:Synovium [Body Part, Organ, or Organ Component]
   789 E C1550315:Synovial [Body Part, Organ, or Organ Component]
   761 E C0039097:Synovia [Body Substance]
Processing 00000000.tx.67: The rate and magnitude of synovial enhancement on magnetic resonance images (MRIs) after intravenous injection of (non-specific) gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) contrast agents has been shown to correlate with disease activity and is sensitive to therapy-induced changes. 

Phrase: "The rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "magnitude of synovial enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449286:magnitude [Quantitative Concept]
   770   C1704240:Magnitude [Quantitative Concept]

Phrase: "on magnetic resonance images (MRIs)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C1704254:Image [Intellectual Product]
   793   C1704922:Image [Entity]
   793   C3542466:Image [Intellectual Product]
   734   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   734   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   734   C1551403:Magnetic resonance [Laboratory Procedure]

Phrase: "after intravenous injection of ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0021494:Intravenous injection [Functional Concept]

Phrase: "non-specific"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205370:Non-specific [Qualitative Concept]
   861   C0205369:Specific [Qualitative Concept]
   861   C1518422:Non [Functional Concept]
   861   C1552740:specific [Intellectual Product]

Phrase: ")"

Phrase: "gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) contrast agents"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0009924:Contrast Agents [Indicator, Reagent, or Diagnostic Aid]
   799   C1979874:Contrast [Qualitative Concept]
   766   C0450442:Agent [Chemical Viewed Functionally]
   766   C1254351:Agent [Pharmacologic Substance]
   766   C1521826:Agent [Intellectual Product]
   734   C0060933:Gadolinium Diethylenetriaminepenta-acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate with disease activity"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "is"

Phrase: "sensitive to therapy-induced changes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.68: This demonstrates that non-specific contrast agents can be beneficial in assessing crucial parameters in clinical management [13]. 

Phrase: "This"

Phrase: "demonstrates"

Phrase: "that non-specific contrast agents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0009924:Contrast Agents [Indicator, Reagent, or Diagnostic Aid]
   812   C1979874:Contrast [Qualitative Concept]
   779   C0450442:Agent [Chemical Viewed Functionally]
   779   C1254351:Agent [Pharmacologic Substance]
   779   C1521826:Agent [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "beneficial in assessing crucial parameters"

Phrase: "in clinical management"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1516615:Clinical Management [Health Care Activity]
   861   C0001554:Management [Occupational Activity]
   861   C0376636:management [Health Care Activity]
   861   C1273870:Management [Occupational Activity]
   861   C3273539:Management [Occupation or Discipline]

Phrase: "[13"

Phrase: "]."
Processing 00000000.tx.69: Targeted imaging agents These are usually created by coupling a signal molecule to affinity a ligand, such as an antibody, antibody fragment, peptide, a small molecule or a larger multivalent construct. 

Phrase: "Targeted imaging agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: "These"

Phrase: "are"

Phrase: "usually"

Phrase: "created by coupling"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C1707531:Created By [Qualitative Concept]
   790   C1706214:Created [Activity]
   790   C1948027:Coupling [Functional Concept]
   756 E C3244320:create [Functional Concept]

Phrase: "a signal molecule to affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0567416:Molecule [Substance]

Phrase: "a ligand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "such as an antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "antibody fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "a small molecule"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1328819:Small Molecule [Organic Chemical]
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "or"

Phrase: "a larger multivalent construct."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]
Processing 00000000.tx.70: This ligand binds with high specificity to a certain target which might be, for instance, a receptor [9]. 

Phrase: "This ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "binds with high specificity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0037791:Specificity [Quantitative Concept]
   770   C0205250:High [Qualitative Concept]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1299351:High [Qualitative Concept]
   770   C1511884:Specificity [Quantitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "to a certain target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]

Phrase: "which"

Phrase: "might"

Phrase: "be"

Phrase: ","

Phrase: "for instance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "a receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "[9"

Phrase: "]."
Processing 00000000.tx.71: In RA, this kind of imaging agent can be used to evaluate receptor expression and distribution (e.g. imaging of cytokine receptors involved in disease) [7, 8]. 

Phrase: "In RA,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]

Phrase: "this kind of imaging agent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332307:Kind [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "receptor expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597360:receptor expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "("

Phrase: "e.g."

Phrase: "imaging of cytokine receptors"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0206552:Receptors, Cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: "involved in disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0012634:Disease [Disease or Syndrome]
   790   C1314939:Involved [Functional Concept]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "[7,"

Phrase: "8"

Phrase: "]."
Processing 00000000.tx.72: Shortcomings of targeted imaging agents are that both the unbound and the non-specifically bound fractions of an agent produce a signal, potentially resulting in high background noise. 

Phrase: "Shortcomings of targeted imaging agents"

Phrase: "are"

Phrase: "that"

Phrase: "both the unbound"

Phrase: "and"

Phrase: "the non-specifically bound fractions of an agent"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   754   C1264633:Fraction of [Quantitative Concept]
           Fractions
   711 E C1554103:Fraction [Idea or Concept]

Phrase: "produce"

Phrase: "a signal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "potentially"

Phrase: "resulting in high background noise."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0332294:Resulting in [Functional Concept]
   760   C0028263:Noise [Phenomenon or Process]
   760   C0205250:High [Qualitative Concept]
   760   C0678226:resulting [Functional Concept]
   760   C1299351:High [Qualitative Concept]
   760   C1706907:Background [Conceptual Entity]
   760   C2700149:HIGH [Intellectual Product]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]
Processing 00000000.tx.73: In addition, targeted imaging agents require a certain amount of time for washout. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "targeted imaging agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: "require"

Phrase: "a certain amount of time"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "for washout."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1710661:Washout [Temporal Concept]
  1000   C2986829:Washout [Functional Concept]
Processing 00000000.tx.74: To improve the sensitivity of the imaging method, signal amplification strategies, such as pretargeting and avidinbiotin amplification, can be used to boost target/background ratios. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "improve"

Phrase: "the sensitivity of the imaging method,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "signal amplification strategies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategies [Mental Process]

Phrase: "such as pretargeting"

Phrase: "and"

Phrase: "avidinbiotin amplification,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "can"

Phrase: "be"

Phrase: "used to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C1273517:used [Finding]
   799 E C0042153:use [Functional Concept]
   799 E C0457083:Use [Functional Concept]
   799 E C1947944:Use [Intellectual Product]

Phrase: "boost"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511253:Boost [Functional Concept]
  1000   C1874596:BOOST [Food]

Phrase: "target/background ratios."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0456603:Ratios [Quantitative Concept]
   827   C1521840:Target [Functional Concept]
   827   C1610540:*Ratios [Quantitative Concept]
   827   C1706907:Background [Conceptual Entity]
   827   C2986546:TARGET [Diagnostic Procedure]
   793 E C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.75: Additional efforts to improve the attributes of an imaging agent include optimization of pharmacological properties [9]. 

Phrase: "Additional efforts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0015264:Effort [Organism Function]

Phrase: "improve"

Phrase: "the attributes of an imaging agent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0449234:Attribute [Idea or Concept]
   719   C1704772:Attribute [Conceptual Entity]
   719   C1882133:Attribute [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "optimization of pharmacological properties"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2698650:Optimization [Activity]

Phrase: "[9"

Phrase: "]."
Processing 00000000.tx.76: Activatable imaging agents (smart or responsive probes) These undergo a physicochemical change after interacting with their intended target. 

Phrase: "Activatable imaging agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: "(smart"

Phrase: "or"

Phrase: "responsive probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")"

Phrase: "These"

Phrase: "undergo"

Phrase: "a physicochemical change after interacting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "with their intended target."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.77: In their native injected state, they are almost undetectable. 

Phrase: "In their native injected state,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "they"

Phrase: "are"

Phrase: "almost undetectable."
Processing 00000000.tx.78: Upon target interaction, the detectable signal increases substantially. 

Phrase: "Upon target interaction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]

Phrase: "the detectable signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "substantially."
Processing 00000000.tx.79: Since one target molecule (enzyme) can activate several molecules of the imaging probe, an enormous signal amplification occurs, resulting in high signal-to-noise ratios through background suppression. 

Phrase: "Since"

Phrase: "one target molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "(enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: ")"

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "several molecules of the imaging probe,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0567416:molecules [Substance]
   742   C0026381:Probe, Molecular [Indicator, Reagent, or Diagnostic Aid]
   742   C1537028:Molecular Imaging [Diagnostic Procedure]

Phrase: "an enormous signal amplification"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1517480:Amplification [Molecular Biology Research Technique]
   827   C1521871:Amplification [Phenomenon or Process]
   827   C1705759:Amplification [Cell or Molecular Dysfunction]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "resulting in high signal-to-noise ratios"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   853   C2986823:Signal-To-Noise Ratios [Quantitative Concept]
   778   C0332294:Resulting in [Functional Concept]
   774   C0028263:Signal Noise [Phenomenon or Process]
           Noise
   748   C0205250:High [Qualitative Concept]
   748   C0456603:Ratios [Quantitative Concept]
   748   C0678226:resulting [Functional Concept]
   748   C1299351:High [Qualitative Concept]
   748   C1610540:*Ratios [Quantitative Concept]
   748   C1710082:Signal [Phenomenon or Process]
   748   C2700149:HIGH [Intellectual Product]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C1547037:Ratio [Intellectual Product]
   714 E C2825142:Result [Finding]

Phrase: "through background suppression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0221103:Suppression [Pathologic Function]
   861   C0301625:Suppression [Organism Function]
   861   C0439181:% suppression [Quantitative Concept]
   861   C0728721:suppression [Mental Process]
Processing 00000000.tx.80: Activatable imaging agents have been developed for MRT and fluorescence imaging. 

Phrase: "Activatable imaging agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "developed for MRT"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   806   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   806   C1551403:Magnetic resonance [Laboratory Procedure]
   760   C0024488:Magnetic [Occupation or Discipline]
   760   C0040395:tomography [Diagnostic Procedure]
   760   C0040405:tomography [Diagnostic Procedure]
   760   C0231881:Resonance [Finding]
   760   C0459800:resonance [Natural Phenomenon or Process]
   760   C0563532:magnetic [Natural Phenomenon or Process]
   760   C0684213:Resonance [Qualitative Concept]

Phrase: "and"

Phrase: "fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "imaging."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.81: Examples of such agents include protease-sensitive imaging probes, which are activated upon enzymatic cleavage [9]. 

Phrase: "Examples of such agents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1707959:Example [Conceptual Entity]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "protease-sensitive imaging probes,"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   812   C0011923:Imaging [Diagnostic Procedure]
   812   C0079595:Imaging [Diagnostic Procedure]
   812   C0182400:Probes [Medical Device]
   779 E C1704254:Image [Intellectual Product]
   779 E C1704681:Probe [Gene or Genome]
   779 E C1704922:Image [Entity]
   779 E C2347609:Probe [Chemical Viewed Functionally]
   779 E C3536729:Probe [Manufactured Object]
   779 E C3542466:Image [Intellectual Product]

Phrase: "which"

Phrase: "are"

Phrase: "activated upon enzymatic cleavage"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "[9"

Phrase: "]."
Processing 00000000.tx.82: In RA, these probes can be used for monitoring the activity of matrix-degrading enzymes, such as matrix metalloproteinases (MMPs) and cathepsins [7, 9].  

Phrase: "In RA,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]

Phrase: "these probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "can"

Phrase: "be"

Phrase: "used for monitoring"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0150369:Monitoring [Health Care Activity]
   790   C1273517:used [Finding]
   790   C1516647:monitoring [Research Activity]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "the activity of matrix-degrading enzymes,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0243102:enzyme activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "such as matrix metalloproteinases (MMPs)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "and"

Phrase: "cathepsins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007428:Cathepsins [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "[7,"

Phrase: "9"

Phrase: "]."
Processing 00000000.tx.83: Imaging modalities Top Abstract Background Development of novel molecular... 

Phrase: "Imaging modalities Top Abstract Background Development of novel molecular..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0243107:development [Physiologic Function]
   742   C0678723:Development [Organism Function]
   742   C1527148:Development [Functional Concept]
Processing 00000000.tx.84: Imaging modalities Recent advances in molecular... 

Phrase: "Imaging modalities Recent advances in molecular..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0725066:Advance [Medical Device]
Processing 00000000.tx.85: Molecular imaging in RA Outlook References  Various imaging modalities, such as conventional radiography, CT, ultrasound, MRT, nuclear imaging methods such as single photon emission computed tomography (SPECT) and positron emission tomography (PET), as well as other methods, including optical imaging methods such as fluorescence imaging and bioluminescence imaging, are available. 

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "imaging in RA Outlook"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   806   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   760   C0003864:Arthritis [Disease or Syndrome]
   760   C0004271:Outlook [Mental Process]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0079595:Imaging [Diagnostic Procedure]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Various imaging modalities,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C1275506:imaging modalities [Functional Concept]
   884 E C1551339:imaging modality [Manufactured Object]
   827   C0695347:modalities [Idea or Concept]
   793 E C1547664:Modality [Diagnostic Procedure]

Phrase: "such as conventional radiography,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0034571:radiography [Functional Concept]
   861   C0043299:radiography [Diagnostic Procedure]
   861   C1962945:Radiography [Diagnostic Procedure]
   789 E C0444708:Radiographic [Natural Phenomenon or Process]
   761 E C1306645:Radiograph [Diagnostic Procedure]
   761 E C1548003:Radiograph [Intellectual Product]

Phrase: "CT,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0040405:computed tomography [Diagnostic Procedure]
           tomography
  1000   C1552357:Computed Tomography [Professional or Occupational Group]
   861   C0040395:tomography [Diagnostic Procedure]
   861   C1441526:Computed [Laboratory Procedure]
   861   C1880157:Computed [Activity]

Phrase: "ultrasound,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041618:Ultrasound [Diagnostic Procedure]
  1000   C0041621:ultrasound [Natural Phenomenon or Process]
  1000   C0220934:ultrasound [Functional Concept]
  1000   C1456803:Ultrasound [Natural Phenomenon or Process]
  1000   C1875843:ULTRASOUND [Medical Device]

Phrase: "MRT,"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   901   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]

Phrase: "nuclear imaging methods such as single photon emission computed tomography (SPECT)"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C1275506:imaging methods [Functional Concept]
   739   C0025663:Methods [Intellectual Product]
   739   C0025664:methods [Intellectual Product]
   739   C0449851:Methods [Functional Concept]
   706 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "positron emission tomography (PET),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   827   C0032744:Positron [Quantitative Concept]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]
   827   C0233929:Emission [Body Substance]
   827   C2349995:Emission [Substance]

Phrase: "as well as"

Phrase: "other methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "optical imaging methods such as fluorescence"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C1275506:imaging methods [Functional Concept]
   783   C1518598:Optical Methods [Laboratory Procedure]
   753   C0025663:Methods [Intellectual Product]
   753   C0025664:methods [Intellectual Product]
   753   C0449851:Methods [Functional Concept]
   719 E C0871511:METHOD [Intellectual Product]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "bioluminescence imaging,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   861   C0162404:Bioluminescence [Biologic Function]
   861   C1367880:bioluminescence [Laboratory Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "available."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]
Processing 00000000.tx.86: In fluorescence imaging, light emitted by a fluorochrome (fluorescence) upon excitation by a light source is detected by sensitive cameras, whereas in bioluminescence imaging no excitation light is necessary. 

Phrase: "In fluorescence imaging, light"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C1306462:Light [Functional Concept]
   827   C1881376:Light [Qualitative Concept]
   734   C0430876:Fluorescence Imaging [Diagnostic Procedure]

Phrase: "emitted by a fluorochrome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]
   737   C0162676:EMIT [Laboratory Procedure]
   737   C1623049:EMIT [Laboratory Procedure]

Phrase: "(fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "upon excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "by a light source"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C0449416:Source [Finding]
   861   C1306462:Light [Functional Concept]
   861   C1705919:Source [Idea or Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "is"

Phrase: "detected by sensitive cameras,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0179533:cameras [Medical Device]
   770   C0332324:Sensitive [Functional Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1550474:sensitive [Idea or Concept]
   737 E C1654607:Camera [Eukaryote]
   737 E C1706254:CAMERA [Medical Device]

Phrase: "whereas in bioluminescence imaging"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0162404:Bioluminescence [Biologic Function]
   770   C1367880:bioluminescence [Laboratory Procedure]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: "no excitation light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "is"

Phrase: "necessary."
Processing 00000000.tx.87: Bioluminescence imaging is based on the expression of luciferase by transfected cells, which catalyses the oxidation of luciferin and results in the release of photons. 

Phrase: "Bioluminescence imaging"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   861   C0162404:Bioluminescence [Biologic Function]
   861   C1367880:bioluminescence [Laboratory Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: "is"

Phrase: "based on the expression of luciferase"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "by transfected cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "catalyses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:Catalyses [Natural Phenomenon or Process]

Phrase: "the oxidation of luciferin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "and"

Phrase: "results in the release of photons."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0030685:Release [Health Care Activity]
   753   C0086805:Photons [Substance]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1274040:Result [Functional Concept]
   753   C1283071:Release [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
   753   C2825142:Result [Finding]
Processing 00000000.tx.88: In case of fluorescence imaging, several modalities are available, e.g. fluorescence reflectance imaging (FRI; the light source and the detector are on the same side of the subject; 2-dimensional images) and fluorescence-mediated tomography (FMT; the subject is illuminated by different sources and the emitted light is captured by multiple detectors; 3-dimensional images) [46, 9]. 

Phrase: "In case of fluorescence imaging, several modalities"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   875   C1275506:imaging modalities [Functional Concept]
   858 E C1551339:imaging modality [Manufactured Object]
   812   C0695347:modalities [Idea or Concept]
   779 E C1547664:Modality [Diagnostic Procedure]

Phrase: "are"

Phrase: "available,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]

Phrase: "e.g. fluorescence reflectance"

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "(FRI"

Phrase: ";"

Phrase: "the light source"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C0449416:Source [Finding]
   861   C1306462:Light [Functional Concept]
   861   C1705919:Source [Idea or Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "the detector"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0180392:Detector [Medical Device]
  1000   C1705235:Detector [Manufactured Object]

Phrase: "are on the same side of the subject"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0441987:Side [Spatial Concept]
   744   C0445247:Same [Qualitative Concept]
   744   C0681850:Subject [Group]
   744   C1550501:{Subject} [Idea or Concept]
   744   C1551058:Are [Quantitative Concept]
   744   C1706203:Subject [Idea or Concept]
   744   C2349001:Subject [Human]
   744   C2697811:Subject [Functional Concept]

Phrase: "; 2-dimensional images"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1704254:Image [Intellectual Product]
   793   C1704922:Image [Entity]
   793   C3542466:Image [Intellectual Product]
   734   C1705052:2-Dimensional [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "fluorescence-mediated tomography"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]

Phrase: "(FMT"

Phrase: ";"

Phrase: "the subject"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "is"

Phrase: "illuminated by different sources"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0449416:sources [Finding]
   770   C1705242:Different [Qualitative Concept]
   737 E C1705919:Source [Idea or Concept]

Phrase: "and"

Phrase: "the emitted light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "is"

Phrase: "captured by multiple detectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0180392:Detectors [Medical Device]
   770   C0439064:Multiple [Quantitative Concept]
   737 E C1705235:Detector [Manufactured Object]

Phrase: "; 3-dimensional images"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1704254:Image [Intellectual Product]
   793   C1704922:Image [Entity]
   793   C3542466:Image [Intellectual Product]
   734   C0450363:3-Dimensional [Spatial Concept]

Phrase: ")"

Phrase: "[46,"

Phrase: "9"

Phrase: "]."
Processing 00000000.tx.89: The imaging methods differ with respect to spatial resolution, the ability to produce 3-dimensional images, depth limit, sensitivity, the possibility of quantification, the availability of imaging agents, the potential to gather information at the anatomical, physiological, cellular and molecular levels, costs and effort (Table 1). 

Phrase: "The imaging methods"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1275506:imaging methods [Functional Concept]
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "differ with respect to spatial resolution,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0679133:respect [Social Behavior]
   753   C1428114:spatial [Gene or Genome]
   753   C1514893:Resolution [Idea or Concept]
   753   C1706463:Resolution [Quantitative Concept]
   753   C2699488:Resolution [Conceptual Entity]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "produce"

Phrase: "3-dimensional images,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1704254:Image [Intellectual Product]
   793   C1704922:Image [Entity]
   793   C3542466:Image [Intellectual Product]
   734   C0450363:3-Dimensional [Spatial Concept]

Phrase: "depth limit,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0439801:limit [Functional Concept]
   861   C1549649:Limit [Idea or Concept]
   861   C2349209:Limit [Conceptual Entity]
   789 E C3542948:Limited [Intellectual Product]

Phrase: "sensitivity,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0036667:Sensitivity [Quantitative Concept]
  1000   C0312418:Sensitivity [Mental Process]
  1000   C0427965:Sensitivity [Finding]
  1000   C1511883:Sensitivity [Quantitative Concept]
  1000   C1522640:Sensitivity [Qualitative Concept]
  1000   C2346484:SENSITIVITY [Phenomenon or Process]
  1000   C2349185:Sensitivity [Qualitative Concept]
   928 E C0332324:Sensitive [Functional Concept]
   928 E C1550474:sensitive [Idea or Concept]

Phrase: "the possibility of quantification,"

Phrase: "the availability of imaging agents,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "the potential to gather information"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3245505:Potential [Qualitative Concept]

Phrase: "at the anatomical, physiological, cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0007634:Cellular [Cell]
   827   C0178539:Cellular [Functional Concept]
   755 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "molecular levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "costs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010186:Costs [Quantitative Concept]
  1000   C0220812:Costs [Quantitative Concept]

Phrase: "and"

Phrase: "effort"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:Effort [Organism Function]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.90: Therefore, the choice of imaging modality for molecular imaging depends on the kind and location of the cellular or molecular event that needs to be monitored, as well as the biological questions that need to be answered [46, 9]. 

Phrase: "Therefore,"

Phrase: "the choice of imaging modality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0008300:choice [Individual Behavior]
   760   C1707391:Choice [Activity]

Phrase: "for molecular imaging"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1537028:Molecular Imaging [Diagnostic Procedure]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: "depends on the kind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332307:Kind [Qualitative Concept]
   770   C0725813:depend [Medical Device]

Phrase: "and"

Phrase: "location of the cellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0450429:Location [Spatial Concept]
   770   C1515974:Location [Body Location or Region]

Phrase: "or"

Phrase: "molecular event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "that"

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: ","

Phrase: "as well as"

Phrase: "the biological questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522634:Question [Intellectual Product]

Phrase: "that"

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "answered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706817:Answer [Intellectual Product]

Phrase: "[46,"

Phrase: "9"

Phrase: "]."
Processing 00000000.tx.91: View this table: [in this window] [in a new window]  TABLE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.92: Main features of major imaging modalities and their role in RA  Conventional radiography, CT, ultrasound and MRT provide high-resolution images at the anatomical level, whereas morphological information provided by nuclear and optical imaging methods are limited, because they are based on the detection of a signal coming from a radiolabelled or fluorescent imaging agent. 

Phrase: "Main features of major imaging modalities"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   750   C2346469:Image Feature [Qualitative Concept]
           Feature
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "their role in RA  Conventional radiography,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "CT,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0040405:computed tomography [Diagnostic Procedure]
           tomography
  1000   C1552357:Computed Tomography [Professional or Occupational Group]
   861   C0040395:tomography [Diagnostic Procedure]
   861   C1441526:Computed [Laboratory Procedure]
   861   C1880157:Computed [Activity]

Phrase: "ultrasound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041618:Ultrasound [Diagnostic Procedure]
  1000   C0041621:ultrasound [Natural Phenomenon or Process]
  1000   C0220934:ultrasound [Functional Concept]
  1000   C1456803:Ultrasound [Natural Phenomenon or Process]
  1000   C1875843:ULTRASOUND [Medical Device]

Phrase: "and"

Phrase: "MRT"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   901   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "high-resolution images at the anatomical level,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]

Phrase: "whereas"

Phrase: "morphological information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "provided by nuclear"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0521447:Nuclear [Spatial Concept]
   790   C1999230:Provided [Activity]

Phrase: "and"

Phrase: "optical imaging methods"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1518598:Optical Methods [Laboratory Procedure]
   901   C1275506:imaging methods [Functional Concept]
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]
   734   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]

Phrase: "are"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: ","

Phrase: "because"

Phrase: "they"

Phrase: "are"

Phrase: "based on the detection of a signal coming"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   767   C0206100:Signal Detection [Mental Process]
   744   C1511790:Detection [Therapeutic or Preventive Procedure]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   744   C1710082:Signal [Phenomenon or Process]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "from a radiolabelled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "fluorescent imaging agent."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]
Processing 00000000.tx.93: Therefore, when nuclear or optical imaging methods are used it is beneficial to combine them with imaging modalities providing detailed information at the anatomical level in order to combine anatomical and functional information [46, 9]. 

Phrase: "Therefore,"

Phrase: "when"

Phrase: "nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "or"

Phrase: "optical imaging methods"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1518598:Optical Methods [Laboratory Procedure]
   901   C1275506:imaging methods [Functional Concept]
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]
   734   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]

Phrase: "are"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "it"

Phrase: "is"

Phrase: "beneficial to"

Phrase: "combine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336789:Combine [Manufactured Object]

Phrase: "them with imaging modalities"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C1275506:imaging modalities [Functional Concept]
   816 E C1551339:imaging modality [Manufactured Object]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0695347:modalities [Idea or Concept]
   737 E C1547664:Modality [Diagnostic Procedure]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "detailed information at the anatomical level"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1533716:Information [Idea or Concept]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "combine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336789:Combine [Manufactured Object]

Phrase: "anatomical"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0220784:Anatomical [Qualitative Concept]
   928 E C0002808:Anatomies [Biomedical Occupation or Discipline]
   928 E C0700276:anatomy [Anatomical Structure]
   928 E C1384516:anatomy [Qualitative Concept]

Phrase: "and"

Phrase: "functional information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "[46,"

Phrase: "9"

Phrase: "]."
Processing 00000000.tx.94: The major limitation of conventional radiography and CT in molecular imaging is their low inherent sensitivity for label detection. 

Phrase: "The major limitation of conventional radiography"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449295:Limitation [Functional Concept]

Phrase: "and"

Phrase: "CT in molecular imaging"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   844   C0729619:Computed tomography imaging [Diagnostic Procedure]
   806   C0040405:computed tomography [Diagnostic Procedure]
           tomography
   806   C1552357:Computed Tomography [Professional or Occupational Group]
   762   C0040395:Tomographic imaging [Diagnostic Procedure]
           tomography
   760   C1441526:Computed [Laboratory Procedure]
   760   C1880157:Computed [Activity]

Phrase: "is"

Phrase: "their low inherent sensitivity for label detection."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.95: In order to produce detectable contrast, large quantities of a contrast agent at the target site are necessary. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "produce"

Phrase: "detectable contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979874:Contrast [Qualitative Concept]

Phrase: "large quantities of a contrast agent"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1265611:QUANTITIES [Quantitative Concept]
   719 E C1554108:Quantity [Intellectual Product]
   719 E C1561573:Quantity [Intellectual Product]

Phrase: "at the target site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "necessary."
Processing 00000000.tx.96: Furthermore, the adverse effects of ionizing radiation can be restrictive, especially when repeated imaging is required. 

Phrase: "Furthermore,"

Phrase: "the adverse effects of ionizing radiation"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   820   C0034525:Effects of radiation [Biologic Function]
           Effects radiation NOS
   804   C0392615:EFFECT, ADVERSE, RADIATION [Injury or Poisoning]
   790   C0001688:adverse effects [Functional Concept]
   790   C0879626:Adverse effects [Pathologic Function]
   783   C0034526:radiation effects [Intellectual Product]
   756 E C0559546:Adverse Effect [Finding]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "restrictive, especially"

Phrase: "when"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "is"

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.97: At present, the main value of X-ray-based methods for molecular imaging is the function of CT as a complementary modality to nuclear or optical imaging, as it provides high-resolution images at the anatomical level. 

Phrase: "At present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "the main value of X-ray-based methods"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1522609:Value [Quantitative Concept]

Phrase: "for molecular imaging"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1537028:Molecular Imaging [Diagnostic Procedure]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: "is"

Phrase: "the function of CT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "as a complementary modality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0695347:Modality [Idea or Concept]
   861   C1547664:Modality [Diagnostic Procedure]

Phrase: "to nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "or"

Phrase: "optical imaging,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]

Phrase: "as"

Phrase: "it"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "high-resolution images at the anatomical level."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]
Processing 00000000.tx.98: In contrast to X-ray-based methods, ultrasound has been successfully advanced so that it can go beyond anatomical imaging: Doppler ultrasound and colour-coded duplex sonography enables measurements of blood flow, direction and speed. 

Phrase: "In contrast to X-ray-based methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: "ultrasound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041618:Ultrasound [Diagnostic Procedure]
  1000   C0041621:ultrasound [Natural Phenomenon or Process]
  1000   C0220934:ultrasound [Functional Concept]
  1000   C1456803:Ultrasound [Natural Phenomenon or Process]
  1000   C1875843:ULTRASOUND [Medical Device]

Phrase: "has"

Phrase: "been"

Phrase: "successfully"

Phrase: "advanced"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205179:Advanced [Qualitative Concept]
   966 E C0725066:Advance [Medical Device]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "it"

Phrase: "can"

Phrase: "go beyond anatomical imaging"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0220784:Anatomical [Qualitative Concept]
   770   C1822658:GO [Gene or Genome]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: ":"

Phrase: "Doppler ultrasound"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0162481:Doppler ultrasound [Diagnostic Procedure]
   861   C0041618:Ultrasound [Diagnostic Procedure]
   861   C0041621:ultrasound [Natural Phenomenon or Process]
   861   C0220934:ultrasound [Functional Concept]
   861   C0554756:Doppler [Diagnostic Procedure]
   861   C1456803:Ultrasound [Natural Phenomenon or Process]
   861   C1875843:ULTRASOUND [Medical Device]

Phrase: "and"

Phrase: "colour-coded duplex sonography"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   812   C0009393:Color [Natural Phenomenon or Process]
   812   C0041618:sonography [Diagnostic Procedure]
   812   C0444916:Duplex [Spatial Concept]
   812   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   812   C1705245:Color [Pharmacologic Substance]
   779   C0009219:code [Occupational Activity]
   779   C0805701:Code [Intellectual Product]
   756 E C0175676:ultrasonography [Diagnostic Procedure]
   741 E C0522507:colored [Qualitative Concept]

Phrase: "enables"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "measurements of blood flow,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   865   C0005776:blood flow measurement [Diagnostic Procedure]
   770   C0242485:measurements [Functional Concept]
   769   C0429854:Vascular measurements [Laboratory or Test Result]

Phrase: "direction"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0449738:Direction [Spatial Concept]
   900 E C1707761:Directionality [Functional Concept]
   900 E C3274524:Directionality [Functional Concept]

Phrase: "and"

Phrase: "speed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678536:Speed [Quantitative Concept]
Processing 00000000.tx.99: Furthermore, the development of targeted, acoustically reflective contrast agents has added molecular imaging capabilities, as evidenced by several experimental studies. 

Phrase: "Furthermore,"

Phrase: "the development of targeted, acoustically reflective contrast agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0243107:development [Physiologic Function]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]

Phrase: "has"

Phrase: "added molecular imaging capabilities,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2698977:Capability [Qualitative Concept]

Phrase: "as"

Phrase: "evidenced by several experimental studies."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0681814:experimental studies [Research Activity]
   760   C0947630:studies [Laboratory Procedure]
   760   C1517586:Experimental [Qualitative Concept]
   726   C0332120:Evidence [Functional Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]
Processing 00000000.tx.100: Ultrasound is very sensitive for label detection, but achieving sufficient stability of such echogenic formulations is difficult (see the following section). 

Phrase: "Ultrasound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041618:Ultrasound [Diagnostic Procedure]
  1000   C0041621:ultrasound [Natural Phenomenon or Process]
  1000   C0220934:ultrasound [Functional Concept]
  1000   C1456803:Ultrasound [Natural Phenomenon or Process]
  1000   C1875843:ULTRASOUND [Medical Device]

Phrase: "is"

Phrase: "very sensitive for label detection,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332324:Sensitive [Functional Concept]
   760   C1550474:sensitive [Idea or Concept]

Phrase: "but"

Phrase: "achieving sufficient stability of such echogenic formulations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205360:Stability [Qualitative Concept]
   748   C2347098:Stability [Qualitative Concept]

Phrase: "is"

Phrase: "difficult"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332218:Difficult [Qualitative Concept]
   928 E C1299586:Difficulty [Finding]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "the following section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205155:Section [Spatial Concept]
   861   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   861   C1522472:Section [Substance]
   861   C1552923:Section [Quantitative Concept]
   861   C1705191:Section [Physical Object]

Phrase: ")."
Processing 00000000.tx.101: Moreover, spatial resolution of ultrasound rapidly decreases with depth and therefore sonography does not provide as much detail about deeply located structures. 

Phrase: "Moreover,"

Phrase: "spatial resolution of ultrasound rapidly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514893:Resolution [Idea or Concept]
   760   C1706463:Resolution [Quantitative Concept]
   760   C2699488:Resolution [Conceptual Entity]

Phrase: "decreases with depth"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205125:Depth [Spatial Concept]
   790   C0392756:Decrease [Qualitative Concept]
   790   C0547047:Decrease [Quantitative Concept]
   718 E C1422002:DEEPEST [Gene or Genome]

Phrase: "and"

Phrase: "therefore sonography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0041618:sonography [Diagnostic Procedure]
   805 E C0175676:ultrasonography [Diagnostic Procedure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "provide as much detail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1522508:Detail [Qualitative Concept]
   770   C1561567:detail [Functional Concept]
   770   C1999230:Provide [Activity]

Phrase: "about deeply located structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]
Processing 00000000.tx.102: MRT has a particular advantage for use in molecular imaging: information at the anatomical and molecular levels can be recorded simultaneously, as shown in numerous experimental approaches. 

Phrase: "MRT"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   901   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]

Phrase: "has"

Phrase: "a particular advantage for use"

Phrase: "in molecular imaging"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1537028:Molecular Imaging [Diagnostic Procedure]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: ":"

Phrase: "information at the anatomical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1533716:Information [Idea or Concept]

Phrase: "and"

Phrase: "molecular levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "can"

Phrase: "be"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "simultaneously,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]

Phrase: "as"

Phrase: "shown in numerous experimental approaches."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0439064:Numerous [Quantitative Concept]
   760   C0449445:Approaches [Spatial Concept]
   760   C1292724:Approaches [Functional Concept]
   760   C1517586:Experimental [Qualitative Concept]
   726   C1547282:Show [Intellectual Product]
Processing 00000000.tx.103: Because MRT does not achieve the sensitivity of nuclear or optical methods, it necessitates higher amounts of contrast agent at the intended target to provide sufficient contrast. 

Phrase: "Because"

Phrase: "MRT"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   901   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "achieve"

Phrase: "the sensitivity of nuclear"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "or"

Phrase: "optical methods,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1518598:Optical Methods [Laboratory Procedure]
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "it"

Phrase: "necessitates"

Phrase: "higher amounts of contrast agent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "at the intended target to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521840:Target [Functional Concept]
   827   C2986546:TARGET [Diagnostic Procedure]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "sufficient contrast."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1979874:Contrast [Qualitative Concept]
Processing 00000000.tx.104: In addition to the high complexity of such probes (see the following section), this is one of the reasons why the design of MRT-based molecular imaging probes remains a challenge [46, 9]. 

Phrase: "In addition to the high complexity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0439855:Complex [Qualitative Concept]
   789   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "of such probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0182400:Probes [Medical Device]
   966 E C1704681:Probe [Gene or Genome]
   966 E C2347609:Probe [Chemical Viewed Functionally]
   966 E C3536729:Probe [Manufactured Object]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "the following section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205155:Section [Spatial Concept]
   861   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   861   C1522472:Section [Substance]
   861   C1552923:Section [Quantitative Concept]
   861   C1705191:Section [Physical Object]

Phrase: ")"

Phrase: ","

Phrase: "this"

Phrase: "is"

Phrase: "one of the reasons why"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "the design of MRT-based molecular imaging probes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1707689:Design [Activity]
   739   C2983265:DESIGN [Intellectual Product]

Phrase: "remains"

Phrase: "a challenge"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0798503:Challenge [Clinical Attribute]
  1000   C0805586:Challenge [Health Care Activity]
  1000   C3274764:Challenge [Conceptual Entity]

Phrase: "[46,"

Phrase: "9"

Phrase: "]."
Processing 00000000.tx.105: Exquisite sensitivity, especially for PET, which is even more sensitive than SPECT, is the primary advantage of nuclear imaging methods. 

Phrase: "Exquisite sensitivity,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "especially for PET,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   760   C0032744:Positron [Quantitative Concept]
   760   C0040395:tomography [Diagnostic Procedure]
   760   C0040405:tomography [Diagnostic Procedure]
   760   C0233929:Emission [Body Substance]
   760   C2349995:Emission [Substance]

Phrase: "which"

Phrase: "is"

Phrase: "even more sensitive than SPECT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332324:Sensitive [Functional Concept]
   742   C1550474:sensitive [Idea or Concept]

Phrase: "is"

Phrase: "the primary advantage of nuclear imaging methods."
Processing 00000000.tx.106: Also advantageous is their ability to provide quantitative measurements. 

Phrase: "Also advantageous"

Phrase: "is"

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "quantitative measurements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]
Processing 00000000.tx.107: The limiting factor is low spatial resolution, which can make it difficult to assign the signal to a specific anatomicalmorphological structure, a disadvantage which can be partly compensated for by combining nuclear imaging techniques with CT. 

Phrase: "The limiting factor"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0439801:limiting [Functional Concept]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]
   827 E C1549649:Limit [Idea or Concept]
   827 E C2349209:Limit [Conceptual Entity]

Phrase: "is"

Phrase: "low spatial resolution,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514893:Resolution [Idea or Concept]
   827   C1706463:Resolution [Quantitative Concept]
   827   C2699488:Resolution [Conceptual Entity]

Phrase: "which"

Phrase: "can"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "it difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "assign"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516050:Assign [Functional Concept]

Phrase: "the signal to a specific anatomicalmorphological structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "a disadvantage"

Phrase: "which"

Phrase: "can"

Phrase: "be"

Phrase: "partly"

Phrase: "compensated for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205432:Compensated [Qualitative Concept]

Phrase: "by combining nuclear imaging techniques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0079595:Imaging Techniques [Diagnostic Procedure]
   812   C0025664:techniques [Intellectual Product]
   812   C0449851:Techniques [Functional Concept]

Phrase: "with CT."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0040405:computed tomography [Diagnostic Procedure]
           tomography
  1000   C1552357:Computed Tomography [Professional or Occupational Group]
   861   C0040395:tomography [Diagnostic Procedure]
   861   C1441526:Computed [Laboratory Procedure]
   861   C1880157:Computed [Activity]
Processing 00000000.tx.108: Like nuclear imaging techniques, optical imaging methods are very sensitive. 

Phrase: "Like nuclear imaging techniques,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0079595:Imaging Techniques [Diagnostic Procedure]
   827   C0025664:techniques [Intellectual Product]
   827   C0449851:Techniques [Functional Concept]

Phrase: "optical imaging methods"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1518598:Optical Methods [Laboratory Procedure]
   901   C1275506:imaging methods [Functional Concept]
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]
   734   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]

Phrase: "are"

Phrase: "very sensitive."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.109: Their major shortcoming is low spatial resolution and primarily limited depth penetration, due to light scattering and absorption in tissue. 

Phrase: "Their major shortcoming"

Phrase: "is"

Phrase: "low spatial resolution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514893:Resolution [Idea or Concept]
   827   C1706463:Resolution [Quantitative Concept]
   827   C2699488:Resolution [Conceptual Entity]

Phrase: "and"

Phrase: "primarily limited depth penetration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205321:Penetration [Functional Concept]

Phrase: "due to light scattering"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0596837:Light Scattering [Phenomenon or Process]
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C0439742:Scattering [Spatial Concept]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "absorption in tissue."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0000854:Absorption [Natural Phenomenon or Process]
   790   C0220777:absorption [Functional Concept]
   790   C2347023:Absorption [Phenomenon or Process]
   790   C2347080:Absorption [Phenomenon or Process]
   790   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   790   C2825050:Absorption [Phenomenon or Process]
Processing 00000000.tx.110: For imaging superficial tissues located at outer surfaces (e.g. skin lesions and arthritic finger joints) or at inner surfaces by using endoscopic devices (e.g. gastrointestinal lesions), optical imaging can provide a fast and inexpensive method, with relatively simple instrumentation requirements [46, 9]. 

Phrase: "For imaging superficial tissues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1525427:Superficial tissue [Tissue]
   827   C0040300:Tissues [Tissue]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "located at outer surfaces"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205101:Outer [Spatial Concept]
   737   C0205148:Surface [Spatial Concept]

Phrase: "("

Phrase: "e.g. skin lesions"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   966   C0037284:Skin lesion [Disease or Syndrome]
   861   C0221198:lesions [Finding]
   861   C0444099:Skin [Body Substance]
   861   C1123023:Skin [Body System]
   861   C1278993:Skin [Body System]
   827 E C1546698:Lesion [Intellectual Product]
   805 E C0221912:Cutaneous [Spatial Concept]
   805 E C0221928:Dermal [Qualitative Concept]
   805 E C1522447:Cutaneous [Functional Concept]
   738 E C0011646:Dermis [Tissue]

Phrase: "and"

Phrase: "arthritic finger joints"
Meta Candidates (Total=14; Excluded=9; Pruned=0; Remaining=5)
   901   C0016125:Joints, Finger [Body Space or Junction]
   827   C0016129:Finger [Body Location or Region]
   827   C0022417:Joints [Body Space or Junction]
   827   C0392905:Joints [Body System]
   827   C1281584:Finger [Body Part, Organ, or Organ Component]
   793 E C1269611:Joint [Body Space or Junction]
   793 E C1706309:Joint [Medical Device]
   771 E C0442015:Digital [Intellectual Product]
   771 E C1883674:Digital [Qualitative Concept]
   755 E C0521339:Articular [Functional Concept]
   743 E C0549188:fingers [Quantitative Concept]
   734 E C0582802:Digit [Body Part, Organ, or Organ Component]
   734 E C1283912:Digit [Body Part, Organ, or Organ Component]
   734 E C3241971:Digit [Quantitative Concept]

Phrase: ")"

Phrase: "or at inner surfaces"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205102:Inner [Spatial Concept]
   737   C0205148:Surface [Spatial Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "endoscopic devices"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   947   C0809784:Endoscopy device [Medical Device]
   861   C0025080:DEVICES [Medical Device]
   861   C0220819:devices [Manufactured Object]
   861   C0699733:Devices [Manufactured Object]

Phrase: "("

Phrase: "e.g. gastrointestinal lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "optical imaging"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]

Phrase: "can"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a fast"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015663:Fast [Finding]
  1000   C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "inexpensive method,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "with relatively simple instrumentation requirements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1514873:Requirement [Functional Concept]

Phrase: "[46,"

Phrase: "9"

Phrase: "]."
Processing 00000000.tx.111: In recent years, imaging instrumentation dedicated to small animal imaging has also become available for all major clinical modalities (microCT, small animal ultrasound systems, microMRI, microSPECT, microPET), as well as combinations of different imaging modalities (e.g. microSPECT/CT or microPET/CT). 

Phrase: "In recent years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "instrumentation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0021632:instrumentation [Qualitative Concept]
  1000   C0348000:Instrumentation [Medical Device]
  1000   C1704339:Instrumentation [Quantitative Concept]

Phrase: "dedicated to small animal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003062:Animal [Animal]
   770   C0700321:Small [Quantitative Concept]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "has"

Phrase: "also"

Phrase: "become"

Phrase: "available for all major clinical modalities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0470187:Available [Functional Concept]

Phrase: "(microCT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2350281:MicroCT [Diagnostic Procedure]

Phrase: "small animal ultrasound systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]

Phrase: "microMRI,"

Phrase: "microSPECT,"

Phrase: "microPET"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986783:MicroPET [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "combinations of different imaging modalities"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0453882:Combinations [Manufactured Object]
   726 E C0205195:Combination [Qualitative Concept]
   726 E C1947911:Combination [Physical Object]

Phrase: "("

Phrase: "e.g. microSPECT/CT"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0040405:computed tomography [Diagnostic Procedure]
           tomography
   901   C1552357:Computed Tomography [Professional or Occupational Group]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C1441526:Computed [Laboratory Procedure]
   827   C1880157:Computed [Activity]

Phrase: "or"

Phrase: "microPET/CT"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0040405:computed tomography [Diagnostic Procedure]
           tomography
   901   C1552357:Computed Tomography [Professional or Occupational Group]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C1441526:Computed [Laboratory Procedure]
   827   C1880157:Computed [Activity]

Phrase: ")."
Processing 00000000.tx.112: Since clinical systems are usually available in larger hospitals and small animal imaging systems often require a high initial investment, there is also a parallel trend to adapt clinical scanners to the needs of small animal imaging, for instance by using dedicated animal coils in MRT [10]. 

Phrase: "Since"

Phrase: "clinical systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "are"

Phrase: "usually available in larger hospitals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0470187:Available [Functional Concept]

Phrase: "and"

Phrase: "small animal imaging systems often"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   937   C1519361:Small Animal Imaging Systems [Research Device]
   823   C2697665:Imaging System [Manufactured Object]
   771   C0449913:System [Functional Concept]
   771   C1553451:System [Manufactured Object]
   771   C1704459:System [Medical Device]
   721 E C0205373:Systemic [Functional Concept]

Phrase: "require"

Phrase: "a high initial investment,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021953:investment [Manufactured Object]

Phrase: "there"

Phrase: "is"

Phrase: "also"

Phrase: "a parallel trend to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1521798:trend [Temporal Concept]

Phrase: "adapt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2937289:adapt [Organic Chemical]

Phrase: "clinical scanners to the needs of small animal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0183115:scanners [Medical Device]
   711 E C1710020:Scanner [Medical Device]

Phrase: "imaging,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "for instance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "dedicated animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animal [Animal]

Phrase: "coils in MRT"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   806   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   806   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   806   C1551403:Magnetic resonance [Laboratory Procedure]
   760   C0024488:Magnetic [Occupation or Discipline]
   760   C0040395:tomography [Diagnostic Procedure]
   760   C0040405:tomography [Diagnostic Procedure]
   760   C0231881:Resonance [Finding]
   760   C0444764:Coils [Spatial Concept]
   760   C0459800:resonance [Natural Phenomenon or Process]
   760   C0563532:magnetic [Natural Phenomenon or Process]
   760   C0684213:Resonance [Qualitative Concept]
   760   C1413568:COIL [Gene or Genome]
   760   C1705945:COILS [Intellectual Product]
   760   C1705946:Coil [Medical Device]

Phrase: "[10"

Phrase: "]."
Processing 00000000.tx.113: Various instrumentations also exist for small animal optical-based imaging [11].  

Phrase: "Various instrumentations also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0021632:instrumentation [Qualitative Concept]
   793   C0348000:Instrumentation [Medical Device]
   793   C1704339:Instrumentation [Quantitative Concept]

Phrase: "exist for small animal optical-based imaging"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   774   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]
   748   C0003062:Animal [Animal]
   748   C0011923:Imaging [Diagnostic Procedure]
   748   C0079595:Imaging [Diagnostic Procedure]
   748   C0700321:Small [Quantitative Concept]
   748   C1527178:Based [Functional Concept]
   748   C1705938:Based [Idea or Concept]
   748   C2987476:Exist [Conceptual Entity]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1704254:Image [Intellectual Product]
   714 E C1704922:Image [Entity]
   714 E C1880279:Base [Biomedical or Dental Material]
   714 E C3542466:Image [Intellectual Product]

Phrase: "[11"

Phrase: "]."
Processing 00000000.tx.114: Recent advances in molecular imaging Top Abstract Background Development of novel molecular... 

Phrase: "Recent advances in molecular imaging Top Abstract Background Development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0725066:Advance [Medical Device]

Phrase: "of novel molecular..."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
Processing 00000000.tx.115: Imaging modalities Recent advances in molecular... 

Phrase: "Imaging modalities Recent advances in molecular..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0725066:Advance [Medical Device]
Processing 00000000.tx.116: Molecular imaging in RA Outlook References  Various imaging agents with molecular specificity (targeted and activatable probes) have been designed for ultrasound, MRT, nuclear and optical imaging. 

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "imaging in RA Outlook"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   806   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   760   C0003864:Arthritis [Disease or Syndrome]
   760   C0004271:Outlook [Mental Process]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0079595:Imaging [Diagnostic Procedure]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Various imaging agents with molecular specificity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   719   C0450442:Agent [Chemical Viewed Functionally]
   719   C1254351:Agent [Pharmacologic Substance]
   719   C1521826:Agent [Intellectual Product]

Phrase: "("

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "activatable probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "designed for ultrasound,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0041618:Ultrasound [Diagnostic Procedure]
   790   C0041621:ultrasound [Natural Phenomenon or Process]
   790   C0220934:ultrasound [Functional Concept]
   790   C1456803:Ultrasound [Natural Phenomenon or Process]
   790   C1875843:ULTRASOUND [Medical Device]
   756   C1707689:Design [Activity]
   756   C2983265:DESIGN [Intellectual Product]

Phrase: "MRT,"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   901   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]

Phrase: "nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "and"

Phrase: "optical imaging."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]
Processing 00000000.tx.117: They can be used to image cellular and molecular events, such as gene expression, angiogenesis, apoptosis and cell trafficking [46, 9]. 

Phrase: "They"

Phrase: "can"

Phrase: "be"

Phrase: "used to image"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C1273517:used [Finding]
   790   C1704254:Image [Intellectual Product]
   790   C1704922:Image [Entity]
   790   C3542466:Image [Intellectual Product]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007634:Cellular [Cell]
  1000   C0178539:Cellular [Functional Concept]
   928 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "molecular events,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "such as gene expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "angiogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "[46,"

Phrase: "9"

Phrase: "]."
Processing 00000000.tx.118: Targeted imaging agents Targeted ultrasound imaging agents have been developed by conjugating affinity ligands to acoustically reflective particles, including microbubbles and liposomes. 

Phrase: "Targeted imaging agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: "Targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "ultrasound imaging agents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]
   734   C0041618:Ultrasound Imaging [Diagnostic Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "developed by conjugating affinity ligands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0023688:Ligands [Chemical]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   726   C0301869:Conjugate [Immunologic Factor]

Phrase: "to acoustically reflective particles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597177:particles [Chemical Viewed Structurally]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "microbubbles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1258018:Microbubbles [Medical Device]

Phrase: "and"

Phrase: "liposomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023828:Liposomes [Lipid]
Processing 00000000.tx.119: For clinical purposes, these agents have been developed for imaging, thrombosis, endothelial cell adhesion molecules, tissue factors, activated leucocytes and angiogenesis. 

Phrase: "For clinical purposes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285529:purposes [Functional Concept]

Phrase: "these agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "developed for imaging, thrombosis,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0040053:Thrombosis [Pathologic Function]
   770   C0079595:Imaging [Diagnostic Procedure]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: "endothelial cell adhesion molecules,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   988   C1424976:ENDOTHELIAL CELL ADHESION MOLECULE [Gene or Genome]
   923   C0007578:Cell Adhesion Molecules [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   812   C0567416:molecules [Substance]
   729 E C1521991:Molecular [Qualitative Concept]

Phrase: "tissue factors,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0040048:Tissue Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   966   C1333522:TISSUE FACTOR [Gene or Genome]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "activated leucocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023516:leucocytes [Cell]

Phrase: "and"

Phrase: "angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.120: Among the potential limitations of ultrasound-targeted contrast agents are their stability and the relatively large size of such formulations (>250 nm), limiting their ability to overcome biological barriers [12, 13]. 

Phrase: "Among the potential limitations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449295:limitations [Functional Concept]

Phrase: "of ultrasound-targeted contrast agents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0009924:Contrast Agents [Indicator, Reagent, or Diagnostic Aid]
   812   C1979874:Contrast [Qualitative Concept]
   779   C0450442:Agent [Chemical Viewed Functionally]
   779   C1254351:Agent [Pharmacologic Substance]
   779   C1521826:Agent [Intellectual Product]

Phrase: "are"

Phrase: "their stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "the relatively large size of such formulations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0456389:size [Spatial Concept]

Phrase: "("

Phrase: ">250 nm),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "limiting"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0439801:limiting [Functional Concept]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "biological barriers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706912:BARRIER [Medical Device]

Phrase: "[12,"

Phrase: "13"

Phrase: "]."
Processing 00000000.tx.121: Targeted MRT agents are based on superparamagnetic iron oxide nanoparticles or on lanthanide chelates such as gadolinium-DTPA. 

Phrase: "Targeted MRT agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C0450442:Agent [Chemical Viewed Functionally]
   771   C1254351:Agent [Pharmacologic Substance]
   771   C1521826:Agent [Intellectual Product]

Phrase: "are"

Phrase: "based on superparamagnetic iron oxide nanoparticles"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   833   C0246249:Superparamagnetic iron oxide [Inorganic Chemical,Pharmacologic Substance]
   790   C0060240:Iron oxide [Inorganic Chemical,Pharmacologic Substance]
   753   C0030015:oxide [Inorganic Chemical]
   753   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0376520:Iron [Inorganic Chemical]
   753   C1166521:iron [Pharmacologic Substance]
   753   C1450054:Nanoparticles [Manufactured Object]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C2986642:oxide [Chemical Viewed Functionally]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "or on lanthanide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205838:lanthanide [Element, Ion, or Isotope]

Phrase: "chelates such as gadolinium-DTPA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0060933:Gadolinium DTPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   806   C0060934:Gadolinium DTPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0013254:DTPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   760   C0016911:Gadolinium [Element, Ion, or Isotope,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.122: Superparamagnetic iron oxide particles usually consist of a crystalline iron oxide core containing thousands of iron atoms, surrounded by a polymer coating. 

Phrase: "Superparamagnetic iron oxide particles usually"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0597177:particles [Chemical Viewed Structurally]
   717   C0246249:Superparamagnetic iron oxide [Inorganic Chemical,Pharmacologic Substance]

Phrase: "consist of a crystalline iron oxide core containing thousands of iron atoms,"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   753   C0060240:Iron oxide [Inorganic Chemical,Pharmacologic Substance]
   736   C0030015:oxide [Inorganic Chemical]
   736   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   736   C0332256:Containing [Functional Concept]
   736   C0332529:CONSIST [Qualitative Concept]
   736   C0376520:Iron [Inorganic Chemical]
   736   C0444626:Crystalline [Chemical Viewed Structurally]
   736   C0444669:Core [Spatial Concept]
   736   C0567415:Atoms [Element, Ion, or Isotope]
   736   C1166521:iron [Pharmacologic Substance]
   736   C1167518:core [Cell Component]
   736   C1706352:Core [Medical Device]
   736   C1882467:Core [Manufactured Object]
   736   C1883310:Thousand [Quantitative Concept]
   736   C2700400:Containing [Activity]
   736   C2986642:oxide [Chemical Viewed Functionally]
   736   C3274653:Core [Body Substance]
   703 E C1706222:Atom [Conceptual Entity]

Phrase: "surrounded by a polymer coating."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0032521:Polymer [Biomedical or Dental Material,Chemical Viewed Structurally]
   760   C1282914:Surrounded [Spatial Concept]
   760   C1522408:Coating [Qualitative Concept]
   760   C1704806:Coating [Biomedical or Dental Material]
Processing 00000000.tx.123: The individual formulations vary in size (10300 nm), coating (e.g. dextran or polyethyleneglycol) and magnetic properties (R1, R2, susceptibility). 

Phrase: "The individual formulations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0524527:Formulation [Research Activity]

Phrase: "vary in size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456389:size [Spatial Concept]

Phrase: "(10300 nm),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "coating"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1522408:Coating [Qualitative Concept]
  1000   C1704806:Coating [Biomedical or Dental Material]
   966 E C0453946:Coat [Manufactured Object]
   966 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "("

Phrase: "e.g. dextran"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "polyethyleneglycol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032483:Polyethylene Glycol [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "magnetic properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "(R1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1335648:R1 [Gene or Genome]
  1000   C1824685:R1 [Gene or Genome]
  1000   C2697937:R1 [Quantitative Concept]

Phrase: "R2,"

Phrase: "susceptibility"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0012655:Susceptibility [Clinical Attribute]
  1000   C0220898:Susceptibility [Organism Attribute]
  1000   C1264642:Susceptibility [Functional Concept]
  1000   C1547045:*Susceptibility [Quantitative Concept]
   928 E C0231204:Susceptible [Functional Concept]
   928 E C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: ")."
Processing 00000000.tx.124: Efficient targeting also requires strategies such as caging of the dextran coat. 

Phrase: "Efficient targeting also"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1521840:Targeting [Functional Concept]
   793 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "requires"

Phrase: "strategies such as caging of the dextran coat."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0679199:strategies [Mental Process]
Processing 00000000.tx.125: Dextran caging has been achieved by cross-linking the coating and resultant particles (cross-linked iron oxide, CLIO), and is being used as a basis for targeting receptors, integrins or specific cells. 

Phrase: "Dextran caging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0337189:Cage [Manufactured Object]
   827   C0441239:Cage [Medical Device]

Phrase: "has"

Phrase: "been"

Phrase: "achieved by"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "the coating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522408:Coating [Qualitative Concept]
  1000   C1704806:Coating [Biomedical or Dental Material]

Phrase: "and"

Phrase: "resultant particles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597177:particles [Chemical Viewed Structurally]

Phrase: "("

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "iron oxide,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0060240:Iron oxide [Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "CLIO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1915069:Clio [Eukaryote]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "is"

Phrase: "being"

Phrase: "used as a basis"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1273517:used [Finding]
   770   C1527178:Basis [Functional Concept]
   770   C1874451:Basis [Pharmacologic Substance]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "for targeting receptors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "integrins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021701:Integrins [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]

Phrase: "or"

Phrase: "specific cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.126: Lanthanide chelates, such as gadolinium-DTPA, are also used as MRT contrast agents, but their lower intrinsic relaxivity requires larger-sized nanoparticle constructs, such as polymerized liposomes, dendrimers and perfluorocarbon nanoparticles, to achieve high magnetic payloads and longer intravascular lifetimes. 

Phrase: "Lanthanide chelates,"

Phrase: "such as gadolinium-DTPA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0060933:Gadolinium DTPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C0060934:Gadolinium DTPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0013254:DTPA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "are"

Phrase: "also"

Phrase: "used as MRT contrast agents,"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   778   C0009924:Contrast Agents [Indicator, Reagent, or Diagnostic Aid]
   778   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   778   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   778   C1551403:Magnetic resonance [Laboratory Procedure]
   774   C0449900:Contrast used [Diagnostic Procedure]
   757   C0449881:Agent used [Functional Concept]
   748   C0024488:Magnetic [Occupation or Discipline]
   748   C0040395:tomography [Diagnostic Procedure]
   748   C0040405:tomography [Diagnostic Procedure]
   748   C0231881:Resonance [Finding]
   748   C0459800:resonance [Natural Phenomenon or Process]
   748   C0563532:magnetic [Natural Phenomenon or Process]
   748   C0684213:Resonance [Qualitative Concept]
   748   C1273517:used [Finding]
   748   C1979874:Contrast [Qualitative Concept]
   714 E C0042153:use [Functional Concept]
   714   C0450442:Agent [Chemical Viewed Functionally]
   714 E C0457083:Use [Functional Concept]
   714   C1254351:Agent [Pharmacologic Substance]
   714   C1521826:Agent [Intellectual Product]
   714 E C1947944:Use [Intellectual Product]

Phrase: "but"

Phrase: "their"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "intrinsic relaxivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882924:Relaxivity [Qualitative Concept]

Phrase: "requires"

Phrase: "larger-sized nanoparticle constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C2827421:Construct [Classification]

Phrase: "such as polymerized liposomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023828:Liposomes [Lipid]

Phrase: "dendrimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1563732:Dendrimers [Biomedical or Dental Material,Chemical Viewed Structurally]

Phrase: "and"

Phrase: "perfluorocarbon nanoparticles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1450054:Nanoparticles [Manufactured Object]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "high magnetic payloads"

Phrase: "and"

Phrase: "longer intravascular lifetimes."
Processing 00000000.tx.127: However, these agents have been successfully used to image angiogenesis, progenitor cells and thrombotic events in vivo [14, 15]. 

Phrase: "However,"

Phrase: "these agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "successfully"

Phrase: "used to image angiogenesis,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0302600:Angiogenesis [Organ or Tissue Function]
   770   C1273517:used [Finding]
   770   C1519670:angiogenesis [Neoplastic Process]
   770   C1704254:Image [Intellectual Product]
   770   C1704922:Image [Entity]
   770   C3542466:Image [Intellectual Product]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "progenitor cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0038250:Progenitor Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "thrombotic events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "[14,"

Phrase: "15"

Phrase: "]."
Processing 00000000.tx.128: Targeted nuclear imaging agents have been primarily developed for vascular processes and targets, including apoptosis and angiogenesis, viability, atherosclerosis and thrombosis. 

Phrase: "Targeted nuclear imaging agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   779   C0450442:Agent [Chemical Viewed Functionally]
   779   C1254351:Agent [Pharmacologic Substance]
   779   C1521826:Agent [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "primarily"

Phrase: "developed for vascular processes"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0005847:vascular [Body Part, Organ, or Organ Component]
   770   C1558950:VASCULAR [Finding]
   770   C1801960:Vascular [Qualitative Concept]
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]
   715 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   715 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "and"

Phrase: "targets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521840:Target [Functional Concept]
   966   C2986546:TARGET [Diagnostic Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "angiogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "viability,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]

Phrase: "atherosclerosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]

Phrase: "and"

Phrase: "thrombosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040053:Thrombosis [Pathologic Function]
   928 E C0087086:Thrombotic [Pathologic Function]
Processing 00000000.tx.129: Targeted nuclear agents can also visualize gene expression, for example by targeting a gene-transcribed extracellular protein or by detecting expression of a reporter gene such as herpes simplex virus thymidine kinase (HSV-Tk). 

Phrase: "Targeted nuclear agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]

Phrase: "can"

Phrase: "also"

Phrase: "visualize"

Phrase: "gene expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "for example"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "by targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "a gene-transcribed extracellular protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or by detecting expression of a reporter gene"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0206414:Reporter Gene [Gene or Genome]
   767   C0017262:Gene Expression [Genetic Function]
   744   C0017337:Gene [Gene or Genome]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0335038:Reporter [Professional or Occupational Group]
   744   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   744   C1705915:Reporter [Conceptual Entity]
   744   C1709908:Reporter [Group]
   711   C0442726:detect [Finding]

Phrase: "such as herpes simplex virus thymidine kinase (HSV-Tk)."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   924   C0879457:herpes simplex thymidine kinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   884   C0206558:Herpes Simplex Virus [Virus]
   853   C0019369:Herpes Virus [Virus]
   840   C0019348:Herpes Simplex [Disease or Syndrome]
   840   C0040078:Thymidine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0019340:Herpes [Disease or Syndrome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0042776:Virus [Virus]
   804   C0319157:virus [Virus]
   804   C2338991:Simplex [Body Part, Organ, or Organ Component]
Processing 00000000.tx.130: In mammalian cells, exogenous HSV-Tk phosphorylates acylguanosine residues, generating biological signal amplification when the phosphorylated radioisotopes are intracellularly trapped [16, 17]. 

Phrase: "In mammalian cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "exogenous HSV-Tk"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   895   C0879457:herpes simplex thymidine kinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0206558:Herpes Simplex Virus [Virus]
   839   C0019369:Herpes Virus [Virus]
   827   C0019348:Herpes Simplex [Disease or Syndrome]
   827   C0040078:Thymidine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0019340:Herpes [Disease or Syndrome]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0042776:Virus [Virus]
   799   C0319157:virus [Virus]
   799   C2338991:Simplex [Body Part, Organ, or Organ Component]

Phrase: "phosphorylates"

Phrase: "acylguanosine residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "generating"

Phrase: "biological signal amplification"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1517480:Amplification [Molecular Biology Research Technique]
   827   C1521871:Amplification [Phenomenon or Process]
   827   C1705759:Amplification [Cell or Molecular Dysfunction]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "when"

Phrase: "the phosphorylated radioisotopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034595:Radioisotopes [Element, Ion, or Isotope]

Phrase: "are"

Phrase: "intracellularly"

Phrase: "trapped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184047:Trapped [Medical Device]

Phrase: "[16,"

Phrase: "17"

Phrase: "]."
Processing 00000000.tx.131: A number of targeted optical imaging agents have been described, including those with specificity for receptors (e.g. for folate, somatostatin) or specific ligands primarily for imaging cancer cells or apoptotic cells. 

Phrase: "A number of targeted optical imaging agents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "those with specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0037791:Specificity [Quantitative Concept]
   790   C1511884:Specificity [Quantitative Concept]
   718 E C0205369:Specific [Qualitative Concept]
   718 E C1552740:specific [Intellectual Product]

Phrase: "for receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "("

Phrase: "e.g."

Phrase: "for folate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178638:Folate [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "somatostatin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   916 E C0373723:somatostatins [Laboratory Procedure]

Phrase: ")"

Phrase: "or"

Phrase: "specific ligands primarily for imaging cancer cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0023688:Ligands [Chemical]

Phrase: "or"

Phrase: "apoptotic cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.132: Using fluorochromes such as Cy5.5 or Cy7, which absorb and emit light in the near-infrared bandwidth, minimizes autofluorescence and maximizes tissue penetration because the major absorbers, haemoglobin and water, have their lowest absorption coefficients in the near-infrared region. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorochromes such as Cy5.5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0016342:Fluorochromes [Indicator, Reagent, or Diagnostic Aid]
   726 E C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "Cy7,"

Phrase: "which"

Phrase: "absorb"

Phrase: "and"

Phrase: "emit light in the near-infrared bandwidth,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   774   C0021431:infrared light [Natural Phenomenon or Process]
   748   C0023693:Light [Natural Phenomenon or Process]
   748   C1306462:Light [Functional Concept]
   748   C1881376:Light [Qualitative Concept]
   732 E C0181645:infrared lights [Medical Device]

Phrase: "minimizes"

Phrase: "autofluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544711:Autofluorescence [Finding]

Phrase: "and"

Phrase: "maximizes"

Phrase: "tissue penetration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205321:Penetration [Functional Concept]

Phrase: "because"

Phrase: "the major absorbers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706690:Absorber [Manufactured Object]

Phrase: "haemoglobin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "water,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "have"

Phrase: "their lowest absorption coefficients in the near-infrared region."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C1441621:Infrared absorption [Laboratory Procedure]
   742   C0000854:Absorption [Natural Phenomenon or Process]
   742   C0220777:absorption [Functional Concept]
   742   C2347023:Absorption [Phenomenon or Process]
   742   C2347080:Absorption [Phenomenon or Process]
   742   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   742   C2825050:Absorption [Phenomenon or Process]
   708   C1707429:*Coefficient [Quantitative Concept]
Processing 00000000.tx.133: Optical imaging is a rapid and inexpensive method of visualizing biological events. 

Phrase: "Optical imaging"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]

Phrase: "is"

Phrase: "a rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "inexpensive method of visualizing biological events."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.134: The use of spectrally different fluorochromes allows the concurrent imaging of multiple targets (multichannel imaging) [11]. 

Phrase: "The use of spectrally different fluorochromes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the concurrent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205420:Concurrent [Temporal Concept]

Phrase: "imaging of multiple targets"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0439064:Multiple [Quantitative Concept]
   737   C1521840:Target [Functional Concept]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737   C2986546:TARGET [Diagnostic Procedure]
   737 E C3542466:Image [Intellectual Product]

Phrase: "(multichannel"

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: ")"

Phrase: "[11"

Phrase: "]."
Processing 00000000.tx.135: Activatable agents Activatable MRT agents are already detectable in their native form, but target interaction causes a change in relaxivity (activation) which can be detected by MRT. 

Phrase: "Activatable agents Activatable MRT agents"

Phrase: "are"

Phrase: "already detectable in their native form,"

Phrase: "but"

Phrase: "target interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a change in relaxivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "(activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: ")"

Phrase: "which"

Phrase: "can"

Phrase: "be"

Phrase: "detected by MRT."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   806   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   806   C1551403:Magnetic resonance [Laboratory Procedure]
   760   C0024488:Magnetic [Occupation or Discipline]
   760   C0040395:tomography [Diagnostic Procedure]
   760   C0040405:tomography [Diagnostic Procedure]
   760   C0231881:Resonance [Finding]
   760   C0442726:Detected [Finding]
   760   C0459800:resonance [Natural Phenomenon or Process]
   760   C0563532:magnetic [Natural Phenomenon or Process]
   760   C0684213:Resonance [Qualitative Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.136: Several probes based on lanthanide chelate and superparamagnetic nanoparticles with different molecular specificities have been developed in recent years, e.g. to visualize enzyme activity, different affinity targets such as E-selectin, or to evaluate molecular interactions (DNADNA, proteinprotein, protein-small molecule) [1820]. 

Phrase: "Several probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "based on lanthanide chelate"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0205838:lanthanide [Element, Ion, or Isotope]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "superparamagnetic nanoparticles with different molecular specificities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1450054:Nanoparticles [Manufactured Object]

Phrase: "have"

Phrase: "been"

Phrase: "developed in recent years,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332185:Recent [Temporal Concept]
   770   C0439234:years [Temporal Concept]
   737 E C0439508:/year [Temporal Concept]

Phrase: "e.g. to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "visualize"

Phrase: "enzyme activity,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0243102:enzyme activity [Molecular Function]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "different affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "targets such as E-selectin,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0115305:SELECTIN E [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   797   C1337114:SELECTIN E [Gene or Genome]
   760   C0282651:Selectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1325391:selectin [Molecular Function]
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]

Phrase: "or"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "molecular interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1167622:Molecular Interaction [Molecular Function]
   827   C1704675:Interaction [Functional Concept]

Phrase: "(DNADNA,"

Phrase: "proteinprotein,"

Phrase: "protein-small molecule"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1328819:Small Molecule [Organic Chemical]
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: ")"

Phrase: "[1820"

Phrase: "]."
Processing 00000000.tx.137: A number of activatable optical imaging agents have been developed for in vivo imaging of protease activity. 

Phrase: "A number of activatable optical imaging agents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "developed for in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "imaging of protease activity."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C1150095:protease activity [Molecular Function]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   770   C1947941:Protease [Enzyme]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.138: The fluorescence of these probes is quenched until activation by enzymatic cleavage, which results in a marked increase in the fluorescence signal. 

Phrase: "The fluorescence of these probes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0016321:Fluorescent Probes [Indicator, Reagent, or Diagnostic Aid]
   760   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "quenched until activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "by enzymatic cleavage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "which"

Phrase: "results in a marked increase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0442805:Increase [Functional Concept]
   760   C0522501:Marked [Qualitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1706089:Marked [Qualitative Concept]
   760   C2825142:Result [Finding]

Phrase: "in the fluorescence signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.139: Various probes with different specificities (e.g. cathepsins, MMPs, caspases) have been tested and characterized for the imaging of cancer invasiveness and apoptosis [11].  

Phrase: "Various probes with different specificities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0182400:Probes [Medical Device]
   726 E C1704681:Probe [Gene or Genome]
   726 E C2347609:Probe [Chemical Viewed Functionally]
   726 E C3536729:Probe [Manufactured Object]

Phrase: "("

Phrase: "e.g. cathepsins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007428:Cathepsins [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "MMPs,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "caspases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "characterized for the imaging of cancer invasiveness"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   778   C0920779:cancer invasiveness [Pathologic Function]
   748   C0006826:Cancer [Neoplastic Process]
   748   C0011923:Imaging [Diagnostic Procedure]
   748   C0079595:Imaging [Diagnostic Procedure]
   748   C0998265:Cancer [Eukaryote]
   748   C1301757:Invasiveness [Qualitative Concept]
   748   C1306459:Cancer [Finding]
   748   C1880022:Characterized [Activity]
   738 E C0677898:invasive cancer [Neoplastic Process]
   714 E C1704254:Image [Intellectual Product]
   714 E C1704922:Image [Entity]
   714 E C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "[11"

Phrase: "]."
Processing 00000000.tx.140: Molecular imaging in RA Top Abstract Background Development of novel molecular... 

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "imaging in RA Top Abstract Background Development of novel molecular..."
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   756   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   756   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   754   C1537028:Molecular Imaging [Diagnostic Procedure]
   738   C0000857:Abstract [Occupational Activity]
   738   C0003864:Arthritis [Disease or Syndrome]
   738   C0011923:Imaging [Diagnostic Procedure]
   738   C0079595:Imaging [Diagnostic Procedure]
   738   C0205314:Novel [Temporal Concept]
   738   C0243107:development [Physiologic Function]
   738   C0600678:Abstract [Intellectual Product]
   738   C0678723:Development [Organism Function]
   738   C0679622:novel [Intellectual Product]
   738   C1521991:Molecular [Qualitative Concept]
   738   C1527148:Development [Functional Concept]
   738   C1552863:Abstract [Idea or Concept]
   738   C1704458:Top [Spatial Concept]
   738   C1706907:Background [Conceptual Entity]
   704 E C1704254:Image [Intellectual Product]
   704 E C1704922:Image [Entity]
   704 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.141: Imaging modalities Recent advances in molecular... 

Phrase: "Imaging modalities Recent advances in molecular..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0725066:Advance [Medical Device]
Processing 00000000.tx.142: Molecular imaging in RA Outlook References  Potential targets for molecular imaging in RA involve all aspects of its pathophysiology, inflammation and destruction operative in the different compartments of the human joint and in the respective animal models. 

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "imaging in RA Outlook"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   806   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   760   C0003864:Arthritis [Disease or Syndrome]
   760   C0004271:Outlook [Mental Process]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0079595:Imaging [Diagnostic Procedure]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Potential targets for molecular"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   737   C1521840:Target [Functional Concept]
   737   C2986546:TARGET [Diagnostic Procedure]

Phrase: "imaging in RA"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   833   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   770   C0003864:Arthritis [Disease or Syndrome]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: "involve"

Phrase: "all aspects of its pathophysiology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1547011:Aspect [Quantitative Concept]
   726   C1879746:Aspect [Qualitative Concept]

Phrase: "inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: "and"

Phrase: "destruction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1261381:Destruction [Therapeutic or Preventive Procedure]
  1000   C1948029:Destruction [Activity]

Phrase: "operative in the different compartments of the human joint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1882154:Operative [Temporal Concept]

Phrase: "and in the respective animal models."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0599779:Models, Animal [Animal]
   753   C0003062:Animal [Animal]
   753   C1515981:And [Idea or Concept]
   753   C3161035:Models [Intellectual Product]
Processing 00000000.tx.143: In addition, the detection, tracking and monitoring of molecules driving or inhibiting the arthritic process are also of considerable interest for the development of novel therapeutic strategies. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the detection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "tracking"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0546881:Tracking [Spatial Concept]
   966 E C0040594:Track [Manufactured Object]

Phrase: "and"

Phrase: "monitoring of molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150369:Monitoring [Health Care Activity]
   790   C1516647:monitoring [Research Activity]

Phrase: "driving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004379:Driving [Daily or Recreational Activity]
   966 E C0013126:Drive [Mental Process]

Phrase: "or"

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "the arthritic process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "are"

Phrase: "also of considerable interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0543488:Interest [Mental Process]

Phrase: "for the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of novel therapeutic strategies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategies [Mental Process]
Processing 00000000.tx.144: Studies using molecular imaging agents in RA are currently limited to nuclear and optical imaging methods. 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "molecular imaging agents in RA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   719   C0450442:Agent [Chemical Viewed Functionally]
   719   C1254351:Agent [Pharmacologic Substance]
   719   C1521826:Agent [Intellectual Product]

Phrase: "are"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "limited to nuclear"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0439801:Limited [Functional Concept]
   790   C0521447:Nuclear [Spatial Concept]
   790   C3542948:Limited [Intellectual Product]
   756 E C1549649:Limit [Idea or Concept]
   756 E C2349209:Limit [Conceptual Entity]

Phrase: "and"

Phrase: "optical imaging methods."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1518598:Optical Methods [Laboratory Procedure]
   901   C1275506:imaging methods [Functional Concept]
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]
   734   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]
Processing 00000000.tx.145: Nuclear imaging approaches Recent strategies to target and visualize specific processes in arthritic synovium using nuclear imaging approaches include targets that mark soluble factors, cells or surface molecules, or the activation of cells and apoptosis, or that indicate dynamic processes such as proliferation [2130]. 

Phrase: "Nuclear imaging approaches Recent strategies to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0679199:strategies [Mental Process]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "visualize"

Phrase: "specific processes in arthritic synovium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "nuclear imaging approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "that mark soluble factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "surface molecules,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205148:Surface [Spatial Concept]
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "or"

Phrase: "the activation of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1326120:activation cells [Cell Function]
   770   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "or"

Phrase: "that"

Phrase: "indicate"

Phrase: "dynamic processes such as proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "[2130"

Phrase: "]."
Processing 00000000.tx.146: Interleukin-1 and TNF are key molecules driving arthritis and inflammation in RA synovium, and numerous groups have successfully used radiolabelled interleukin-1 receptor antagonist (123-J IL-1ra) [21] and anti-TNF monoclonal antibody [22] to localize these molecules in synovium. 

Phrase: "Interleukin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "TNF"

Phrase: "are"

Phrase: "key molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "driving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004379:Driving [Daily or Recreational Activity]
   966 E C0013126:Drive [Mental Process]

Phrase: "arthritis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003864:Arthritis [Disease or Syndrome]
   907 E C0018099:Gout [Disease or Syndrome]

Phrase: "and"

Phrase: "inflammation in RA synovium,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0333423:Rheumatoid inflammation [Pathologic Function]
   760   C0021368:Inflammation [Pathologic Function]

Phrase: "and"

Phrase: "numerous groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "have"

Phrase: "successfully"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "radiolabelled interleukin-1 receptor antagonist"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   937   C1416402:INTERLEUKIN 1 RECEPTOR ANTAGONIST [Gene or Genome]
   937   C1704264:interleukin-1 receptor antagonist [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   937   C3536785:Interleukin-1 Receptor Antagonist [Pharmacologic Substance]
   804   C0231491:Antagonist [Organ or Tissue Function]
   717   C0063710:Interleukin 1 Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C1416395:INTERLEUKIN 1 RECEPTOR [Gene or Genome]
   704 E C0680242:antagonism [Social Behavior]

Phrase: "(123-J IL-1ra"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1149393:IL-1ra [Molecular Function]
   861   C1704264:IL-1Ra [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C3273854:IL-1ra [Gene or Genome]

Phrase: ")"

Phrase: "[21"

Phrase: "]"

Phrase: "and"

Phrase: "anti-TNF monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]

Phrase: "[22"

Phrase: "] to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:localize [Spatial Concept]

Phrase: "these molecules in synovium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0567416:molecules [Substance]
Processing 00000000.tx.147: Using leucocytes labelled with 99mTc-hexamethylpropylene amine oxime (99mTc-HMPAO), synovial inflammation could be visualized, and estimation of disease activity was also possible [23]. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "leucocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023516:leucocytes [Cell]

Phrase: "labelled with 99mTc-hexamethylpropylene amine oxime (99mTc-HMPAO),"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0002508:Amine [Organic Chemical]
   753   C0030020:Oxime [Organic Chemical]
   753   C1879694:Amine [Organic Chemical]
   719   C0181496:Label [Manufactured Object]
   719   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "synovial inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021368:Inflammation [Pathologic Function]

Phrase: "could"

Phrase: "be"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "estimation of disease activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0680844:estimation [Mental Process]
   770   C0681916:Estimation [Quantitative Concept]
   770   C0750572:Estimation [Quantitative Concept]

Phrase: "was"

Phrase: "also possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "[23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "]."
Processing 00000000.tx.148: In a similar approach, 99mTc-E-selectin binding peptide could localize this important adhesion molecule [24]. 

Phrase: "In a similar approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "99mTc-E-selectin binding peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "could"

Phrase: "localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:localize [Spatial Concept]

Phrase: "this important adhesion molecule"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0007578:Adhesion Molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "[24"

Phrase: "]."
Processing 00000000.tx.149: Of interest, 99mTc-anti-E-selectin-Fab can be used successfully to image synovitis with better specificity than 99mTc-HDP bone scanning [25]. 

Phrase: "Of interest,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "99mTc-anti-E-selectin-Fab"

Phrase: "can"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "successfully to image synovitis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039103:Synovitis [Disease or Syndrome]
   770   C1704254:Image [Intellectual Product]
   770   C1704922:Image [Entity]
   770   C3542466:Image [Intellectual Product]

Phrase: "with better specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "than 99mTc-HDP bone scanning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0203668:bone scanning [Diagnostic Procedure]
   812   C0034606:Scanning [Diagnostic Procedure]
   812   C0441633:Scanning [Diagnostic Procedure]

Phrase: "[25"

Phrase: "]."
Processing 00000000.tx.150: Methyl-11C-choline is a marker of cellular proliferation. 

Phrase: "Methyl-11C-choline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008405:Choline [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "a marker of cellular proliferation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514486:Proliferation Marker [Qualitative Concept]
   760   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.151: Based on the knowledge that choline is a precursor for the biosynthesis of phospholipids (in particular phosphatidylcholine), which is the essential component of all eukaryotic cell membranes, and that the proliferative changes occurring in arthritic synovium enhance membrane synthesis, which increases the demand for phospholipids, this molecular marker was able to indicate general proliferative activity in arthritic synovium [26]. 

Phrase: "Based on the knowledge"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   819   C0022752:based knowledge [Intellectual Product]
   770   C0376554:Knowledge [Intellectual Product]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that choline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008405:Choline [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "a precursor for the biosynthesis of phospholipids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709634:Precursor [Idea or Concept]

Phrase: "("

Phrase: "in particular phosphatidylcholine"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1959616:Phosphatidyl choline [Biologically Active Substance,Lipid,Pharmacologic Substance]
   805 E C0031617:Lecithin [Biologically Active Substance,Lipid,Pharmacologic Substance]
   805 E C0885520:lecithin [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "the essential component of all eukaryotic cell membranes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0243092:Cell component [Cell Component]
   767   C1178969:Cell Component [Cell Component]
   744   C0449432:Component [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "that"

Phrase: "the proliferative changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "occurring in arthritic synovium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039099:Synovium [Body Part, Organ, or Organ Component]
   737   C1709305:Occur [Activity]
   737   C2745955:OCCUR [Temporal Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "membrane synthesis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0920582:membrane synthesis [Research Device]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "which"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the demand for phospholipids,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441516:Demand [Therapeutic or Preventive Procedure]
   770   C0699784:demand [Idea or Concept]

Phrase: "this molecular marker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005516:Molecular Marker [Clinical Attribute]
           Marker

Phrase: "was"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "indicate"

Phrase: "general proliferative activity in arthritic synovium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0441655:General activity [Activity]
           Activity
   753   C0205177:Activity [Functional Concept]
   753   C0334094:Proliferative [Pathologic Function]
   753   C0439167:% activity [Quantitative Concept]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "[26"

Phrase: "]."
Processing 00000000.tx.152: Similarly, based on the fact that maintenance of arthritis requires a considerable amount of energy, enhanced glucose metabolism could be successfully imaged by 18F-fluorodeoxyglucose (FDG) PET imaging (Fig. 3) [2629]. 

Phrase: "Similarly,"

Phrase: "based on the fact"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that maintenance of arthritis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0024501:Maintenance [Activity]

Phrase: "requires"

Phrase: "a considerable amount of energy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "enhanced glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "successfully"

Phrase: "imaged by 18F-fluorodeoxyglucose (FDG) PET"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   853   C0872169:fluorodeoxyglucose positron emission tomography [Diagnostic Procedure]
   814   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   778   C0046056:18F Fluorodeoxyglucose [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0032744:Positron [Quantitative Concept]
   748   C0040395:tomography [Diagnostic Procedure]
   748   C0040405:tomography [Diagnostic Procedure]
   748   C0233929:Emission [Body Substance]
   748   C0872172:fluorodeoxyglucose [Carbohydrate,Pharmacologic Substance]
   748   C2349995:Emission [Substance]
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "[2629"

Phrase: "]."
Processing 00000000.tx.153: In addition, a recent study showed that 18F-FDG PET can assess the metabolic activity of synovitis and even measure disease activity in RA [29]. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that 18F-FDG PET"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C0872169:fluorodeoxyglucose positron emission tomography [Diagnostic Procedure]
   884   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   840   C0046056:18F Fluorodeoxyglucose [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0032744:Positron [Quantitative Concept]
   804   C0040395:tomography [Diagnostic Procedure]
   804   C0040405:tomography [Diagnostic Procedure]
   804   C0233929:Emission [Body Substance]
   804   C0872172:fluorodeoxyglucose [Carbohydrate,Pharmacologic Substance]
   804   C2349995:Emission [Substance]

Phrase: "can"

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the metabolic activity of synovitis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "even"

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "disease activity in RA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "[29"

Phrase: "]."
Processing 00000000.tx.154: Moreover, the volume of enhancing pannus (VEP) was determined from fat-suppressed MRIs. 

Phrase: "Moreover,"

Phrase: "the volume of enhancing pannus (VEP)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0449468:*Volume [Quantitative Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]

Phrase: "was"

Phrase: "determined from fat-suppressed MRIs."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   778   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   778   C1551403:Magnetic resonance [Laboratory Procedure]
   748   C0024488:Magnetic [Occupation or Discipline]
   748   C0231881:Resonance [Finding]
   748   C0424612:FAT [Organism Attribute]
   748   C0459800:resonance [Natural Phenomenon or Process]
   748   C0563532:magnetic [Natural Phenomenon or Process]
   748   C0684213:Resonance [Qualitative Concept]
   748   C1260953:Suppressed [Functional Concept]
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]
Processing 00000000.tx.155: VEP and FDG uptake were closely correlated, as were changes in VEP and standardized uptake volume. 

Phrase: "VEP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449468:*Volume [Quantitative Concept]
   770   C1690016:% volume [Qualitative Concept]
   770   C1705102:Volume [Intellectual Product]
   770   C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "FDG uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "were"

Phrase: "closely"

Phrase: "correlated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlated [Qualitative Concept]

Phrase: ","

Phrase: "as"

Phrase: "were"

Phrase: "changes in VEP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0155094:Pannus [Disease or Syndrome]
   753   C0333350:Pannus [Finding]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C0449468:*Volume [Quantitative Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C1705241:Change [Quantitative Concept]
   753   C2700258:Volume [Laboratory Procedure]
   719   C2349975:Enhance [Activity]

Phrase: "and"

Phrase: "standardized uptake volume."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]
Processing 00000000.tx.156: VEP and FDG uptake were strongly associated with clinical findings in wrists but not with treatment outcomes. 

Phrase: "VEP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449468:*Volume [Quantitative Concept]
   770   C1690016:% volume [Qualitative Concept]
   770   C1705102:Volume [Intellectual Product]
   770   C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "FDG uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "were"

Phrase: "strongly"

Phrase: "associated with clinical findings"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   833   C0037088:Clinical findings [Sign or Symptom]
       E   Finding
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   816 E C3540840:Clinical Finding [Finding]
   802   C0449380:Associated finding [Finding]
   770   C0205210:Clinical [Qualitative Concept]
   770   C2607943:findings [Functional Concept]
   770   C2926606:Findings [Clinical Attribute]
   770   C3539655:Findings [Intellectual Product]
   737 E C0243095:Finding [Finding]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   737 E C2825141:Finding [Finding]

Phrase: "in wrists"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0043262:Wrists [Body Location or Region]
   966 E C1283836:Wrist [Body Location or Region]
   966 E C1322271:Wrist [Body Space or Junction]
   928 E C0007285:carpal [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "not with treatment outcomes."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0085415:TREATMENT OUTCOMES [Qualitative Concept]
   816 E C0599860:treatment outcome [Qualitative Concept]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1518422:Not [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737   C1274040:Outcome [Functional Concept]
Processing 00000000.tx.157: Contrast material-enhanced MRI and PET allow quantification of volumetric and metabolic changes in joint inflammation and comparison of efficacies of anti-inflammatory agents [28]. 

Phrase: "Contrast material-enhanced MRI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1707501:Contrast-enhanced MRI [Diagnostic Procedure]
   812   C0024485:MRI [Diagnostic Procedure]
   812   C1824234:MRI [Gene or Genome]

Phrase: "and"

Phrase: "PET"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   827   C0032744:Positron [Quantitative Concept]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]
   827   C0233929:Emission [Body Substance]
   827   C2349995:Emission [Substance]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "quantification of volumetric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709793:Quantification [Quantitative Concept]

Phrase: "and"

Phrase: "metabolic changes in joint inflammation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "comparison of efficacies of anti-inflammatory agents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707455:Comparison [Activity]

Phrase: "[28"

Phrase: "]."
Processing 00000000.tx.158: In contrast, the use of radiolabelled annexin V to image apoptosis, which may be used for monitoring therapies that induce reduced proliferation and apoptosis, is also feasible [30]. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the use of radiolabelled annexin V"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "to image apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "used for monitoring therapies"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0087111:therapies [Therapeutic or Preventive Procedure]
   770   C0150369:Monitoring [Health Care Activity]
   770   C1273517:used [Finding]
   770   C1516647:monitoring [Research Activity]
   737 E C0039798:therapy [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1363945:Therapy [Finding]
   737 E C1947944:Use [Intellectual Product]

Phrase: "that"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "reduced proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "also feasible"

Phrase: "[30"

Phrase: "]."
Processing 00000000.tx.159: View larger version (83K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(83K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.160: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.161: 18F-Flurorodeoxyglocose (FDG) positron emission tomography (PET) imaging in arthritis. 

Phrase: "18F-Flurorodeoxyglocose"

Phrase: "(FDG) positron emission tomography"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0872169:fluorodeoxyglucose positron emission tomography [Diagnostic Procedure]
   923   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   812   C0032744:Positron [Quantitative Concept]
   812   C0040395:tomography [Diagnostic Procedure]
   812   C0040405:tomography [Diagnostic Procedure]
   812   C0233929:Emission [Body Substance]
   812   C0872172:fluorodeoxyglucose [Carbohydrate,Pharmacologic Substance]
   812   C2349995:Emission [Substance]

Phrase: "(PET"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   827   C0032744:Positron [Quantitative Concept]
   827   C0040395:tomography [Diagnostic Procedure]
   827   C0040405:tomography [Diagnostic Procedure]
   827   C0233929:Emission [Body Substance]
   827   C2349995:Emission [Substance]

Phrase: ")"

Phrase: "imaging in arthritis."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0003864:Arthritis [Disease or Syndrome]
   790   C0011923:Imaging [Diagnostic Procedure]
   790   C0079595:Imaging [Diagnostic Procedure]
   756 E C1704254:Image [Intellectual Product]
   756 E C1704922:Image [Entity]
   756 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.162: Images of a healthy control subject (A and B) and an RA patient with active RA (C and D). 

Phrase: "Images of a healthy control subject"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0449302:Image control [Therapeutic or Preventive Procedure]
   719   C1704254:Image [Intellectual Product]
   719   C1704922:Image [Entity]
   719   C3542466:Image [Intellectual Product]

Phrase: "(A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "an RA patient with active RA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030705:*^patient [Patient or Disabled Group]

Phrase: "(C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.163: Normal tracer distribution in knee (A) and in hand and wrist (B). 

Phrase: "Normal tracer distribution in knee"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0028377:Normal Distribution [Quantitative Concept]
   797   C0332617:Normal distribution [Qualitative Concept]
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "in hand"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0018563:Hand [Body Part, Organ, or Organ Component]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1281583:Hand [Body Part, Organ, or Organ Component]
   861   C1552914:hand [Quantitative Concept]
   805 E C0024763:Manual [Intellectual Product,Manufactured Object]
   805 E C0175674:Manual [Functional Concept]

Phrase: "and"

Phrase: "wrist"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043262:Wrist [Body Location or Region]
  1000   C1283836:Wrist [Body Location or Region]
  1000   C1322271:Wrist [Body Space or Junction]
   944 E C0007285:carpal [Body Part, Organ, or Organ Component]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.164: Tracer distribution in rheumatoid knee (C) and wrist (D). 

Phrase: "Tracer distribution in rheumatoid knee"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "wrist"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043262:Wrist [Body Location or Region]
  1000   C1283836:Wrist [Body Location or Region]
  1000   C1322271:Wrist [Body Space or Junction]
   944 E C0007285:carpal [Body Part, Organ, or Organ Component]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.165: The figure shows that 18F-FDG PET can assess the high metabolic activity of inflamed joints. 

Phrase: "The figure"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that 18F-FDG PET"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C0872169:fluorodeoxyglucose positron emission tomography [Diagnostic Procedure]
   884   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   840   C0046056:18F Fluorodeoxyglucose [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0032744:Positron [Quantitative Concept]
   804   C0040395:tomography [Diagnostic Procedure]
   804   C0040405:tomography [Diagnostic Procedure]
   804   C0233929:Emission [Body Substance]
   804   C0872172:fluorodeoxyglucose [Carbohydrate,Pharmacologic Substance]
   804   C2349995:Emission [Substance]

Phrase: "can"

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the high metabolic activity of inflamed joints."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.166: Reprinted from [29].  

Phrase: "Reprinted from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C3273171:Reprint [Intellectual Product]

Phrase: "[29"

Phrase: "]."
Processing 00000000.tx.167: Optical imaging approaches A number of recently published studies in experimental settings have shown the potential of optical-based imaging technologies (fluorescence reflectance imaging and bioluminescence imaging) to evaluate cellular and molecular events in arthritis. 

Phrase: "Optical imaging"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C3494219:Optical Imaging [Diagnostic Procedure,Research Activity]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]
   805   C0042789:Vision [Organism Function]
   805   C2707266:Vision [Clinical Attribute]

Phrase: "approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449445:Approach [Spatial Concept]
  1000   C1292724:Approaches [Functional Concept]

Phrase: "A number of recently published studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "in experimental settings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0542559:setting [Functional Concept]
   827   C1318139:{Setting} [Quantitative Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the potential of optical-based imaging technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3245505:Potential [Qualitative Concept]

Phrase: "(fluorescence reflectance"

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "bioluminescence imaging"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   861   C0162404:Bioluminescence [Biologic Function]
   861   C1367880:bioluminescence [Laboratory Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007634:Cellular [Cell]
  1000   C0178539:Cellular [Functional Concept]
   928 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "molecular events in arthritis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441471:Events [Event]
   770   C3541888:Events [Classification]
Processing 00000000.tx.168: These approaches include non-invasive monitoring of inflammatory cells or transcription factors involved in disease, imaging gene transfer, and apoptosis or the activity of enzymes involved in joint destruction to monitor treatment response [3136]. 

Phrase: "These approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449445:Approaches [Spatial Concept]
  1000   C1292724:Approaches [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "non-invasive monitoring of inflammatory cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150369:Monitoring [Health Care Activity]
   753   C1516647:monitoring [Research Activity]

Phrase: "or"

Phrase: "transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "involved in disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0012634:Disease [Disease or Syndrome]
   790   C1314939:Involved [Functional Concept]
   734 E C1836721:MALS [Finding]
   734 E C3538764:MALS [Gene or Genome]
   734 E C3540595:MAL [Gene or Genome]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "gene transfer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1517499:Gene Transfer [Molecular Biology Research Technique]
   861   C0017337:Gene [Gene or Genome]
   861   C0040671:Transfer [Mental Process]
   861   C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "or"

Phrase: "the activity of enzymes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C0243102:enzyme activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "involved in joint destruction to"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0541875:joint destruction [Finding]
   760   C0022417:Joint [Body Space or Junction]
   760   C0392905:Joint, NOS [Body System]
   760   C1261381:Destruction [Therapeutic or Preventive Procedure]
   760   C1269611:Joint [Body Space or Junction]
   760   C1314939:Involved [Functional Concept]
   760   C1706309:Joint [Medical Device]
   760   C1948029:Destruction [Activity]
   704 E C0521339:Articular [Functional Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "treatment response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "[3136"

Phrase: "]."
Processing 00000000.tx.169: Using antimacrophage monoclonal antibodies (anti-F4/80) labelled with a near-infrared fluorochrome, Hansch and colleagues [31] demonstrated the feasibility of fluorescence reflectance imaging in visualizing inflammatory cells in arthritic joints in vivo in a murine arthritis model. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antimacrophage monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0746619:monoclonal [Finding]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(anti-F4/80"

Phrase: ")"

Phrase: "labelled with a near-infrared fluorochrome,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]
   753   C1532326:Infrared [Qualitative Concept]
   719   C0181496:Label [Manufactured Object]
   719   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "Hansch"

Phrase: "and"

Phrase: "colleagues"

Phrase: "[31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "]"

Phrase: "demonstrated"

Phrase: "the feasibility of fluorescence reflectance"

Phrase: "imaging in visualizing inflammatory cells"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   806   C0440752:inflammatory cells [Cell]
   781   C1537000:cell imaging [Diagnostic Procedure]
   760   C0007634:Cells [Cell]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0079595:Imaging [Diagnostic Procedure]
   760   C0333348:Inflammatory [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704653:Cell [Medical Device]
   726 E C1704922:Image [Entity]
   726 E C1948049:Cell [Spatial Concept]
   726 E C3542466:Image [Intellectual Product]

Phrase: "in arthritic joints"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0022417:Joints [Body Space or Junction]
   861   C0392905:Joints [Body System]
   827 E C1269611:Joint [Body Space or Junction]
   827 E C1706309:Joint [Medical Device]
   789 E C0521339:Articular [Functional Concept]

Phrase: "in vivo in a murine arthritis model."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1515657:In Vivo Model [Research Activity]
   778   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.170: Fluorescence reflectance imaging showed accumulation of the imaging agents in the inflamed knee joints and, to a lesser extent, in the contralateral (non-arthritic) knee joints. 

Phrase: "Fluorescence reflectance"

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "accumulation of the imaging agents"

Phrase: "in the inflamed knee joints"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   913   C0574941:inflamed joints [Finding]
   901   C0022745:Knee Joints [Body Space or Junction]
           Knee
   867 E C1269073:Knee joint [Body Space or Junction]
   827   C0022417:Joints [Body Space or Junction]
   827   C0022742:Knee [Body Part, Organ, or Organ Component]
   827   C0392905:Joints [Body System]
   827   C1283838:Knee [Body Location or Region]
   827   C1963703:Knee [Body Location or Region]
   793 E C1269611:Joint [Body Space or Junction]
   793 E C1706309:Joint [Medical Device]
   755 E C0521339:Articular [Functional Concept]

Phrase: "and"

Phrase: ","

Phrase: "to a lesser extent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extent [Spatial Concept]

Phrase: "in the contralateral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441988:Contralateral [Spatial Concept]

Phrase: "(non-arthritic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: ")"

Phrase: "knee joints."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
  1000   C0022745:Knee Joints [Body Space or Junction]
           Knee
   966 E C1269073:Knee joint [Body Space or Junction]
   861   C0022417:Joints [Body Space or Junction]
   861   C0022742:Knee [Body Part, Organ, or Organ Component]
   861   C0392905:Joints [Body System]
   861   C1283838:Knee [Body Location or Region]
   861   C1963703:Knee [Body Location or Region]
   827 E C1269611:Joint [Body Space or Junction]
   827 E C1706309:Joint [Medical Device]
   789 E C0521339:Articular [Functional Concept]
Processing 00000000.tx.171: In this approach, monitoring of these inflammatory cells was optimal until 12 h after injection of the fluorochrome, but fluorescence measurements could be realized over a period of 7 days. 

Phrase: "In this approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "monitoring of these inflammatory cells"
Meta Candidates (Total=14; Excluded=8; Pruned=0; Remaining=6)
   806   C0440752:inflammatory cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0150369:Monitoring [Health Care Activity]
   760   C0333348:Inflammatory [Functional Concept]
   760   C1516647:monitoring [Research Activity]
   760   C3282337:Cells [Cell]
   726 E C0030695:monitor [Health Care Activity]
   726 E C0181904:Monitor [Medical Device]
   726 E C0596972:Monitor [Medical Device]
   726 E C1269647:Cell [Cell]
   726 E C1521743:Monitor [Professional or Occupational Group]
   726 E C1704646:Monitor [Manufactured Object]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "optimal until 12 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2698651:Optimal [Qualitative Concept]

Phrase: "after injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of the fluorochrome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]

Phrase: "but"

Phrase: "fluorescence measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "realized over a period of 7 days."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0439228:days [Temporal Concept]
   748   C0439531:/period [Temporal Concept]
   748   C1948053:Period [Temporal Concept]
   714 E C0332173:/day [Temporal Concept]
   714 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.172: Carlsen et al. have developed transgenic mice that express luciferase under the control of the transcription factor NF-B, enabling non-invasive real-time bioluminescence imaging of NF-B activity in intact animals. 

Phrase: "Carlsen et al."

Phrase: "have"

Phrase: "developed transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "express"

Phrase: "luciferase under the control of the transcription factor NF-B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "enabling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1171285:Enabling [Mental Process]
   966 E C0562342:enable [Mental Process]

Phrase: "non-invasive real-time bioluminescence imaging of NF-B activity"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   739   C0011923:Imaging [Diagnostic Procedure]
   739   C0079595:Imaging [Diagnostic Procedure]
   739   C0162404:Bioluminescence [Biologic Function]
   739   C1367880:bioluminescence [Laboratory Procedure]
   706 E C1704254:Image [Intellectual Product]
   706 E C1704922:Image [Entity]
   706 E C3542466:Image [Intellectual Product]

Phrase: "in intact animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.173: In a mouse model of RA, joints affected by arthritis produced strong NF-B activity, resulting in a high signal intensity that could be imaged non-invasively. 

Phrase: "In a mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "of RA,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]

Phrase: "joints"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0022417:Joints [Body Space or Junction]
  1000   C0392905:Joints [Body System]
   966 E C1269611:Joint [Body Space or Junction]
   966 E C1706309:Joint [Medical Device]
   928 E C0521339:Articular [Functional Concept]

Phrase: "affected by arthritis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0003864:Arthritis [Disease or Syndrome]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]

Phrase: "produced"

Phrase: "strong NF-B activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "resulting in a high signal intensity"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0332294:Resulting in [Functional Concept]
   790   C0871362:signal intensity [Quantitative Concept]
   753   C0205250:High [Qualitative Concept]
   753   C0522510:Intensity [Qualitative Concept]
   753   C0678226:resulting [Functional Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1710082:Signal [Phenomenon or Process]
   753   C2700149:HIGH [Intellectual Product]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "imaged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "non-invasively."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]
Processing 00000000.tx.174: Since NF-B is an important factor in the pathogenesis of RA, this model is a helpful tool in arthritis research [32]. 

Phrase: "Since"

Phrase: "NF-B is"

Phrase: "an important factor in the pathogenesis of RA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0035448:Rheumatoid Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0201660:Rheumatoid factor NOS [Laboratory Procedure]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]

Phrase: "this model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "is"

Phrase: "a helpful tool in arthritis research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0336791:Tool [Manufactured Object]
   753   C2827396:Tool [Manufactured Object]

Phrase: "[32"

Phrase: "]."
Processing 00000000.tx.175: Molecular imaging techniques can also be used for the visualization of disease- or therapy-related cells in living organisms. 

Phrase: "Molecular imaging techniques"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0079595:Imaging Techniques [Diagnostic Procedure]
   896   C1513384:Molecular Technique [Molecular Biology Research Technique]
   827   C0025664:techniques [Intellectual Product]
   827   C0449851:Techniques [Functional Concept]
   734   C1537028:Molecular Imaging [Diagnostic Procedure]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "used for the visualization of disease-"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   767   C1524063:Use of [Functional Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0175631:Visualization [Mental Process]
   753   C1273517:used [Finding]
   753   C2827662:Visualization [Occupation or Discipline]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "or"

Phrase: "therapy-related cells in living organisms."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C0302189:cells therapy [Therapeutic or Preventive Procedure]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.176: One of the most recent examples is the tracking of genetically altered cells in an adoptive gene therapy setting in which T cells were transduced in a murine model for RA. 

Phrase: "One of the most recent examples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "the tracking of genetically altered cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C2936595:Cell Tracking [Research Activity]
   753   C0546881:Tracking [Spatial Concept]
   719 E C0040594:Track [Manufactured Object]

Phrase: "in an adoptive gene therapy setting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0542559:setting [Functional Concept]
   812   C1318139:{Setting} [Quantitative Concept]

Phrase: "in which T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transduced in a murine model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026809:Murine [Mammal]
   760   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   760   C3161035:Model [Intellectual Product]

Phrase: "for RA."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]
Processing 00000000.tx.177: To be able to demonstrate the ability of injected cells to migrate preferentially into the inflamed articular tissue, in vivo bioluminescence imaging was applied. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "demonstrate"

Phrase: "the ability of injected cells to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "migrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0232902:migrate [Functional Concept]

Phrase: "preferentially into the inflamed articular tissue,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0574941:Inflamed joint [Finding]
   753   C0022417:Articular [Body Space or Junction]
   753   C0040300:Tissue [Tissue]
   753   C0333348:Inflamed [Functional Concept]
   753   C0521339:Articular [Functional Concept]
   753   C1547928:Tissue [Intellectual Product]

Phrase: "in vivo bioluminescence imaging"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   923   C1708481:In Vivo Imaging [Laboratory Procedure]
   812   C0011923:Imaging [Diagnostic Procedure]
   812   C0079595:Imaging [Diagnostic Procedure]
   812   C0162404:Bioluminescence [Biologic Function]
   812   C1367880:bioluminescence [Laboratory Procedure]
   779 E C1704254:Image [Intellectual Product]
   779 E C1704922:Image [Entity]
   779 E C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "applied."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.178: This technology allows longitudinal analyses; 

Phrase: "This technology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:Technology [Occupation or Discipline]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "longitudinal analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: ";"
Processing 00000000.tx.179: for example, adoptively transferred cells can be monitored in individual animals in real time on consecutive days for extended periods of time without the need to kill the animals. 

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "adoptively transferred cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "monitored in individual animals"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0003062:Animals [Animal]
   770   C0027361:Individual [Population Group]
   770   C0237401:Individual [Human]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "in real time"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C1550177:Real Time [Idea or Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0237400:Real [Qualitative Concept]
   861   C3272377:REAL [Intellectual Product]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "on consecutive days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "for extended periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "of time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "without the need to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027552:Need [Qualitative Concept]
   861   C0686904:need [Functional Concept]

Phrase: "kill"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162388:kill [Social Behavior]
  1000   C0681205:Kill [Idea or Concept]
  1000   C1550555:kill [Functional Concept]

Phrase: "the animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]
Processing 00000000.tx.180: For this purpose, the cells of interest were transduced to express the enzyme luciferase prior to the transfer. 

Phrase: "For this purpose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "the cells of interest"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   816   C0007634:THE CELL [Cell]
           Cells
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transduced"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "the enzyme luciferase prior to the transfer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.181: Then, the animals received the luciferase substrate luciferin. 

Phrase: "Then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "the luciferase substrate luciferin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024076:luciferin [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.182: Conversion of luciferin to oxyluciferin by luciferase from transferred cells generated light that could be detected sensitively by a camera system. 

Phrase: "Conversion of luciferin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439836:Conversion [Functional Concept]

Phrase: "to oxyluciferin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069820:oxyluciferin [Organic Chemical]

Phrase: "by luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "from transferred cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023693:Light [Natural Phenomenon or Process]
  1000   C1306462:Light [Functional Concept]
  1000   C1881376:Light [Qualitative Concept]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "sensitively by a camera system."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0179533:Camera [Medical Device]
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1654607:Camera [Eukaryote]
   760   C1704459:System [Medical Device]
   760   C1706254:CAMERA [Medical Device]
Processing 00000000.tx.183: Light intensity was visualized using a false-colour scale in which blue indicated low and red indicated high intensity, and the generated coloured spots were superimposed onto a grey-scale image of the animals that was obtained under weak illumination in the otherwise light-tight image chamber of the camera system. 

Phrase: "Light intensity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0596836:Light intensity [Natural Phenomenon or Process]
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]

Phrase: "was"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a false-colour scale in which blue indicated low"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C2986819:Color Scale [Occupational Activity]
   742   C0175659:Scale [Medical Device]
   742   C0349674:Scale [Intellectual Product]
   742   C1947916:Scale [Activity]
   742   C3536777:Scale [Manufactured Object]

Phrase: "and"

Phrase: "red indicated high intensity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0522510:Intensity [Qualitative Concept]

Phrase: "and"

Phrase: "the generated coloured spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0015230:spots [Disease or Syndrome]
   827   C0329155:Spot [Fish]
   827   C0848332:Spots [Sign or Symptom]
   827   C1427618:SPOT [Gene or Genome]
   827   C1705203:Spot [Conceptual Entity]

Phrase: "were"

Phrase: "superimposed onto a grey-scale image of the animals"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0003062:Animals [Animal]
   742   C0175659:Scale [Medical Device]
   742   C0349674:Scale [Intellectual Product]
   742   C0556636:gray [Quantitative Concept]
   742   C1269776:Gray [Qualitative Concept]
   742   C1704254:Image [Intellectual Product]
   742   C1704922:Image [Entity]
   742   C1947916:Scale [Activity]
   742   C3536777:Scale [Manufactured Object]
   742   C3542466:Image [Intellectual Product]

Phrase: "that"

Phrase: "was"

Phrase: "obtained under weak illumination"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0004093:Weak [Sign or Symptom]
   770   C0023693:Illumination [Natural Phenomenon or Process]
   770   C0023700:Illumination [Human-caused Phenomenon or Process]
   770   C0684292:illumination [Laboratory Procedure]
   770   C1301820:Obtained [Functional Concept]
   770   C1762617:Weak [Qualitative Concept]
   770   C1964256:Illumination [Diagnostic Procedure]
   737 E C1706701:Obtain [Activity]

Phrase: "in the otherwise light-tight image chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "of the camera system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.184: The coloured spots indicated the localization of the adoptively transferred cells (and the encoded gene products) within the different tissues of the animals. 

Phrase: "The coloured spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015230:spots [Disease or Syndrome]
   861   C0329155:Spot [Fish]
   861   C0848332:Spots [Sign or Symptom]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "the localization of the adoptively transferred cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1660153:localisation of cell [Biologic Function]
           cell localization
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "("

Phrase: "and"

Phrase: "the encoded gene products"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017337:Gene [Gene or Genome]
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: ")"

Phrase: "within the different tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "of the animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]
Processing 00000000.tx.185: Figure 4 illustrates a bioluminescence images after adoptive gene transfer [33, 34]. 

Phrase: "Figure 4"

Phrase: "illustrates"

Phrase: "a bioluminescence images after adoptive gene transfer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]

Phrase: "[33,"

Phrase: "34"

Phrase: "]."
Processing 00000000.tx.186: View larger version (99K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(99K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.187: 4. 

Phrase: "4."
Processing 00000000.tx.188: Bioluminescence imaging of adoptive gene transfer in vivo. 

Phrase: "Bioluminescence imaging of adoptive gene transfer"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0011923:Imaging [Diagnostic Procedure]
   753   C0079595:Imaging [Diagnostic Procedure]
   753   C0162404:Bioluminescence [Biologic Function]
   753   C1367880:bioluminescence [Laboratory Procedure]
   719 E C1704254:Image [Intellectual Product]
   719 E C1704922:Image [Entity]
   719 E C3542466:Image [Intellectual Product]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.189: DBA/1 mice with collagen-induced arthritis (CIA) were injected intravenously with type II collagen-specific T-cell hybridomas retrovirally transduced to express the enzyme luciferase. 

Phrase: "DBA/1 mice with collagen-induced arthritis (CIA)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C1511646:DBA/1 Mouse [Mammal]
   774   C0025923:Mice, DBA [Mammal]
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intravenously with type II collagen-specific T-cell hybridomas retrovirally"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   782   C0009331:Type II Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   782   C1413580:COLLAGEN, TYPE II [Gene or Genome]
   777 E C1167376:collagen type II [Cell Component]
   777   C1519715:Type II Cell [Cell]
   760   C0039194:T-cell [Cell]
   760   C0441730:Type II [Classification]
   757   C0007634:Cell Type [Cell]
           Cell
   757   C0449475:cell type [Intellectual Product]
   743   C0020204:cell hybridoma [Cell]
           Hybridomas
   739   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   739   C0205369:Specific [Qualitative Concept]
   739   C0332307:Type [Qualitative Concept]
   739   C1167364:collagen [Cell Component]
   739   C1269647:Cell [Cell]
   739   C1547052:*Type [Quantitative Concept]
   739   C1552740:specific [Intellectual Product]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]

Phrase: "transduced"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "the enzyme luciferase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.190: After intraperitoneal injection of the luciferase substrate luciferin, the cells can be tracked by the resulting bioluminescence, which can be detected using a sensitive camera system. 

Phrase: "After intraperitoneal injection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0442120:Intraperitoneal [Spatial Concept]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "of the luciferase substrate luciferin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024076:luciferin [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "tracked by the resulting bioluminescence,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0162404:Bioluminescence [Biologic Function]
   760   C0678226:resulting [Functional Concept]
   760   C1367880:bioluminescence [Laboratory Procedure]
   726   C0040594:Track [Manufactured Object]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "which"

Phrase: "can"

Phrase: "be"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a sensitive camera system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.191: Detected light intensity is represented on a false colour scale, blue indicating low and red indicating high light intensity. 

Phrase: "Detected light intensity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0596836:Light intensity [Natural Phenomenon or Process]
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C0522510:Intensity [Qualitative Concept]
   827   C1306462:Light [Functional Concept]
   827   C1881376:Light [Qualitative Concept]

Phrase: "is"

Phrase: "represented on a false colour scale,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C2986819:Color Scale [Occupational Activity]
   753   C0009393:Color [Natural Phenomenon or Process]
   753   C0175659:Scale [Medical Device]
   753   C0205237:False [Qualitative Concept]
   753   C0349674:Scale [Intellectual Product]
   753   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   753   C1705245:Color [Pharmacologic Substance]
   753   C1947916:Scale [Activity]
   753   C3536777:Scale [Manufactured Object]
   719   C1882932:Represent [Activity]

Phrase: "blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: "indicating"

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "and"

Phrase: "red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "indicating"

Phrase: "high light intensity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0596836:Light intensity [Natural Phenomenon or Process]
   827   C0522510:Intensity [Qualitative Concept]
Processing 00000000.tx.192: This figure illustrates the accumulation of transferred cells in the severely inflamed left hind paw of an experimental animal on day 3 (A) and day 5 (B) after transfer. 

Phrase: "This figure"

Phrase: "illustrates"

Phrase: "the accumulation of transferred cells"

Phrase: "in the severely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severely [Qualitative Concept]

Phrase: "inflamed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333348:Inflamed [Functional Concept]

Phrase: "left hind paw of an experimental animal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0230459:Hindpaw, NOS [Body Location or Region]
   748   C0687080:Paw [Body Part, Organ, or Organ Component]
   748   C2983612:Hind [Spatial Concept]

Phrase: "on day 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "day 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "after"

Phrase: "transfer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040671:Transfer [Mental Process]
  1000   C1705822:Transfer [Activity]
Processing 00000000.tx.193: On day 5 (B), a weak signal is also detected in the right hind paw, which developed low grade inflammation over the course of the experiment. 

Phrase: "On day 5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "a weak signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "is"

Phrase: "also"

Phrase: "detected in the right hind paw,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0230459:Hindpaw, NOS [Body Location or Region]
   753   C0205090:Right [Spatial Concept]
   753   C0442726:Detected [Finding]
   753   C0687080:Paw [Body Part, Organ, or Organ Component]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C2983612:Hind [Spatial Concept]

Phrase: "which"

Phrase: "developed"

Phrase: "low grade inflammation over the course of the experiment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0021368:Inflammation [Pathologic Function]
Processing 00000000.tx.194: Adapted from [33].  

Phrase: "Adapted from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2937289:adapted [Organic Chemical]

Phrase: "[33"

Phrase: "]."
Processing 00000000.tx.195: In very recent approaches, we showed that near-infrared fluorescence imaging with a fluorescence reflectance imaging system can be used for non-invasive imaging of the treatment response in mouse models of RA using fluorescence-labelled annexin V as a biomarker of apoptosis and an enzyme-activatable fluorescent imaging probe as a marker of joint destruction. 

Phrase: "In very recent approaches,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approaches [Spatial Concept]
   827   C1292724:Approaches [Functional Concept]

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that near-infrared fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "imaging with a fluorescence reflectance imaging system"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   800   C0494012:SYSTEM, IMAGING, FLUORESCENCE [Medical Device]
   774   C0430876:Fluorescence Imaging [Diagnostic Procedure]
   774   C2697665:Imaging System [Manufactured Object]
   748   C0011923:Imaging [Diagnostic Procedure]
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0079595:Imaging [Diagnostic Procedure]
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   714 E C1704254:Image [Intellectual Product]
   714 E C1704922:Image [Entity]
   714 E C3542466:Image [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "used for non-invasive"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0205303:Non-invasive [Functional Concept]
   770   C0205281:Invasive [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1518422:Non [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "imaging of the treatment response"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0039798:treatment [Functional Concept]
   760   C0079595:Imaging [Diagnostic Procedure]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0871261:Response [Organism Attribute]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1704632:Response [Finding]
   760   C1705169:Treatment [Conceptual Entity]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]
   760   C3538994:TREATMENT [Research Activity]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "in mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "models of RA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   833   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   770   C0003864:Arthritis [Disease or Syndrome]
   770   C3161035:Model [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorescence-labelled annexin V as a biomarker of apoptosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1332095:ANNEXIN V [Gene or Genome]
   762   C0231966:V A [Clinical Attribute]
   742   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "an enzyme-activatable fluorescent imaging probe as a marker of joint destruction."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   751   C0016321:fluorescent probe [Indicator, Reagent, or Diagnostic Aid]
   751   C0203668:Joint imaging [Diagnostic Procedure]
   751   C0203679:Joint imaging [Diagnostic Procedure]
   736   C0011923:Imaging [Diagnostic Procedure]
   736   C0079595:Imaging [Diagnostic Procedure]
   736   C0182400:Probe [Medical Device]
   736   C1704681:Probe [Gene or Genome]
   736   C2347609:Probe [Chemical Viewed Functionally]
   736   C3536729:Probe [Manufactured Object]
   703 E C1704254:Image [Intellectual Product]
   703 E C1704922:Image [Entity]
   703 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.196: Annexin V binds with high affinity to phosphatidylserine, a constitutive membrane phospholipid that is normally restricted to the inner leaflet of the plasma membrane lipid bilayer but is selectively exposed on the surface of cells as they undergo apoptosis. 

Phrase: "Annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds with high affinity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205250:High [Qualitative Concept]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   770   C1299351:High [Qualitative Concept]
   770   C1510827:Affinity [Natural Phenomenon or Process]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "to phosphatidylserine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: "a constitutive membrane phospholipid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031676:Phospholipid [Biologically Active Substance,Lipid]
   827   C0202177:Phospholipid [Laboratory Procedure]

Phrase: "that"

Phrase: "is"

Phrase: "normally"

Phrase: "restricted to the inner leaflet of the plasma membrane lipid bilayer"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   825   C1512782:Inner Leaflet of the Lipid Bilayer [Cell Component]
   806   C1179839:Lipid bilayer of plasma membrane [Cell Component]
   797   C0007603:plasma membrane lipid bilayer [Cell Component]
           Plasma membrane
   772   C0023768:lipid bilayer membrane [Cell Component]
           Lipid bilayer
   756   C0025249:Membrane lipid [Cell Component,Lipid]
   754   C1278073:plasma lipid [Laboratory Procedure]
   738   C0023779:Lipid [Lipid]
   738   C0025255:Membrane [Tissue]
   738   C0032105:Plasma [Body Substance]
   738   C0205102:Inner [Spatial Concept]
   738   C0443288:Restricted [Functional Concept]
   738   C0596901:Membrane [Cell Component]
   738   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   738   C1706182:Membrane [Manufactured Object]
   738   C1708664:Leaflet [Manufactured Object]
   738   C3273178:Leaflet [Intellectual Product]

Phrase: "but"

Phrase: "is"

Phrase: "selectively"

Phrase: "exposed on the surface of cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   822   C0699040:Surface of cell [Cell Component]
           Cell surface
   753   C0007634:Cells [Cell]
   753   C0205148:Surface [Spatial Concept]
   753   C0332157:Exposed [Clinical Attribute]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "they"

Phrase: "undergo"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.197: Arthritic paws of mice treated with methotrexate (MTX) showed a significantly higher fluorescence intensity than arthritic paws of untreated mice and non-arthritic paws of MTX-treated mice. 

Phrase: "Arthritic paws of mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0687080:paws [Body Part, Organ, or Organ Component]

Phrase: "treated with methotrexate (MTX)"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0025677:Methotrexate [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a significantly higher fluorescence intensity than arthritic paws of untreated mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0016315:Fluorescence [Natural Phenomenon or Process]
   738   C0522510:Intensity [Qualitative Concept]

Phrase: "and"

Phrase: "non-arthritic paws of MTX-treated mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0687080:paws [Body Part, Organ, or Organ Component]
Processing 00000000.tx.198: Thus, monitoring the uptake of fluorescence-labelled annexin V in arthritic paws by fluorescence imaging may provide a method of assessing the treatment response to antirheumatic drugs such as MTX, a response which was readily quantitated with simple instrumentation and which occurred before conventional measurements of the treatment response [35]. 

Phrase: "Thus,"

Phrase: "monitoring"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0150369:Monitoring [Health Care Activity]
  1000   C1516647:monitoring [Research Activity]
   966 E C0030695:monitor [Health Care Activity]
   966 E C0181904:Monitor [Medical Device]
   966 E C0596972:Monitor [Medical Device]
   966 E C1521743:Monitor [Professional or Occupational Group]
   966 E C1704646:Monitor [Manufactured Object]

Phrase: "the uptake of fluorescence-labelled annexin V"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]

Phrase: "in arthritic paws"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0687080:paws [Body Part, Organ, or Organ Component]

Phrase: "by fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a method of assessing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025663:Method [Intellectual Product]
   770   C0449851:Method [Functional Concept]
   770   C0871511:METHOD [Intellectual Product]

Phrase: "the treatment response to antirheumatic drugs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   820   C0521982:Response to treatment [Clinical Attribute]
   809   C0683154:response to drug [Organism Function]
           drugs response
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "such as MTX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025677:Methotrexate [Organic Chemical,Pharmacologic Substance]

Phrase: "a response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "which"

Phrase: "was"

Phrase: "readily"

Phrase: "quantitated with simple instrumentation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021632:instrumentation [Qualitative Concept]
   770   C0205352:Simple [Qualitative Concept]
   770   C0348000:Instrumentation [Medical Device]
   770   C1704339:Instrumentation [Quantitative Concept]

Phrase: "and"

Phrase: "which"

Phrase: "occurred before conventional measurements of the treatment response"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   767   C2945704:Conventional Treatment [Therapeutic or Preventive Procedure]
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C0242485:measurements [Functional Concept]
   744   C0439858:Conventional [Qualitative Concept]
   744   C0871261:Response [Organism Attribute]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1704632:Response [Finding]
   744   C1705169:Treatment [Conceptual Entity]
   744   C1706817:Response [Intellectual Product]
   744   C1709305:Occurred [Activity]
   744   C2911692:Response [Mental Process]
   744   C3538994:TREATMENT [Research Activity]
   711 E C2745955:OCCUR [Temporal Concept]

Phrase: "[35"

Phrase: "]."
Processing 00000000.tx.199: In another approach, we used an enzyme-activatable near-infrared fluorescence imaging agent and fluorescence reflectance imaging to image protease activity for the non-invasive monitoring of the treatment response. 

Phrase: "In another approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an enzyme-activatable near-infrared fluorescence imaging agent"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   893   C0360722:Enzyme agent [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   818   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   795   C0450442:Agent [Chemical Viewed Functionally]
   795   C1254351:Agent [Pharmacologic Substance]
   795   C1521826:Agent [Intellectual Product]

Phrase: "and"

Phrase: "fluorescence reflectance"

Phrase: "imaging to image protease activity"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C1150095:protease activity [Molecular Function]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0079595:Imaging [Diagnostic Procedure]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
   760   C1947941:Protease [Enzyme]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "for the non-invasive monitoring"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0150369:Monitoring [Health Care Activity]
   827   C1516647:monitoring [Research Activity]
   734   C0205303:Non-invasive [Functional Concept]

Phrase: "of the treatment response."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]
Processing 00000000.tx.200: Since matrix-degrading proteases such as cathepsins and MMPs are key players in joint destruction, we hypothesized that these enzymes would be suitable targets to visualize treatment effects in vivo. 

Phrase: "Since"

Phrase: "matrix-degrading proteases such as cathepsins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C1947941:Proteases [Enzyme]

Phrase: "and"

Phrase: "MMPs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "are"

Phrase: "key players in joint destruction,"

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "these enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "would"

Phrase: "be"

Phrase: "suitable targets to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521840:Target [Functional Concept]
   793   C2986546:TARGET [Diagnostic Procedure]

Phrase: "visualize"

Phrase: "treatment effects"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   966   C1518681:Treatment Effect [Finding]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1280500:effects [Qualitative Concept]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.201: To test this principle, we used an imaging agent consisting of multiple Cy5.5 fluorochromes bound to a graft copolymer backbone of polylysine. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this principle,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an imaging agent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   861   C0450442:Agent [Chemical Viewed Functionally]
   861   C1254351:Agent [Pharmacologic Substance]
   861   C1521826:Agent [Intellectual Product]

Phrase: "consisting of multiple Cy5.5 fluorochromes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   753   C0016342:Fluorochromes [Indicator, Reagent, or Diagnostic Aid]
   753   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0439064:Multiple [Quantitative Concept]
   719 E C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]
   719   C0332529:CONSIST [Qualitative Concept]

Phrase: "bound to a graft copolymer backbone of polylysine."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   744   C0032518:Polylysine [Amino Acid, Peptide, or Protein]
   744   C0037949:Backbone [Body Part, Organ, or Organ Component]
   744   C0181074:{Graft} [Biomedical or Dental Material]
   744   C0332297:bound [Spatial Concept]
   744   C0332835:Graft [Tissue]
   744   C0596383:Copolymer [Chemical Viewed Structurally]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1267072:Backbone [Body Part, Organ, or Organ Component]
   744   C1689898:% bound [Quantitative Concept]
   744   C1961139:Graft, NOS [Therapeutic or Preventive Procedure]
   744   C2349209:Bound [Conceptual Entity]
Processing 00000000.tx.202: Due to interactions between the fluorochromes, fluorescence quenching occurs. 

Phrase: "Due to interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1704675:Interaction [Functional Concept]

Phrase: "between the fluorochromes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016342:Fluorochromes [Indicator, Reagent, or Diagnostic Aid]
   966 E C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]

Phrase: "fluorescence quenching"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "occurs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.203: Therefore, the probe is relatively non-detectable in its native injected state. 

Phrase: "Therefore,"

Phrase: "the probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "is"

Phrase: "relatively non-detectable in its native injected state."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1518422:Non [Functional Concept]
Processing 00000000.tx.204: Enzymatic cleavage of the backbone in vivo by enzymes such as cathepsin B releases Cy5.5 and results in a significant increase in fluorescence (activation). 

Phrase: "Enzymatic cleavage of the backbone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "in vivo by enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "such as cathepsin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "releases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "Cy5.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0388267:CY5.5 [Organic Chemical,Pharmacologic Substance]
   861   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "results in a significant increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0237881:significant [Quantitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   760   C2825142:Result [Finding]

Phrase: "in fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: ")."
Processing 00000000.tx.205: After intravenous injection of the imaging probe, arthritic toes and paws showed a high fluorescence intensity. 

Phrase: "After intravenous injection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0021494:Intravenous injection [Functional Concept]
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0348016:Intravenous [Spatial Concept]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "of the imaging probe,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   861   C0182400:Probe [Medical Device]
   861   C1704681:Probe [Gene or Genome]
   861   C2347609:Probe [Chemical Viewed Functionally]
   861   C3536729:Probe [Manufactured Object]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: "arthritic toes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040357:Toes [Body Part, Organ, or Organ Component]
   827 E C1281589:Toe [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "paws"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0687080:paws [Body Part, Organ, or Organ Component]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a high fluorescence intensity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   827   C0522510:Intensity [Qualitative Concept]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.206: In MTX-treated animals, a significantly lower fluorescence signal was observed (Fig. 5). 

Phrase: "In MTX-treated animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "a significantly lower fluorescence signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.207: Using this experimental strategy, we could demonstrate not only that enzyme-activatable imaging probes can be used to visualize protease activity in vivo, but also that the reduction in activity following MTX therapy can be used to monitor the response to treatment [36]. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this experimental strategy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategy [Mental Process]

Phrase: "we"

Phrase: "could"

Phrase: "demonstrate"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "that enzyme-activatable imaging probes"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   812   C0011923:Imaging [Diagnostic Procedure]
   812   C0079595:Imaging [Diagnostic Procedure]
   812   C0182400:Probes [Medical Device]
   779 E C1704254:Image [Intellectual Product]
   779 E C1704681:Probe [Gene or Genome]
   779 E C1704922:Image [Entity]
   779 E C2347609:Probe [Chemical Viewed Functionally]
   779 E C3536729:Probe [Manufactured Object]
   779 E C3542466:Image [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "visualize"

Phrase: "protease activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150095:protease activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "but"

Phrase: "also"

Phrase: "that"

Phrase: "the reduction in activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C2267000:Reduction Activity [Molecular Function]
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "MTX therapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039798:therapy [Functional Concept]
   861   C0087111:Therapy [Therapeutic or Preventive Procedure]
   861   C1363945:Therapy [Finding]

Phrase: "can"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "the response to treatment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   909   C0521982:Response to treatment [Clinical Attribute]
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "[36"

Phrase: "]."
Processing 00000000.tx.208: View larger version (69K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(69K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.209: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.210: Fluorescence reflectance imaging of protease activity for monitoring treatment response in arthritis non-invasively. 

Phrase: "Fluorescence reflectance"

Phrase: "imaging of protease activity"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C1150095:protease activity [Molecular Function]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   770   C1947941:Protease [Enzyme]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: "for monitoring treatment response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "in arthritis non-invasively."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003864:Arthritis [Disease or Syndrome]
   734 E C0018099:Gout [Disease or Syndrome]
Processing 00000000.tx.211: Colour-coded near-infrared fluorescence images are superimposed on white light images of untreated (A) and MTX-treated (B) DBA/1 mice with collagen-induced arthritis (CIA) affecting the right hind paw (left) or toes (right; red arrowheads) 24 h after injection of a smart imaging probe that is activated by proteases such as cathepsin B. 

Phrase: "Colour-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0009393:Color [Natural Phenomenon or Process]
  1000   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
  1000   C1705245:Color [Pharmacologic Substance]
   928 E C0522507:colored [Qualitative Concept]

Phrase: "coded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0009219:code [Occupational Activity]
   966   C0805701:Code [Intellectual Product]

Phrase: "near-infrared fluorescence images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1704254:Image [Intellectual Product]
   779   C1704922:Image [Entity]
   779   C3542466:Image [Intellectual Product]

Phrase: "are"

Phrase: "superimposed on white light images of untreated"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0563228:White light [Natural Phenomenon or Process]
   748   C0007457:White [Population Group]
   748   C0023693:Light [Natural Phenomenon or Process]
   748   C0043157:White [Population Group]
   748   C0220938:White [Qualitative Concept]
   748   C0332155:untreated [Finding]
   748   C1306462:Light [Functional Concept]
   748   C1881376:Light [Qualitative Concept]
   714   C1704254:Image [Intellectual Product]
   714   C1704922:Image [Entity]
   714   C3542466:Image [Intellectual Product]

Phrase: "(A)"

Phrase: "and"

Phrase: "MTX-treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332293:treated [Therapeutic or Preventive Procedure]
   861   C1522326:Treated [Functional Concept]
   827 E C1292734:TREAT [Functional Concept]

Phrase: "(B) DBA/1 mice with collagen-induced arthritis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   789   C1511646:DBA/1 Mouse [Mammal]
   767   C0025923:Mice, DBA [Mammal]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]

Phrase: "(CIA"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0971858:Arthritis, Collagen-Induced [Experimental Model of Disease]
           Collagen Arthritis
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0205263:Induced [Functional Concept]
   827   C1167364:collagen [Cell Component]
   755 E C0439689:Collagenous [Qualitative Concept]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: ")"

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the right hind paw"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0230459:Hindpaw, NOS [Body Location or Region]
   827   C0687080:Paw [Body Part, Organ, or Organ Component]
   827   C2983612:Hind [Spatial Concept]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "toes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040357:Toes [Body Part, Organ, or Organ Component]
   966 E C1281589:Toe [Body Part, Organ, or Organ Component]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: "; red arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1080898:Arrowheads [Plant]
   827 E C0453107:Arrowhead [Food]

Phrase: ")"

Phrase: "24 h after injection of a smart imaging probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0033727:H+ [Element, Ion, or Isotope]
   742   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441932:H+ [Classification]
   742   C0564385:/h [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "activated by proteases"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C1879547:Activated [Activity]
   790   C1947941:Proteases [Enzyme]
   756 E C1515877:Activate [Functional Concept]

Phrase: "such as cathepsin B."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.212: MTX reduced fluorescence intensity from arthritic toes and paws compared with untreated mice. 

Phrase: "MTX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025677:Methotrexate [Organic Chemical,Pharmacologic Substance]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "fluorescence intensity from arthritic toes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "and"

Phrase: "paws"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0687080:paws [Body Part, Organ, or Organ Component]

Phrase: "compared with untreated mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0332155:untreated [Finding]
   770   C1707455:Compared [Activity]
Processing 00000000.tx.213: The time course of fluorescence intensities in arthritic and non-arthritic toes and paws of mice after probe injection is shown in panel C. 

Phrase: "The time course of fluorescence intensities"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0449247:Time course [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0750729:Course [Temporal Concept]
   753   C3541383:Time [Temporal Concept]

Phrase: "in arthritic"

Phrase: "and"

Phrase: "non-arthritic toes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0040357:Toes [Body Part, Organ, or Organ Component]
   793 E C1281589:Toe [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "paws of mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0687080:paws [Body Part, Organ, or Organ Component]

Phrase: "after probe injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "is"

Phrase: "shown in panel C."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441833:Panel [Idea or Concept]
   770   C1999270:Panel [Intellectual Product]
   770   C3537156:Panel [Manufactured Object]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.214: Values are expressed as relative fluorescence intensity (RFI; mean  S.E.M.). 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "expressed as relative fluorescence intensity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C0522510:Intensity [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "(RFI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1424884:RFI [Gene or Genome]
  1000   C1882541:RFI [Event]

Phrase: "; mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.215: MTX treatment decreased fluorescence significantly 12 and 24 h after injection (P<0.001). 

Phrase: "MTX treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0746573:methotrexate treatment [Therapeutic or Preventive Procedure]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "fluorescence significantly 12"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "24 h after injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.216: At 6 h, the level of significance was P<0.001 for toes and P = 0.01 for paws. 

Phrase: "At 6 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the level of significance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0814896:Significance Level [Research Activity]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "P<0.001 for toes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0040357:Toes [Body Part, Organ, or Organ Component]
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C2603361:P' [Clinical Attribute]
   726 E C1281589:Toe [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "P = 0.01 for paws."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0687080:paws [Body Part, Organ, or Organ Component]
   760   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.217: Inflamed toes of arthritic mice showed a 5-fold higher RFI than toes of healthy mice (paws, 7-fold) at 24 h (P<0.001). 

Phrase: "Inflamed toes of arthritic mice"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0040357:Toes [Body Part, Organ, or Organ Component]
   726 E C1281589:Toe [Body Part, Organ, or Organ Component]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a 5-fold higher RFI than toes of healthy mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1424884:RFI [Gene or Genome]
   739   C1882541:RFI [Event]

Phrase: "(paws,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0687080:paws [Body Part, Organ, or Organ Component]

Phrase: "7-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "at 24 h (P<0.001"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0033727:H+ [Element, Ion, or Isotope]
   804   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441932:H+ [Classification]
   804   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.218: Adapted from [36].   

Phrase: "Adapted from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2937289:adapted [Organic Chemical]

Phrase: "[36"

Phrase: "]."
Processing 00000000.tx.219: Outlook Top Abstract Background Development of novel molecular... 

Phrase: "Outlook Top Abstract Background Development of novel molecular..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0243107:development [Physiologic Function]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]
Processing 00000000.tx.220: Imaging modalities Recent advances in molecular... 

Phrase: "Imaging modalities Recent advances in molecular..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0725066:Advance [Medical Device]
Processing 00000000.tx.221: Molecular imaging in RA Outlook References  Parallel to our continuously increasing knowledge of molecular actions and interactions within the arthritic joint and its cellular and subcellular components, the various imaging techniques that have been developed in recent years will not only allow better identification, visualization and quantitation of key processes of the disease but most likely will also provide substantially improved capabilities for early diagnosis of RA, monitoring of treatment efficacy and more effective therapies.  

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "imaging in RA Outlook References"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   790   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   790   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   753   C0003864:Arthritis [Disease or Syndrome]
   753   C0004271:Outlook [Mental Process]
   753   C0011923:Imaging [Diagnostic Procedure]
   753   C0079595:Imaging [Diagnostic Procedure]
   750   C3645598:Image reference [Intellectual Product]
   719   C1514811:Reference [Idea or Concept]
   719 E C1704254:Image [Intellectual Product]
   719 E C1704922:Image [Entity]
   719   C1706462:Reference [Conceptual Entity]
   719 E C3542466:Image [Intellectual Product]

Phrase: "Parallel to our continuously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C2348042:Parallel [Qualitative Concept]
   770   C2826345:PARALLEL [Research Activity]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "knowledge of molecular actions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0376554:Knowledge [Intellectual Product]

Phrase: "and"

Phrase: "interactions within the arthritic joint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "its cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007634:Cellular [Cell]
  1000   C0178539:Cellular [Functional Concept]
   928 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "subcellular components,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "the various imaging techniques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0079595:Imaging Techniques [Diagnostic Procedure]
   827   C0025664:techniques [Intellectual Product]
   827   C0449851:Techniques [Functional Concept]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "developed in recent years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332185:Recent [Temporal Concept]
   770   C0439234:years [Temporal Concept]
   737 E C0439508:/year [Temporal Concept]

Phrase: "will"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "better identification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020792:Identification [Mental Process]
   861   C0205396:Identification [Qualitative Concept]

Phrase: "visualization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175631:Visualization [Mental Process]
  1000   C2827662:Visualization [Occupation or Discipline]

Phrase: "and"

Phrase: "quantitation of key processes of the disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709793:Quantitation [Quantitative Concept]

Phrase: "but"

Phrase: "most likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0750501:most likely [Idea or Concept]
   861   C0205393:Most [Quantitative Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "will"

Phrase: "also"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "substantially improved capabilities for early diagnosis of RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C2698977:Capability [Qualitative Concept]

Phrase: "monitoring of treatment efficacy"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   833   C0087113:Treatment Efficacy [Qualitative Concept]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0150369:Monitoring [Health Care Activity]
   770   C1280519:Efficacy [Qualitative Concept]
   770   C1516647:monitoring [Research Activity]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C1707887:EFFICACY [Research Activity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0030695:monitor [Health Care Activity]
   737 E C0181904:Monitor [Medical Device]
   737 E C0596972:Monitor [Medical Device]
   737 E C1521743:Monitor [Professional or Occupational Group]
   737 E C1704646:Monitor [Manufactured Object]

Phrase: "and"

Phrase: "more effective therapies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0087111:therapies [Therapeutic or Preventive Procedure]
   793 E C0039798:therapy [Functional Concept]
   793 E C1363945:Therapy [Finding]
Processing 00000000.tx.222: Acknowledgments  The authors are indebted to Dr I. 

Phrase: "Acknowledgments"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "are"

Phrase: "indebted to Dr I."
Processing 00000000.tx.223: Tarner, Division of Rheumatology and Clinical Immunology, Department of Internal Medicine I, University of Regensburg, Germany for providing Figure 3 and Prof. 

Phrase: "Tarner,"

Phrase: "Division of Rheumatology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: "and"

Phrase: "Clinical Immunology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1319413:Clinical immunology [Biomedical Occupation or Discipline]
   861   C0152036:Immunology [Biomedical Occupation or Discipline]
   861   C1522005:immunology [Qualitative Concept]
   789 E C0205470:Immunological [Functional Concept]

Phrase: "Department of Internal Medicine I,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "University of Regensburg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Germany for providing Figure 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017480:Germany [Geographic Area]

Phrase: "and"

Phrase: "Prof."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599518:Prof. [Professional or Occupational Group]
Processing 00000000.tx.224: Dr U. 

Phrase: "Dr U."
Processing 00000000.tx.225: Bogdahn, Department of Neurology, University of Regensburg, Germany for his backing. 

Phrase: "Bogdahn,"

Phrase: "Department of Neurology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587475:Neurology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "University of Regensburg,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Germany for his backing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017480:Germany [Geographic Area]
Processing 00000000.tx.226: The work was supported by a grant of the German Research Society (DFG Mu 1383/34). 

Phrase: "The work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by a grant of the German Research Society"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C1568415:Support of Research [Intellectual Product]
   762   C0035176:research supported [Quantitative Concept]
   762   C0260206:research grant [Research Activity]
   742   C0018173:Grant [Quantitative Concept]
   742   C0035168:research [Research Activity]
   742   C0037455:society [Organization]
   742   C0242481:Research [Research Activity]
   742   C1521721:Supported [Conceptual Entity]
   742   C1548284:Grant [Idea or Concept]
   742   C1556085:German [Population Group]
   708 E C0183683:Support [Medical Device]

Phrase: "(DFG Mu 1383/34"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0347978:Mu [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.227: The authors have declared no conflicts of interest.  

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "have"

Phrase: "declared"

Phrase: "no conflicts of interest."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0079152:Conflict of Interest [Idea or Concept]
           conflicts interest
   827   C0009671:Conflicts [Individual Behavior]
   827   C0543488:Interest [Mental Process]
   793 E C1705242:Conflict [Qualitative Concept]
Processing 00000000.tx.228: References Top Abstract Background Development of novel molecular... 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Background Development of novel molecular..."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
Processing 00000000.tx.229: Imaging modalities Recent advances in molecular... 

Phrase: "Imaging modalities Recent advances in molecular..."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0725066:Advance [Medical Device]
Processing 00000000.tx.230: Molecular imaging in RA Outlook References  Taylor PC. 

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "imaging in RA Outlook"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   806   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   760   C0003864:Arthritis [Disease or Syndrome]
   760   C0004271:Outlook [Mental Process]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0079595:Imaging [Diagnostic Procedure]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Taylor PC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]
Processing 00000000.tx.231: The value of sensitive imaging modalities in rheumatoid arthritis. 

Phrase: "The value of sensitive imaging modalities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522609:Value [Quantitative Concept]

Phrase: "in rheumatoid arthritis."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]
Processing 00000000.tx.232: Arthritis Res Ther 2003;5:2103.[CrossRef][ISI][Medline] Peterfy CG. 

Phrase: "Arthritis Res Ther 2003"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0003864:Arthritis [Disease or Syndrome]
   812   C2347379:RES [Finding]
   719 E C0018099:Gout [Disease or Syndrome]

Phrase: ";5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "2103."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Peterfy CG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]
Processing 00000000.tx.233: New developments in imaging in rheumatoid arthritis. 

Phrase: "New developments in"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0243107:development [Physiologic Function]
   756   C0678723:Development [Organism Function]
   756   C1527148:Development [Functional Concept]
   706 E C0458003:Developmental [Qualitative Concept]

Phrase: "imaging in rheumatoid arthritis."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   833   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   770   C0003864:Arthritis [Disease or Syndrome]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.234: Curr Opin Rheumatol 2003;15:28895.[CrossRef][ISI][Medline] Hoving JL, Buchbinder R, Hall S et al. 

Phrase: "Curr Opin Rheumatol 2003"

Phrase: ";15"

Phrase: ":"

Phrase: "28895."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hoving JL,"

Phrase: "Buchbinder R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hall S et al."
Processing 00000000.tx.235: A comparison of magnetic resonance imaging, sonography, and radiography of the hand in patients with early rheumatoid arthritis. 

Phrase: "A comparison of magnetic resonance imaging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "sonography,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0041618:sonography [Diagnostic Procedure]
   944 E C0175676:ultrasonography [Diagnostic Procedure]

Phrase: "and"

Phrase: "radiography of the hand"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C0203244:Radiography of hand [Diagnostic Procedure]
   770   C0034571:radiography [Functional Concept]
   770   C0043299:radiography [Diagnostic Procedure]
   770   C1962945:Radiography [Diagnostic Procedure]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with early rheumatoid arthritis."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   901   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   827   C0003864:Arthritis [Disease or Syndrome]
   734 E C0018099:Gout [Disease or Syndrome]
Processing 00000000.tx.236: J Rheumatol 2004;31:66375.[ISI][Medline] Weissleder R, Mahmood U. 

Phrase: "J Rheumatol 2004"

Phrase: ";31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ":"

Phrase: "66375."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weissleder R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Mahmood U."
Processing 00000000.tx.237: Molecular imaging. 

Phrase: "Molecular imaging."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1537028:Molecular Imaging [Diagnostic Procedure]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.238: Radiology 2001;219:31633.[Abstract/Free FullText] Massoud TF, Gambhir SS. 

Phrase: "Radiology 2001"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0034599:Radiology [Biomedical Occupation or Discipline]
   861   C0043299:radiology [Diagnostic Procedure]
   861   C0807679:Radiology [Diagnostic Procedure]
   861   C1962945:Radiology [Diagnostic Procedure]
   789 E C0205483:Radiologic [Functional Concept]

Phrase: ";219"

Phrase: ":"

Phrase: "31633."

Phrase: "[Abstract/Free FullText"

Phrase: "] Massoud TF,"

Phrase: "Gambhir SS."
Processing 00000000.tx.239: Molecular imaging in living subjects: seeing fundamental biological processes in a new light. 

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "imaging in living subjects"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   816   C1552741:living subject [Idea or Concept]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0376558:Living [Idea or Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
   737 E C3542466:Image [Intellectual Product]

Phrase: ":"

Phrase: "seeing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042789:seeing [Organism Function]
  1000   C0871317:Seeing [Mammal]
   966 E C1947903:See [Activity]

Phrase: "fundamental biological processes in a new light."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0031845:Biological Processes [Physiologic Function]
   714   C1184743:Process [Body Part, Organ, or Organ Component]
   714   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.240: Genes Dev 2003;17:54580.[Free FullText] Herschman HR. 

Phrase: "Genes Dev 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: ";17"

Phrase: ":"

Phrase: "54580."

Phrase: "[Free FullText"

Phrase: "] Herschman HR."
Processing 00000000.tx.241: Molecular imaging: looking at problems, seeing solutions. 

Phrase: "Molecular imaging"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1537028:Molecular Imaging [Diagnostic Procedure]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: ":"

Phrase: "looking at problems,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1546466:Problems [Idea or Concept]
   756 E C0033213:Problem [Finding]
   756   C0233426:look [Organism Attribute]

Phrase: "seeing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042789:seeing [Organism Function]
  1000   C0871317:Seeing [Mammal]
   966 E C1947903:See [Activity]

Phrase: "solutions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.242: Science 2003;302:6058.[Abstract/Free FullText] Wunder A, Grimm J, Mller-Ladner U. 

Phrase: "Science 2003"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ";302"

Phrase: ":"

Phrase: "6058."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wunder A,"

Phrase: "Grimm J,"

Phrase: "Mller-Ladner U."
Processing 00000000.tx.243: Molecular imaging in rheumatoid arthritis. 

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "imaging in rheumatoid arthritis."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   833   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   770   C0003864:Arthritis [Disease or Syndrome]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.244: Z Rheumatol 2003;62:II336.[Medline] Biswal S. 

Phrase: "Z Rheumatol 2003"

Phrase: ";62"

Phrase: ":"

Phrase: "II336."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Biswal S."
Processing 00000000.tx.245: Molecular imaging of musculoskeletal diseases. 

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "imaging of musculoskeletal diseases."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0026857:Musculoskeletal Diseases [Disease or Syndrome]
   819   C1536986:musculoskeletal imaging [Diagnostic Procedure]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0012634:Diseases [Disease or Syndrome]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0497254:Musculoskeletal [Functional Concept]
   770   C2707260:Musculoskeletal [Clinical Attribute]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.246: Semin Musculoskelet Radiol 2003;7:31750.[CrossRef][Medline] Weissleder R. 

Phrase: "Semin Musculoskelet Radiol 2003"

Phrase: ";7"

Phrase: ":"

Phrase: "31750."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weissleder R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.247: Scaling down imaging: molecular mapping of cancer in mice. 

Phrase: "Scaling down imaging"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0237849:Scaling [Finding]
   790   C0392757:Scaling [Educational Activity]
   790   C1947916:Scaling [Activity]

Phrase: ":"

Phrase: "molecular mapping of cancer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1283195:Mapping [Activity]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.248: Nat Rev Cancer 2002;2:118.[CrossRef][ISI][Medline] Cherry SR. 

Phrase: "Nat Rev Cancer 2002"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0006826:Cancer [Neoplastic Process]
   812   C0998265:Cancer [Eukaryote]
   812   C1306459:Cancer [Finding]
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ";2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "118."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cherry SR."
Processing 00000000.tx.249: In vivo molecular and genomic imaging: new challenges for imaging physics. 

Phrase: "In vivo molecular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1521991:Molecular [Qualitative Concept]
   755 E C0567416:Molecule [Substance]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "and"

Phrase: "genomic imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: ":"

Phrase: "new challenges for imaging physics."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0805586:challenges [Health Care Activity]
   726 E C0798503:Challenge [Clinical Attribute]
   726 E C3274764:Challenge [Conceptual Entity]
Processing 00000000.tx.250: Phys Med Biol 2004;49:R1348.[CrossRef][ISI][Medline] Weissleder R, Ntziachristos V. 

Phrase: "Phys Med Biol 2004"

Phrase: ";49"

Phrase: ":"

Phrase: "R1348."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Weissleder R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Ntziachristos V."
Processing 00000000.tx.251: Shedding light onto live molecular targets. 

Phrase: "Shedding light onto live molecular targets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0023693:Light [Natural Phenomenon or Process]
   753   C1306462:Light [Functional Concept]
   753   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.252: Nat Med 2003;9:1238.[CrossRef][Medline] Dayton PA, Ferrara KW. 

Phrase: "Nat Med 2003"

Phrase: ";9"

Phrase: ":"

Phrase: "1238."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dayton PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Ferrara KW."
Processing 00000000.tx.253: Targeted imaging using ultrasound. 

Phrase: "Targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ultrasound."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041618:Ultrasound [Diagnostic Procedure]
  1000   C0041621:ultrasound [Natural Phenomenon or Process]
  1000   C0220934:ultrasound [Functional Concept]
  1000   C1456803:Ultrasound [Natural Phenomenon or Process]
  1000   C1875843:ULTRASOUND [Medical Device]
Processing 00000000.tx.254: J Magn Reson Imaging 2002;16:36277.[CrossRef][ISI][Medline] Lindner JR. 

Phrase: "J Magn Reson"

Phrase: "Imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "2002"

Phrase: ";16"

Phrase: ":"

Phrase: "36277."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lindner JR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.255: Molecular imaging with contrast ultrasound and targeted microbubbles. 

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "imaging with contrast ultrasound"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   819   C0041618:Ultrasound Imaging [Diagnostic Procedure]
           Ultrasound
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0041621:ultrasound [Natural Phenomenon or Process]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0220934:ultrasound [Functional Concept]
   770   C1456803:Ultrasound [Natural Phenomenon or Process]
   770   C1875843:ULTRASOUND [Medical Device]
   770   C1979874:Contrast [Qualitative Concept]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "targeted microbubbles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1258018:Microbubbles [Medical Device]
Processing 00000000.tx.256: J Nucl Cardiol 2004;11:21521.[CrossRef][ISI][Medline] Aime S, Cabella C, Colombatto S, Geninatti Crich S, Gianolio E, Maggioni F. 

Phrase: "J Nucl Cardiol 2004"

Phrase: ";11"

Phrase: ":"

Phrase: "21521."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Aime S,"

Phrase: "Cabella C,"

Phrase: "Colombatto S,"

Phrase: "Geninatti Crich S,"

Phrase: "Gianolio E,"

Phrase: "Maggioni F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.257: Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations. 

Phrase: "Insights into the use of paramagnetic Gd(III"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:insights [Mental Process]

Phrase: ")"

Phrase: "complexes in MR-molecular imaging investigations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1704241:Complexes [Chemical Viewed Structurally]
   719 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.258: J Magn Reson Imaging 2002;16:394406.[CrossRef][ISI][Medline] Artemov D. 

Phrase: "J Magn Reson"

Phrase: "Imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "2002"

Phrase: ";16"

Phrase: ":"

Phrase: "394406."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Artemov D."
Processing 00000000.tx.259: Molecular magnetic resonance imaging with targeted contrast agents. 

Phrase: "Molecular magnetic resonance imaging with targeted contrast agents."
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   855   C0202671:Magnetic resonance imaging with contrast [Diagnostic Procedure]
   800   C0024485:Magnetic Resonance Imaging [Diagnostic Procedure]
   800   C1552358:Magnetic Resonance Imaging [Professional or Occupational Group]
   770   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   770   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   770   C1551403:Magnetic resonance [Laboratory Procedure]
   767   C1537028:Molecular Imaging [Diagnostic Procedure]
   750   C1512628:Imaging Agent [Indicator, Reagent, or Diagnostic Aid]
   744   C0011923:Imaging [Diagnostic Procedure]
   744   C0024488:Magnetic [Occupation or Discipline]
   744   C0079595:Imaging [Diagnostic Procedure]
   744   C0231881:Resonance [Finding]
   744   C0459800:resonance [Natural Phenomenon or Process]
   744   C0563532:magnetic [Natural Phenomenon or Process]
   744   C0684213:Resonance [Qualitative Concept]
   711 E C1704254:Image [Intellectual Product]
   711 E C1704922:Image [Entity]
   711 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.260: J Cell Biochem 2003;90:51824.[CrossRef][ISI][Medline] Blankenberg FG, Strauss HW. 

Phrase: "J Cell Biochem 2003"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ";90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "51824."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Blankenberg FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Strauss HW."
Processing 00000000.tx.261: Nuclear medicine applications in molecular imaging. 

Phrase: "Nuclear medicine applications in molecular imaging."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0185125:applications [Health Care Activity]
   719 E C1947919:Application [Intellectual Product]
   719 E C2347934:Application [Intellectual Product]
   719 E C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.262: J Magn Reson Imaging 2002;16:35261.[CrossRef][ISI][Medline] Hnatowich DJ. 

Phrase: "J Magn Reson"

Phrase: "Imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "2002"

Phrase: ";16"

Phrase: ":"

Phrase: "35261."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hnatowich DJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]
Processing 00000000.tx.263: Observations on the role of nuclear medicine in molecular imaging. 

Phrase: "Observations on the role of nuclear medicine"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0302523:observations [Research Activity]
   748   C0700325:observations [Health Care Activity]
   748   C3244290:observations [Functional Concept]
   714 E C1964257:Observation [Diagnostic Procedure]

Phrase: "in molecular imaging."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1537028:Molecular Imaging [Diagnostic Procedure]
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.264: J Cell Biochem Suppl 2002;39:1824.[Medline] Louie AY, Huber MM, Ahrens ET et al. 

Phrase: "J Cell Biochem Suppl 2002"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ";39"

Phrase: ":"

Phrase: "1824."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Louie AY,"

Phrase: "Huber MM,"

Phrase: "Ahrens ET et al."
Processing 00000000.tx.265: In vivo visualization of gene expression using magnetic resonance imaging. 

Phrase: "In vivo visualization of gene expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0175631:Visualization [Mental Process]
   753   C2827662:Visualization [Occupation or Discipline]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "magnetic resonance imaging."
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0024485:Magnetic Resonance Imaging [Diagnostic Procedure]
  1000   C1552358:Magnetic Resonance Imaging [Professional or Occupational Group]
   901   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0011923:Imaging [Diagnostic Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0079595:Imaging [Diagnostic Procedure]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   793 E C1704254:Image [Intellectual Product]
   793 E C1704922:Image [Entity]
   793 E C3542466:Image [Intellectual Product]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]
Processing 00000000.tx.266: Nat Biotechnol 2000;18:3215.[CrossRef][ISI][Medline] Bogdanov A Jr, Matuszewski L, Bremer C, Petrovsky A, Weissleder R. 

Phrase: "Nat Biotechnol 2000"

Phrase: ";18"

Phrase: ":"

Phrase: "3215."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bogdanov"

Phrase: "A Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Matuszewski L,"

Phrase: "Bremer C,"

Phrase: "Petrovsky A,"

Phrase: "Weissleder R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.267: Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. 

Phrase: "Oligomerization of paramagnetic substrates"

Phrase: "result in signal amplification"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1274040:Result [Functional Concept]
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1546471:Result [Idea or Concept]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]
   770   C1710082:Signal [Phenomenon or Process]
   770   C2825142:Result [Finding]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "used for MR"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   790   C2347167:Mr. [Conceptual Entity]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "imaging of molecular targets."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   819   C1537028:Molecular Imaging [Diagnostic Procedure]
   816   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C1521991:Molecular [Qualitative Concept]
   737   C1521840:Target [Functional Concept]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737   C2986546:TARGET [Diagnostic Procedure]
   737 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.268: Mol Imaging 2002;1:1623.[CrossRef][Medline] Perez JM, Josephson L, O'Loughlin T, Hogemann D, Weissleder R. 

Phrase: "Mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]

Phrase: "Imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "2002"

Phrase: ";1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1623."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Perez JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Josephson L,"

Phrase: "O'Loughlin T,"

Phrase: "Hogemann D,"

Phrase: "Weissleder R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.269: Magnetic relaxation switches capable of sensing molecular interactions. 

Phrase: "Magnetic relaxation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035028:Relaxation [Activity]

Phrase: "switches"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707719:SWITCHES [Manufactured Object]

Phrase: "capable of sensing molecular interactions."
Processing 00000000.tx.270: Nat Biotechnol 2002;20:81620.[ISI][Medline] Barrera P, van der Laken CJ, Boerman OC et al. 

Phrase: "Nat Biotechnol 2002"

Phrase: ";20"

Phrase: ":"

Phrase: "81620."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Barrera P,"

Phrase: "van der Laken CJ,"

Phrase: "Boerman OC et al."
Processing 00000000.tx.271: Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis. 

Phrase: "Radiolabelled interleukin-1 receptor antagonist for detection of synovitis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   818   C1416402:INTERLEUKIN 1 RECEPTOR ANTAGONIST [Gene or Genome]
   818   C1704264:interleukin-1 receptor antagonist [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   818   C3536785:Interleukin-1 Receptor Antagonist [Pharmacologic Substance]
   742   C0231491:Antagonist [Organ or Tissue Function]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with rheumatoid arthritis."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]
Processing 00000000.tx.272: Rheumatology 2000;39:8704.[Abstract/Free FullText] Barrera P, Oyen WJ, Boerman OC, van Riel PL. 

Phrase: "Rheumatology 2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035452:Rheumatology [Biomedical Occupation or Discipline]
   861   C0334889:Rheumatology [Professional or Occupational Group]

Phrase: ";39"

Phrase: ":"

Phrase: "8704."

Phrase: "[Abstract/Free FullText"

Phrase: "] Barrera P,"

Phrase: "Oyen WJ,"

Phrase: "Boerman OC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1412791:OC [Gene or Genome]
   861   C3539565:OC [Gene or Genome]

Phrase: "van Riel PL."
Processing 00000000.tx.273: Scintigraphic detection of tumour necrosis factor in patients with rheumatoid arthritis. 

Phrase: "Scintigraphic detection of tumour necrosis factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with rheumatoid arthritis."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]
Processing 00000000.tx.274: Ann Rheum Dis 2003;62:8258.[Abstract/Free FullText] Gaal J, Mezes A, Siro B et al. 

Phrase: "Ann Rheum Dis 2003"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0035431:Rheum [Plant]
   812   C0451119:DIS [Intellectual Product]
   812   C1444662:DIS [Finding]

Phrase: ";62"

Phrase: ":"

Phrase: "8258."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gaal J,"

Phrase: "Mezes A,"

Phrase: "Siro B et al."
Processing 00000000.tx.275: 99m Tc-HMPAO labelled leukocyte scintigraphy in patients with rheumatoid arthritis: a comparison with disease activity. 

Phrase: "99m Tc-HMPAO"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0145055:99m-Tc-HMPAO [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   827   C0041405:TC [Geographic Area]
   827   C0121638:HMPAO [Organic Chemical]
   827   C1824670:TC [Gene or Genome]
   827   C3272447:TC [Gene or Genome]

Phrase: "labelled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0181496:Label [Manufactured Object]
   966   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "leukocyte scintigraphy in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0948898:Leukocyte scintigraphy [Diagnostic Procedure]
   770   C0034606:Scintigraphy [Diagnostic Procedure]

Phrase: "with rheumatoid arthritis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]

Phrase: ":"

Phrase: "a comparison with disease activity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]
Processing 00000000.tx.276: Nucl Med Commun 2002;23:3946.[CrossRef][ISI][Medline] Zinn KR, Chaudhuri TR, Smyth CA et al. 

Phrase: "Nucl Med Commun 2002"

Phrase: ";23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "3946."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zinn KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "Chaudhuri TR,"

Phrase: "Smyth CA et al."
Processing 00000000.tx.277: Specific targeting of activated endothelium in rat adjuvant arthritis with a 99mTc-radiolabeled E-selectin-binding peptide. 

Phrase: "Specific targeting of activated endothelium"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1521840:Targeting [Functional Concept]
   726 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "in rat adjuvant arthritis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0003865:Adjuvant Arthritis [Experimental Model of Disease]
   827   C0001551:Adjuvant, NOS [Immunologic Factor,Pharmacologic Substance]
   827   C0001552:Adjuvant [Chemical Viewed Functionally]
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C1522673:Adjuvant [Functional Concept]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: "with a 99mTc-radiolabeled E-selectin-binding peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.278: Arthritis Rheum 1999;42:6419.[CrossRef][ISI][Medline] Jamar F, Houssiau FA, Devogelaer JP et al. 

Phrase: "Arthritis Rheum 1999"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0035431:Rheum [Plant]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: ";42"

Phrase: ":"

Phrase: "6419."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jamar F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Houssiau FA,"

Phrase: "Devogelaer JP et al."
Processing 00000000.tx.279: Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis. 

Phrase: "Scintigraphy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034606:Scintigraphy [Diagnostic Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a technetium 99m-labelled anti-E-selectin Fab fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0021031:Fab Fragment [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0332255:fragment [Functional Concept]
   793   C1708096:Fragment [Qualitative Concept]

Phrase: "in rheumatoid arthritis."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]
Processing 00000000.tx.280: Rheumatology 2002;41:5361.[Abstract/Free FullText] Roivainen A, Parkkola R, Yli-Kerttula T et al. 

Phrase: "Rheumatology 2002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035452:Rheumatology [Biomedical Occupation or Discipline]
   861   C0334889:Rheumatology [Professional or Occupational Group]

Phrase: ";41"

Phrase: ":"

Phrase: "5361."

Phrase: "[Abstract/Free FullText"

Phrase: "] Roivainen A,"

Phrase: "Parkkola R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Yli-Kerttula T et al."
Processing 00000000.tx.281: Use of positron emission tomography with methyl-11C-choline and 218F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium. 

Phrase: "Use of positron emission tomography"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "with methyl-11C-choline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008405:Choline [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "218F-fluoro-2-deoxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "D-"

Phrase: "glucose in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "with magnetic resonance imaging"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0024485:Magnetic Resonance Imaging [Diagnostic Procedure]
  1000   C1552358:Magnetic Resonance Imaging [Professional or Occupational Group]
   901   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0011923:Imaging [Diagnostic Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0079595:Imaging [Diagnostic Procedure]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   793 E C1704254:Image [Intellectual Product]
   793 E C1704922:Image [Entity]
   793 E C3542466:Image [Intellectual Product]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]

Phrase: "for the assessment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1261322:Assessment [Health Care Activity]
  1000   C1516048:Assessment [Activity]

Phrase: "of inflammatory proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "of synovium."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0039099:Synovium [Body Part, Organ, or Organ Component]
   928 E C1550315:Synovial [Body Part, Organ, or Organ Component]
   900 E C0039097:Synovia [Body Substance]
Processing 00000000.tx.282: Arthritis Rheum 2003;48:307784.[CrossRef][ISI][Medline] Polisson RP, Schoenberg OI, Fischman A et al. 

Phrase: "Arthritis Rheum 2003"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0035431:Rheum [Plant]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: ";48"

Phrase: ":"

Phrase: "307784."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Polisson RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "Schoenberg OI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029434:OI [Congenital Abnormality,Disease or Syndrome]

Phrase: "Fischman"

Phrase: "A et al."
Processing 00000000.tx.283: Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. 

Phrase: "Use of magnetic resonance imaging"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "positron emission tomography in the assessment of synovial volume"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   742   C0032744:Positron [Quantitative Concept]
   742   C0040395:tomography [Diagnostic Procedure]
   742   C0040405:tomography [Diagnostic Procedure]
   742   C0233929:Emission [Body Substance]
   742   C2349995:Emission [Substance]

Phrase: "and"

Phrase: "glucose metabolism in patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0596620:glucose metabolism [Molecular Function]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]

Phrase: "with rheumatoid arthritis."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]
Processing 00000000.tx.284: Arthritis Rheum 1995;38:81925.[ISI][Medline] Palmer WE, Rosenthal DI, Schoenberg OI et al. 

Phrase: "Arthritis Rheum 1995"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0035431:Rheum [Plant]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: ";38"

Phrase: ":"

Phrase: "81925."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Palmer"

Phrase: "WE,"

Phrase: "Rosenthal DI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3538902:DI [Gene or Genome]
   861   C3541881:DI [Idea or Concept]

Phrase: "Schoenberg OI et al."
Processing 00000000.tx.285: Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. 

Phrase: "Quantification of inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709793:Quantification [Quantitative Concept]

Phrase: "in the wrist"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043262:Wrist [Body Location or Region]
  1000   C1283836:Wrist [Body Location or Region]
  1000   C1322271:Wrist [Body Space or Junction]
   944 E C0007285:carpal [Body Part, Organ, or Organ Component]

Phrase: "with gadolinium-enhanced MR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347167:Mr. [Conceptual Entity]

Phrase: "imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "PET with 2-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   760   C0032744:Positron [Quantitative Concept]
   760   C0040395:tomography [Diagnostic Procedure]
   760   C0040405:tomography [Diagnostic Procedure]
   760   C0233929:Emission [Body Substance]
   760   C2349995:Emission [Substance]

Phrase: "[F-18"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "]-fluoro-2-deoxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "D-"

Phrase: "glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.286: Radiology 1995;196:64755.[Abstract/Free FullText] Beckers C, Ribbens C, Andre B et al. 

Phrase: "Radiology 1995"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0034599:Radiology [Biomedical Occupation or Discipline]
   861   C0043299:radiology [Diagnostic Procedure]
   861   C0807679:Radiology [Diagnostic Procedure]
   861   C1962945:Radiology [Diagnostic Procedure]
   789 E C0205483:Radiologic [Functional Concept]

Phrase: ";196"

Phrase: ":"

Phrase: "64755."

Phrase: "[Abstract/Free FullText"

Phrase: "] Beckers C,"

Phrase: "Ribbens C,"

Phrase: "Andre B et al."
Processing 00000000.tx.287: Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. 

Phrase: "Assessment of disease activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1261322:Assessment [Health Care Activity]
   770   C1516048:Assessment [Activity]

Phrase: "in rheumatoid arthritis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]

Phrase: "with"

Phrase: "(18"

Phrase: ")"

Phrase: "F-FDG PET."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C0872169:fluorodeoxyglucose positron emission tomography [Diagnostic Procedure]
   884   C0032743:Positron-Emission Tomography [Diagnostic Procedure]
   804   C0032744:Positron [Quantitative Concept]
   804   C0040395:tomography [Diagnostic Procedure]
   804   C0040405:tomography [Diagnostic Procedure]
   804   C0233929:Emission [Body Substance]
   804   C0872172:fluorodeoxyglucose [Carbohydrate,Pharmacologic Substance]
   804   C2349995:Emission [Substance]
Processing 00000000.tx.288: J Nucl Med 2004;45:95664.[Abstract/Free FullText] Post AM, Katsikis PD, Tait JF, Geaghan SM, Strauss HW, Blankenberg FG. 

Phrase: "J Nucl Med 2004"

Phrase: ";45"

Phrase: ":"

Phrase: "95664."

Phrase: "[Abstract/Free FullText"

Phrase: "] Post"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0687676:Post [Temporal Concept]
  1000   C1704687:Post [Manufactured Object]
   928 E C1514253:Postal [Functional Concept]

Phrase: "AM"

Phrase: ","

Phrase: "Katsikis PD,"

Phrase: "Tait JF,"

Phrase: "Geaghan SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "Strauss HW,"

Phrase: "Blankenberg FG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]
Processing 00000000.tx.289: Imaging cell death with radiolabeled annexin V in an experimental model of rheumatoid arthritis. 

Phrase: "Imaging cell death with radiolabeled annexin V"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0007587:Cell Death [Cell Function]
   774   C1537000:cell imaging [Diagnostic Procedure]
   748   C0007634:Cell [Cell]
   748   C0011065:Death [Organism Function]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "in an experimental model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086272:Experimental Model [Intellectual Product]
   861   C3161035:Model [Intellectual Product]

Phrase: "of rheumatoid arthritis."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]
Processing 00000000.tx.290: J Nucl Med 2002;43:135965.[Abstract/Free FullText] Hansch A, Frey O, Sauner D et al. 

Phrase: "J Nucl Med 2002"

Phrase: ";43"

Phrase: ":"

Phrase: "135965."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hansch A,"

Phrase: "Frey O,"

Phrase: "Sauner D et al."
Processing 00000000.tx.291: In vivo imaging of experimental arthritis with near-infrared fluorescence. 

Phrase: "In vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "imaging of experimental arthritis"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0993582:Arthritis, Experimental [Experimental Model of Disease]
   770   C0003864:Arthritis [Disease or Syndrome]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: "with near-infrared fluorescence."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.292: Arthritis Rheum 2004;50:9617.[CrossRef][ISI][Medline] Carlsen H, Moskaug JO, Fromm SH, Blomhoff R. 

Phrase: "Arthritis Rheum 2004"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0035431:Rheum [Plant]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: ";50"

Phrase: ":"

Phrase: "9617."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Carlsen H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Moskaug JO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022418:JO [Geographic Area]

Phrase: "Fromm SH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]

Phrase: "Blomhoff R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.293: In vivo imaging of NF-kappa B activity. 

Phrase: "In vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "imaging of NF-kappa B activity."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0079904:NF-kappa B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C2986464:NF-kappa-B [Gene or Genome]
   753   C0011923:Imaging [Diagnostic Procedure]
   753   C0079595:Imaging [Diagnostic Procedure]
   753   C0205177:Activity [Functional Concept]
   753   C0439099:Kappa [Intellectual Product]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
   719 E C1704254:Image [Intellectual Product]
   719 E C1704922:Image [Entity]
   719 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.294: J Immunol 2002;168:14416.[Abstract/Free FullText] Nakajima A, Seroogy CM, Sandora MR et al. 

Phrase: "J Immunol 2002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ";168"

Phrase: ":"

Phrase: "14416."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nakajima A,"

Phrase: "Seroogy CM,"

Phrase: "Sandora MR et al."
Processing 00000000.tx.295: Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. 

Phrase: "Antigen-specific T cell-mediated gene therapy"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   877   C1706821:Antigen Gene [Gene or Genome]
   868   C0545322:T cell therapy [Therapeutic or Preventive Procedure]
   845   C0302189:Cell Therapy [Therapeutic or Preventive Procedure]
   829   C1861886:CELL Gene [Gene or Genome]
   818   C0017296:gene therapy [Therapeutic or Preventive Procedure]
   795   C0017337:Gene [Gene or Genome]
   795   C0039798:therapy [Functional Concept]
   795   C0087111:Therapy [Therapeutic or Preventive Procedure]
   795   C1363945:Therapy [Finding]

Phrase: "in collagen-induced arthritis."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0971858:Arthritis, Collagen-Induced [Experimental Model of Disease]
           Collagen Arthritis
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0205263:Induced [Functional Concept]
   827   C1167364:collagen [Cell Component]
   755 E C0439689:Collagenous [Qualitative Concept]
   734 E C0018099:Gout [Disease or Syndrome]
Processing 00000000.tx.296: J Clin Invest 2001;107:1293301.[Abstract/Free FullText] Tarner IH, Slavin AJ, McBride J et al. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "2001"

Phrase: ";107"

Phrase: ":"

Phrase: "1293301."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tarner IH,"

Phrase: "Slavin AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "McBride J et al."
Processing 00000000.tx.297: Treatment of autoimmune disease by adoptive cellular gene therapy. 

Phrase: "Treatment of autoimmune disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "by adoptive cellular gene therapy."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0079613:adoptive cellular therapy [Therapeutic or Preventive Procedure]
   875   C0302189:CELLULAR THERAPY [Therapeutic or Preventive Procedure]
   861   C0017296:gene therapy [Therapeutic or Preventive Procedure]
   812   C0017337:Gene [Gene or Genome]
   812   C0039798:therapy [Functional Concept]
   812   C0087111:Therapy [Therapeutic or Preventive Procedure]
   812   C1363945:Therapy [Finding]
Processing 00000000.tx.298: Ann N Y Acad Sci 2003;998:5129.[Abstract/Free FullText] Wunder A, Schellenberger E, Mahmood U et al. 

Phrase: "Ann N Y Acad Sci 2003"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0268596:ACAD [Disease or Syndrome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ";998"

Phrase: ":"

Phrase: "5129."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wunder A,"

Phrase: "Schellenberger E,"

Phrase: "Mahmood U et al."
Processing 00000000.tx.299: Methotrexate induced accumulation of fluorescent annexin V in collagen induced arthritis. 

Phrase: "Methotrexate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025677:Methotrexate [Organic Chemical,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "accumulation of fluorescent annexin V"

Phrase: "in collagen induced arthritis."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0971858:Arthritis, Collagen-Induced [Experimental Model of Disease]
           Collagen Arthritis
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0205263:Induced [Functional Concept]
   827   C1167364:collagen [Cell Component]
   755 E C0439689:Collagenous [Qualitative Concept]
   734 E C0018099:Gout [Disease or Syndrome]
Processing 00000000.tx.300: Mol Imaging 2005 (in press). 

Phrase: "Mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]

Phrase: "Imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "2005"

Phrase: "("

Phrase: "in press"

Phrase: ")."
Processing 00000000.tx.301: Wunder A, Tung CH, Muller-Ladner U, Weissleder R, Mahmood U. 

Phrase: "Wunder A,"

Phrase: "Tung CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0558269:Ch. [Professional or Occupational Group]
   861   C1552984:[Ch] [Quantitative Concept]

Phrase: "Muller-Ladner U,"

Phrase: "Weissleder R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Mahmood U."
Processing 00000000.tx.302: In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. 

Phrase: "In vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "imaging of protease activity"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C1150095:protease activity [Molecular Function]
   770   C0011923:Imaging [Diagnostic Procedure]
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0079595:Imaging [Diagnostic Procedure]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   770   C1947941:Protease [Enzyme]
   737 E C1704254:Image [Intellectual Product]
   737 E C1704922:Image [Entity]
   737 E C3542466:Image [Intellectual Product]

Phrase: "in arthritis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003864:Arthritis [Disease or Syndrome]
   907 E C0018099:Gout [Disease or Syndrome]

Phrase: ":"

Phrase: "a novel approach for monitoring treatment response."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.303: Arthritis Rheum 2004;50:245965.[CrossRef][ISI][Medline] Submitted 12 December 2004; 

Phrase: "Arthritis Rheum 2004"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0035431:Rheum [Plant]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: ";50"

Phrase: ":"

Phrase: "245965."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: "12 December 2004"

Phrase: ";"
Processing 00000000.tx.304: revised version accepted 13 May 2005. 

Phrase: "revised version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "13 May 2005."
Processing 00000000.tx.305: This Article Abstract Full Text (PDF) All Versions of this Article: 44/11/1341 most recent keh709v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Disclaimer Request Permissions Google Scholar Articles by Wunder, A. 

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "44/11/1341 most recent keh709v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]
   748   C0205314:New [Temporal Concept]
   714   C0033213:Issue [Finding]
   714   C1706387:Issue [Intellectual Product]

Phrase: "Add to My Personal Archive Download"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003738:archive [Manufactured Object]
   753   C0024552:MY [Geographic Area]
   753   C1519021:Personal [Organism Attribute]
   753   C1554162:Archive [Idea or Concept]
   753   C1883712:Add [Functional Concept]

Phrase: "to citation manager Disclaimer Request Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1706852:Article [Intellectual Product]

Phrase: "by Wunder,"

Phrase: "A."
Processing 00000000.tx.306: Articles by Mller-Ladner, U. 

Phrase: "Articles by Mller-Ladner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1706852:Article [Intellectual Product]

Phrase: "U."
Processing 00000000.tx.307: PubMed PubMed Citation Articles by Wunder, A. 

Phrase: "PubMed PubMed Citation Articles by Wunder,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "A."
Processing 00000000.tx.308: Articles by Mller-Ladner, U. 

Phrase: "Articles by Mller-Ladner,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1706852:Article [Intellectual Product]

Phrase: "U."
Processing 00000000.tx.309: Related Collections Rheumatoid Arthritis Online ISSN 1462-0332 - Print ISSN 1462-0324 Copyright  2006 British Society for Rheumatology Oxford Journals Oxford University Press Site Map Privacy Policy Frequently Asked Questions Other Oxford University Press sites: Oxford University Press American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics

Phrase: "Related Collections Rheumatoid Arthritis Online ISSN 1462-0332 - Print ISSN 1462-0324 Copyright  2006 British Society"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   785   C0037455:society [Organization]

Phrase: "for Rheumatology Oxford Journals Oxford University Press Site Map Privacy Policy Frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   801   C2735290:Privacy policy [Intellectual Product]
   788   C0242456:Policy [Intellectual Product]

Phrase: "Asked"

Phrase: "Questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "Other Oxford University Press sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "Oxford University Press American National Biography Booksellers' Information Service Children's Fiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0887933:fiction [Intellectual Product]

Phrase: "and"

Phrase: "Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary"

Phrase: "of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   852   C0947619:Finger.right [Body Part, Organ, or Organ Component]
   782   C0035621:Rights [Qualitative Concept]
   782   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Permissions Science School Books Social Sciences Very Short Introductions World's Classics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0439658:classics [Qualitative Concept]
   755 E C0439858:Classic [Qualitative Concept]

